Topic: BusinessManagement

Last updated: April 6, 2019

IntroductionDiabetes mellitus is a faction of metabolic illness characterized by high glucose level ensuing from defect in insulin secretion, insulin action, or together. Diabetes mellitus is a wide-reaching unrestricted healthiness quandary that affect on new than 366 million citizens and the number is predictable to go up to 552 million by 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Danaei et al., 2011).

The chronic hyperglycemia of diabetes causes both micro and macrovascular complications and diabetic nephropathy is one of the microvascular complications ADDIN EN.CITE <EndNote><Cite><Author>Cade</Author><Year>2008</Year><RecNum>35</RecNum><DisplayText><style face=”bold”>(Cade, 2008)</style></DisplayText><record><rec-number>35</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>35</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Cade, W. T.</author></authors></contributors><auth-address>Washington University School of Medicine, Campus Box 8502, 4444 Forest Park Blvd, St Louis, MO 63108, USA. [email protected]</auth-address><titles><title>Diabetes-related microvascular and macrovascular diseases in the physical therapy setting</title><secondary-title>Phys Ther</secondary-title><alt-title>Physical therapy</alt-title></titles><periodical><full-title>Phys Ther</full-title><abbr-1>Physical therapy</abbr-1></periodical><alt-periodical><full-title>Phys Ther</full-title><abbr-1>Physical therapy</abbr-1></alt-periodical><pages>1322-35</pages><volume>88</volume><number>11</number><edition>2008/09/20</edition><keywords><keyword>Animals</keyword><keyword>Diabetes Complications/mortality/*physiopathology</keyword><keyword>Exercise Therapy/methods</keyword><keyword>Humans</keyword><keyword>Peripheral Vascular Diseases/*etiology/physiopathology</keyword><keyword>*Physical Therapy Modalities</keyword><keyword>Risk Factors</keyword><keyword>Stroke/*etiology/mortality/physiopathology</keyword><keyword>*Vascular Diseases/etiology/metabolism/physiopathology</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0031-9023</isbn><accession-num>18801863</accession-num><urls></urls><custom2>Pmc2579903</custom2><electronic-resource-num>10.

We Will Write a Custom Essay Specifically
For You For Only $13.90/page!


order now

2522/ptj.20080008</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Cade, 2008). Diabetic nephropathy is a severe and progressive problem happened in diabetic patients and it is connected to an improved danger of all-cause death, cardiovascular disease, and progression of end-stage renal disease, requiring valuable renal surrogate therapy in the shape of dialysis or 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Go et al., 2004;Ninomiya et al., 2009).

Diabetic kidney disease is commonly defined as a get higher through urinary albumin secretion microalbuminuria (30-300mg albumin/gm creatinine) next macroalbuminuria (>300mg albumin/gm creatinine), decline glomerular filtration rate and elevation blood pressure 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Stratton et al., 2000). Even though determined albuminuria is the first sign of diabetic nephropathy, albuminuria has numerous confuse issues such as apply, urinary tract infection, acute disease and cardiac breakdown. Moreover, it has be detected to take place in the urine of non-diabetic individuals, instead of the non-specificity of albuminuria for accurate prophecy of diabetic kidney disease ADDIN EN.CITE <EndNote><Cite><Author>Jain</Author><Year>2005</Year><RecNum>39</RecNum><DisplayText><style face=”bold”>(Jain et al.

, 2005)</style></DisplayText><record><rec-number>39</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>39</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jain, S.</author><author>Rajput, A.</author><author>Kumar, Y.</author><author>Uppuluri, N.</author><author>Arvind, A. S.</author><author>Tatu, U.</author></authors></contributors><auth-address>Department of Biochemistry, Indian Institute of Science, Bangalore 560 012, India.

</auth-address><titles><title>Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder</title><secondary-title>J Assoc Physicians India</secondary-title><alt-title>The Journal of the Association of Physicians of India</alt-title></titles><periodical><full-title>J Assoc Physicians India</full-title><abbr-1>The Journal of the Association of Physicians of India</abbr-1></periodical><alt-periodical><full-title>J Assoc Physicians India</full-title><abbr-1>The Journal of the Association of Physicians of India</abbr-1></alt-periodical><pages>513-20</pages><volume>53</volume><edition>2005/08/27</edition><keywords><keyword>Adult</keyword><keyword>Alpha-Globulins/genetics/*urine</keyword><keyword>Biomarkers/urine</keyword><keyword>Carrier Proteins/genetics/*urine</keyword><keyword>Diabetic Nephropathies/diagnosis/*urine</keyword><keyword>Glycoproteins/genetics/*urine</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Orosomucoid/genetics/*urine</keyword><keyword>Proteinuria/diagnosis/*urine</keyword></keywords><dates><year>2005</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0004-5772 (Print) 0004-5772</isbn><accession-num>16121805</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Jain et al., 2005) and present some diabetic patients enlarge diabetic nephropathy with typical albuminuria ADDIN EN.CITE <EndNote><Cite><Author>Isaka</Author><Year>1997</Year><RecNum>40</RecNum><DisplayText><style face=”bold”>(Isaka et al.

, 1997)</style></DisplayText><record><rec-number>40</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>40</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Isaka, Y.</author><author>Akagi, Y.</author><author>Ando, Y.</author><author>Imai, E.</author></authors></contributors><auth-address>First Department of Medicine, Osaka University School of Medicine, Japan. [email protected]

med.osaka-u.ac.jp</auth-address><titles><title>Application of gene therapy to diabetic nephropathy</title><secondary-title>Kidney Int Suppl</secondary-title><alt-title>Kidney international.

Supplement</alt-title></titles><periodical><full-title>Kidney Int Suppl</full-title><abbr-1>Kidney international. Supplement</abbr-1></periodical><alt-periodical><full-title>Kidney Int Suppl</full-title><abbr-1>Kidney international. Supplement</abbr-1></alt-periodical><pages>S100-3</pages><volume>60</volume><edition>1997/09/01</edition><keywords><keyword>Animals</keyword><keyword>Diabetic Nephropathies/*therapy</keyword><keyword>*Genetic Therapy</keyword><keyword>Humans</keyword></keywords><dates><year>1997</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0098-6577 (Print) 0098-6577</isbn><accession-num>9285910</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Isaka et al., 1997).

Exacting these off-putting, new biomarkers that foresee diabetic nephropathy at a extremely premature phase, yet previously than the manifestation of microalbuminuria are desired for finest medical administration of diabetic patients. Recently, ingrained that a number of biomarkers are appreciably high in type II diabetic patients through normoalbuminuria compared to nondiabetic manage folks and may be used as markers for facing, specific and clear-cut guess of diabetic 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 ADDIN EN.CITE 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 ADDIN EN.CITE.

DATA (Jain et al., 2005;Gatua et al., 2011), cyclophilin A may be one of these biomarkers.

Cyclophilin A is a cytosolic and exceedingly plentiful protein, has a beta-barrel construction by two alpha helices and a beta-sheet. Cyclophilin A is a portion of a range of intracellular functions, such as intracellular signaling, protein trafficking, & yielding the action of other proteins 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 ADDIN EN.CITE 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 ADDIN EN.

CITE.DATA (Satoh et al., 2010). Cyclophilin A is also well predictable as a secreted enlargement factor that is inducing by oxidative stress 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Jin et al.

, 2000). Moreover, veiled cyclophilin A is connected to inflammatory or infectious diseases such as rheumatoid arthritis, asthma, and periodontitis ADDIN EN.CITE <EndNote><Cite><Author>Nigro</Author><Year>2013</Year><RecNum>43</RecNum><DisplayText><style face=”bold”>(Nigro et al., 2013)</style></DisplayText><record><rec-number>43</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>43</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nigro, P.

</author><author>Pompilio, G.</author><author>Capogrossi, M. C.</author></authors></contributors><auth-address>Centro Cardiologico Monzino-IRCCS, Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Milan, Italy.</auth-address><titles><title>Cyclophilin A: a key player for human disease</title><secondary-title>Cell Death Dis</secondary-title><alt-title>Cell death &amp; disease</alt-title></titles><periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></periodical><alt-periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></alt-periodical><pages>e888</pages><volume>4</volume><edition>2013/11/02</edition><keywords><keyword>Animals</keyword><keyword>Arthritis, Rheumatoid/genetics/metabolism</keyword><keyword>Cardiovascular Diseases/genetics/metabolism</keyword><keyword>Cyclophilin A/genetics/*metabolism/*physiology</keyword><keyword>Humans</keyword><keyword>Neurodegenerative Diseases/genetics/metabolism</keyword></keywords><dates><year>2013</year><pub-dates><date>Oct 31</date></pub-dates></dates><accession-num>24176846</accession-num><urls></urls><custom2>Pmc3920964</custom2><electronic-resource-num>10.1038/cddis.

2013.410</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Nigro et al., 2013). Engagingly, veiled cyclophilin A was also detected in diabetic patients’ plasma PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYW1hY2hhbmRyYW48L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+NDQ8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihSYW1hY2hhbmRyYW4gZXQgYWwuLCAyMDE0KTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj40NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+UmFtYWNoYW5kcmFuLCBTLjwvYXV0aG9yPjxhdXRob3I+VmVudWdvcGFsLCBBLjwvYXV0aG9yPjxhdXRob3I+S3V0dHksIFYuIFIuPC9hdXRob3I+PGF1dGhvcj5BLCBWLjwvYXV0aG9yPjxhdXRob3I+RywgRC48L2F1dGhvcj48YXV0aG9yPkNoaXRyYXNyZWUsIFYuPC9hdXRob3I+PGF1dGhvcj5NdWxsYXNzYXJpLCBBLjwvYXV0aG9yPjxhdXRob3I+UHJhdGFwY2hhbmRyYW4sIE4uIFMuPC9hdXRob3I+PGF1dGhvcj5TYW50b3NoLCBLLiBSLjwvYXV0aG9yPjxhdXRob3I+UGlsbGFpLCBNLiBSLjwvYXV0aG9yPjxhdXRob3I+S2FydGhhLCBDLiBDLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2UgQmlvbG9neSwgUmFqaXYgR2FuZGhpIENlbnRyZSBmb3IgQmlvdGVjaG5vbG9neSwgVGhpcnV2YW5hbnRoYXB1cmFtLCBJbmRpYS4gY2NrYXJ0aGFAcmdjYi5yZXMuaW4uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UGxhc21hIGxldmVsIG9mIGN5Y2xvcGhpbGluIEEgaXMgaW5jcmVhc2VkIGluIHBhdGllbnRzIHdpdGggdHlwZSAyIGRpYWJldGVzIG1lbGxpdHVzIGFuZCBzdWdnZXN0cyBwcmVzZW5jZSBvZiB2YXNjdWxhciBkaXNlYXNlPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNhcmRpb3Zhc2MgRGlhYmV0b2w8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkNhcmRpb3Zhc2N1bGFyIGRpYWJldG9sb2d5PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2FyZGlvdmFzYyBEaWFiZXRvbDwvZnVsbC10aXRsZT48YWJici0xPkNhcmRpb3Zhc2N1bGFyIGRpYWJldG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYXJkaW92YXNjIERpYWJldG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2FyZGlvdmFzY3VsYXIgZGlhYmV0b2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zODwvcGFnZXM+PHZvbHVtZT4xMzwvdm9sdW1lPjxlZGl0aW9uPjIwMTQvMDIvMDg8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkJpb21hcmtlcnMvYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+Q3ljbG9waGlsaW4gQS8qYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgTWVsbGl0dXMsIFR5cGUgMi8qYmxvb2QvZGlhZ25vc2lzL2VwaWRlbWlvbG9neTwva2V5d29yZD48a2V5d29yZD5EaWFiZXRpYyBBbmdpb3BhdGhpZXMvKmJsb29kL2RpYWdub3Npcy9lcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RmViIDc8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDc1LTI4NDA8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjQ1MDI2MTg8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxjdXN0b20yPlBtYzM5MjI0MDU8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjExODYvMTQ3NS0yODQwLTEzLTM4PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5sbTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+ ADDIN EN.CITE 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 ADDIN EN.

CITE.DATA (Ramachandran et al., 2014) and was exposed to be buried by monocytes in answer to high glucose level 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Ramachandran et al.

, 2012) representing that out of sight cyclophilin A could be a impending escritoire marker in type II diabetes mellitus. still, a relatively high expression level of cyclophilin A in normal kidneys ADDIN EN.CITE ;EndNote;;Cite;;Author;Ryffel;/Author;;Year;1991;/Year;;RecNum;45;/RecNum;;DisplayText;;style face=”bold”;(Ryffel et al., 1991);/style;;/DisplayText;;record;;rec-number;45;/rec-number;;foreign-keys;;key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″;45;/key;;/foreign-keys;;ref-type name=”Journal Article”;17;/ref-type;;contributors;;authors;;author;Ryffel, B.

;/author;;author;Woerly, G.;/author;;author;Greiner, B.;/author;;author;Haendler, B.;/author;;author;Mihatsch, M.

J.;/author;;author;Foxwell, B. M.;/author;;/authors;;/contributors;;auth-address;Sandoz Pharma Ltd, Drug Safety Assessment, Basle, Switzerland.;/auth-address;;titles;;title;Distribution of the cyclosporine binding protein cyclophilin in human tissues;/title;;secondary-title;Immunology;/secondary-title;;alt-title;Immunology;/alt-title;;/titles;;periodical;;full-title;Immunology;/full-title;;abbr-1;Immunology;/abbr-1;;/periodical;;alt-periodical;;full-title;Immunology;/full-title;;abbr-1;Immunology;/abbr-1;;/alt-periodical;;pages;399-404;/pages;;volume;72;/volume;;number;3;/number;;edition;1991/03/01;/edition;;keywords;;keyword;Amino Acid Isomerases/*analysis/blood</keyword><keyword>Animals</keyword><keyword>Blotting, Northern</keyword><keyword>Blotting, Western</keyword><keyword>Carrier Proteins/*analysis/blood</keyword><keyword>Cell Line</keyword><keyword>Cyclosporins/*metabolism</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Peptidylprolyl Isomerase</keyword><keyword>Rabbits</keyword></keywords><dates><year>1991</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0019-2805 (Print) 0019-2805</isbn><accession-num>2026447</accession-num><urls></urls><custom2>Pmc1384402</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Ryffel et al., 1991) has led to the theory that secreted cyclophilin A may be associated with solid organ damage. Serum cyclophilin A can be used as a potential biomarker of diabetic nephropathy and may be raised earlier than albuminuria..

Aim of The workRevealing the power of using serum cyclophilin A as an early and consistent biomarker for diabetic nephropathy Study objectives• Measurement of serum cyclophilin A level in healthy individuals, patients with type II diabetes mellitus lacking nephropathy and patients with type II diabetes mellitus with nephropathy.• Discovery if there is a association among serum cyclophilin A level, albuminuria and glomerular filtration rate.• Discovery if there is a parallel between serum cyclophilin A level and additional risk factors.• Finding if there is a connection between serum cyclophilin A level and the austerity of the disease.Diabetes mellitus1-Definition of diabetes mellitus Diabetes mellitus(DM) is a constant sickness caused by present at birth and/or acquire lack in the manufacture of insulin by the pancreas, or by the incompetence of the insulin creation ADDIN EN.CITE <EndNote><Cite><Author>Alberti</Author><Year>2006</Year><RecNum>74</RecNum><DisplayText><style face=”bold”>(Alberti et al.

, 2006;Kharroubi and Darwish, 2015)</style></DisplayText><record><rec-number>74</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>74</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Alberti, Kurt George Matthew Mayer</author><author>Zimmet, Paul</author><author>Shaw, Jonathan</author></authors></contributors><titles><title>Metabolic syndrome—a new world?wide definition. A consensus statement from the international diabetes federation</title><secondary-title>Diabetic medicine</secondary-title></titles><periodical><full-title>Diabetic medicine</full-title></periodical><pages>469-480</pages><volume>23</volume><number>5</number><dates><year>2006</year></dates><isbn>1464-5491</isbn><urls></urls></record></Cite><Cite><Author>Kharroubi</Author><Year>2015</Year><RecNum>76</RecNum><record><rec-number>76</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>76</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kharroubi, Akram T</author><author>Darwish, Hisham M</author></authors></contributors><titles><title>Diabetes mellitus: The epidemic of the century</title><secondary-title>World journal of diabetes</secondary-title></titles><periodical><full-title>World journal of diabetes</full-title></periodical><pages>850</pages><volume>6</volume><number>6</number><dates><year>2015</year></dates><urls></urls></record></Cite></EndNote>(Alberti et al., 2006;Kharroubi and Darwish, 2015).Insulin is a hormone prepared by the pancreas, all carbohydrate foods are broken down into glucose in the blood, and insulin helps glucose get a hold into the cells. Not being able to produce insulin or use it effectively leads to raised glucose levels in the blood (known as hyperglycemia). Over the long-term high glucose levels are related with break to the body and failure of various organs and tissues.2- Prevalence of diabetes mellitus Diabetes mellitus is in all odds one of the oldest diseases known to the human being.

It was earliest reported in Egyptian manuscript about 3000 years before 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Ahmed, 2002).

It is reported that 366 million people had diabetes mellitus by 2011; with 2030 this will be improved to 552 million, diabetes mellitus caused 4.6 million deaths in 2011 ADDIN EN.CITE <EndNote><Cite><Author>Whiting</Author><Year>2011</Year><RecNum>81</RecNum><DisplayText><style face=”bold”>(Whiting et al., 2011)</style></DisplayText><record><rec-number>81</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>81</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Whiting, David R</author><author>Guariguata, Leonor</author><author>Weil, Clara</author><author>Shaw, Jonathan</author></authors></contributors><titles><title>IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030</title><secondary-title>Diabetes research and clinical practice</secondary-title></titles><periodical><full-title>Diabetes Res Clin Pract</full-title><abbr-1>Diabetes research and clinical practice</abbr-1></periodical><pages>311-321</pages><volume>94</volume><number>3</number><dates><year>2011</year></dates><isbn>0168-8227</isbn><urls></urls></record></Cite></EndNote>(Whiting et al., 2011).

2.1-Diabetes mellitus in Egypt Diabetes is a fast-growing health problem in Egypt with a significant impact on morbidity, death, and healthcare resources. The International Diabetes Federation (IDF) planned Egypt between the world top 10 countries in the quantity of patients with diabetes ADDIN EN.

CITE <EndNote><Cite><Author>Federation</Author><Year>2013</Year><RecNum>78</RecNum><DisplayText><style face=”bold”>(International Diabetes Federation, 2013)</style></DisplayText><record><rec-number>78</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>78</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author> International Diabetes Federation,</author></authors></contributors><titles><title>IDF diabetes atlas</title><secondary-title>Brussels: International Diabetes Federation</secondary-title></titles><periodical><full-title>Brussels: International Diabetes Federation</full-title></periodical><dates><year>2013</year></dates><urls></urls></record></Cite></EndNote>(International Diabetes Federation, 2013). In 2013, the IDF predictable that 7.5 million persons have diabetes and approximately 2.2 million have prediabetes in Egypt. In addition, information indicated that 43% of patients with diabetes and the majority patients with prediabetes in Egypt are likely undiagnosed. It is startling that diabetes frequency in Egypt has enlarged in haste within a reasonably short occasion from roughly 4.4 million in 2007 to 7.5 million in 2013 and it is projected that the amount will be jumped up to 13.

1 million by 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Whiting et al., 2011;International Diabetes Federation, 2013).3-Classification of diabetesCategorization of diabetes is imperative for decisive rehabilitation, but a quantity of folks cannot be evidently classify as having type I or type II diabetes at the time of verdict. The conventional models of type II diabetes taking place just in adults and type I diabetes barely in offspring are no longer perfect, as both diseases happen in the both.

Intermittently, patients with type II diabetes may nearby with diabetic ketoacidosis (DKA) 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Dabelea et al., 2014). Offspring with type I diabetes classically at hand with the trademark symptoms of polyuria /polydipsia, and around one-third nearby with DKA 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 ADDIN EN.CITE 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 ADDIN EN.CITE.

DATA (Newton and Raskin, 2004) .The inception of type I diabetes may be more changeable in adults, and they may not there with the typical symptoms seen in kids. Even though difficulties in characteristic diabetes type may arise in all age-groups at onset, the correct judgment becomes more noticeable over time. In both type I and type II diabetes, different heritable and ecological factors can result in the progressive loss of ?-cell mass and/or meaning that manifests clinically as hyperglycemia ADDIN EN.CITE <EndNote><Cite><Author>Skyler</Author><Year>2017</Year><RecNum>53</RecNum><DisplayText><style face=”bold”>(Skyler et al., 2017)</style></DisplayText><record><rec-number>53</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>53</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Skyler, J.

S.</author><author>Bakris, G. L.</author><author>Bonifacio, E.</author></authors></contributors><auth-address>Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL. The University of Chicago Medicine, Chicago, IL.

</auth-address><titles><title>Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis</title></titles><pages>241-255</pages><volume>66</volume><number>2</number><dates><year>2017</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0012-1797</isbn><accession-num>27980006</accession-num><urls></urls><electronic-resource-num>10.2337/db16-0806</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider></record></Cite></EndNote>(Skyler et al., 2017).3.

1-Type I diabetes; Insulin-dependent, populace with type 1 diabetes are possibly roughly 10 % of all effects of diabetes. Type I diabetes is caused by insulin absence due to demolition of pancreatic ?-cells predominantly through an autoimmune effect, which is itself triggered by dissimilar factors. It is normally regarded as mounting rapidly in infantile people, but it can transpire in any age group.3.1.

1- Risk factors for type I diabetes Even if the exact foundation of type I diabetes is unidentified, factors that may be enlarged risk incorporate;3.1.1.

1 – relatives history (family factors): peril increases if a parent or sibling has type I diabetes ADDIN EN.CITE <EndNote><Cite><Author>Bonifacio</Author><Year>2004</Year><RecNum>265</RecNum><DisplayText><style face=”bold”>(Bonifacio et al., 2004)</style></DisplayText><record><rec-number>265</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>265</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bonifacio, Ezio</author><author>Hummel, Michael</author><author>Walter, Markus</author><author>Schmid, Sandra</author><author>Ziegler, Anette-G</author></authors></contributors><titles><title>IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>2695-2700</pages><volume>27</volume><number>11</number><dates><year>2004</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Bonifacio et al., 2004).3.

1.1.2 – Environmental factors:  such as revelation to a viral infection likely acting several part in type I diabetes ADDIN EN.CITE <EndNote><Cite><Author>Åkerblom</Author><Year>2002</Year><RecNum>267</RecNum><DisplayText><style face=”bold”>(Åkerblom et al.

, 2002)</style></DisplayText><record><rec-number>267</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>267</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Åkerblom, Hans K</author><author>Vaarala, Outi</author><author>Hyöty, Heikki</author><author>Ilonen, Jorma</author><author>Knip, Mikael</author></authors></contributors><titles><title>Environmental factors in the etiology of type 1 diabetes</title><secondary-title>American Journal of Medical Genetics Part A</secondary-title></titles><periodical><full-title>American Journal of Medical Genetics Part A</full-title></periodical><pages>18-29</pages><volume>115</volume><number>1</number><dates><year>2002</year></dates><isbn>1096-8628</isbn><urls></urls></record></Cite></EndNote>(Åkerblom et al., 2002).3.1.1.3 -The incidence of destructive impervious system cells (autoantibodies):  occasionally folks members of community with type I diabetes are tested for the existence of diabetes autoantibodies. If somebody has these autoantibodies, so has an augmented risk of upward type I diabetes.

But not each person who has these autoantibodies develops diabetes ADDIN EN.CITE <EndNote><Cite><Author>Ziegler</Author><Year>1999</Year><RecNum>266</RecNum><DisplayText><style face=”bold”>(Ziegler et al., 1999)</style></DisplayText><record><rec-number>266</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>266</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ziegler, Anette-G</author><author>Hummel, Michael</author><author>Schenker, Michael</author><author>Bonifacio, Ezio</author></authors></contributors><titles><title>Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>460-468</pages><volume>48</volume><number>3</number><dates><year>1999</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Ziegler et al.

, 1999).3.1.1.4 -nutritional factors:  comprise low vitamin D utilization, early publicity to cow’s milk 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 ADDIN EN.CITE 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 ADDIN EN.

CITE.DATA (Knip et al., 2010), and coverage to cereals before 4 months of age. None of these factors has been shown to frankly source type I diabetes.3.1.1.5-Geography: certain countries, such as Finland and Sweden, have advanced rates of type I diabetes ADDIN EN.

CITE <EndNote><Cite><Author>LaPorte</Author><Year>1985</Year><RecNum>268</RecNum><DisplayText><style face=”bold”>(LaPorte et al., 1985)</style></DisplayText><record><rec-number>268</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>268</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>LaPorte, Ronald E</author><author>Tajima, Naoko</author><author>Åkerblom, Hans K</author><author>Berlin, Nina</author><author>Brosseau, James</author><author>Christy, Morten</author><author>Drash, Allan L</author><author>Fishbein, Howard</author><author>Green, Anders</author><author>Hamman, Richard</author></authors></contributors><titles><title>Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>101-107</pages><volume>8</volume><number>Supplement 1</number><dates><year>1985</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(LaPorte et al., 1985).3.2-Type II diabetes (Noninsulin-dependent diabetes” or “adult-onset diabetes,” account for 90–95% of all diabetes ADDIN EN.

CITE <EndNote><Cite><Author>Association</Author><Year>2017</Year><RecNum>82</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2017)</style></DisplayText><record><rec-number>82</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>82</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>2. Classification and diagnosis of diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S11-S24</pages><volume>40</volume><number>Supplement 1</number><dates><year>2017</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2017). Type II diabetes is caused by progressive beating of ?-cell insulin emission recurrently on the environment of insulin conflict). Pancreatic ?-cell utility is retained to a definite quantity so insulin injections are rarely necessary for endurance.3.2.1- Risk factors for and type II diabetesResearchers don’t wholly appreciate why some public enlarge type II diabetes and others don’t.

It’s apparent that confident factors enlarge the risk, nonetheless, including;3.2.1.

1-Overweight/Obesity; require of keep fit and detrimental meal arrangement choices can front to fatness, or build it inferior. Being overweight makes insulin resistance and can also lead to many other health harms ADDIN EN.CITE <EndNote><Cite><Author>Yaturu</Author><Year>2011</Year><RecNum>270</RecNum><DisplayText><style face=”bold”>(Yaturu, 2011)</style></DisplayText><record><rec-number>270</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>270</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Yaturu, Subhashini</author></authors></contributors><titles><title>Obesity and type 2 diabetes</title><secondary-title>Journal of Diabetes Mellitus</secondary-title></titles><periodical><full-title>Journal of Diabetes Mellitus</full-title></periodical><pages>79</pages><volume>1</volume><number>04</number><dates><year>2011</year></dates><urls></urls></record></Cite></EndNote>(Yaturu, 2011).3.2.1.

2-Inactivity; substantial doings helps in manage body burden, uses up glucose as power and makes body cells more susceptible to insulin ADDIN EN.CITE <EndNote><Cite><Author>Colberg</Author><Year>2010</Year><RecNum>271</RecNum><DisplayText><style face=”bold”>(Colberg et al., 2010)</style></DisplayText><record><rec-number>271</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>271</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Colberg, S. R.</author><author>Sigal, R. J.

</author><author>Fernhall, B.</author><author>Regensteiner, J. G.

</author><author>Blissmer, B. J.</author><author>Rubin, R. R.</author><author>Chasan-Taber, L.</author><author>Albright, A. L.</author><author>Braun, B.

</author></authors></contributors><auth-address>Human Movement Sciences Department, Old Dominion University, Norfolk, Virginia, USA. [email protected]</auth-address><titles><title>Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement</title><secondary-title>Diabetes Care</secondary-title><alt-title>Diabetes care</alt-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><alt-periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></alt-periodical><pages>e147-67</pages><volume>33</volume><number>12</number><edition>2010/12/01</edition><keywords><keyword>Diabetes Mellitus, Type 2/diagnosis/*physiopathology/*prevention &amp; control</keyword><keyword>Exercise/*physiology</keyword><keyword>Humans</keyword></keywords><dates><year>2010</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0149-5992</isbn><accession-num>21115758</accession-num><urls></urls><custom2>Pmc2992225</custom2><electronic-resource-num>10.2337/dc10-9990</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Colberg et al., 2010).3.

2.1.3-Family history; the risk increases if a parent or sibling has type II diabetes 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 ADDIN EN.CITE 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 ADDIN EN.CITE.

DATA (Scott et al., 2013). 3.2.1.4-Race; Even though it’s indistinct why, people of certain races- including blacks, Hispanics, American Indians and Asian-Americans are at elevated risk ADDIN EN.CITE <EndNote><Cite><Author>Harris</Author><Year>2001</Year><RecNum>274</RecNum><DisplayText><style face=”bold”>(Harris, 2001)</style></DisplayText><record><rec-number>274</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>274</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Harris, Maureen I</author></authors></contributors><titles><title>Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>454-459</pages><volume>24</volume><number>3</number><dates><year>2001</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Harris, 2001).

3.2.1.

5-Age; The risk increases when in receipt of older, at age 45, the peril starts to climb, and behind age 65, risk increases exponentially. This may perhaps be since the penchant to implement less, mislay strength throng and gain power but type II diabetes is also superior than ever noticeably between children, teenagers and younger adults ADDIN EN.CITE <EndNote><Cite><Author>Fletcher</Author><Year>2002</Year><RecNum>275</RecNum><DisplayText><style face=”bold”>(Fletcher et al., 2002)</style></DisplayText><record><rec-number>275</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>275</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Fletcher, B.</author><author>Gulanick, M.

</author><author>Lamendola, C.</author></authors></contributors><auth-address>University of North Florida, Department of Nursing Jacksonville Beach, USA.</auth-address><titles><title>Risk factors for type 2 diabetes mellitus</title><secondary-title>J Cardiovasc Nurs</secondary-title><alt-title>The Journal of cardiovascular nursing</alt-title></titles><periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></periodical><alt-periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></alt-periodical><pages>17-23</pages><volume>16</volume><number>2</number><edition>2002/01/22</edition><keywords><keyword>Age Factors</keyword><keyword>Diabetes Mellitus, Type 2/*etiology/genetics/nursing/*prevention &amp; control</keyword><keyword>Genetic Predisposition to Disease</keyword><keyword>Humans</keyword><keyword>Insulin Resistance</keyword><keyword>Obesity</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2002</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0889-4655 (Print) 0889-4655</isbn><accession-num>11800065</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Fletcher et al.

, 2002).3.2.1.6- Gestational diabetes; If gestational diabetes residential through pregnancy, the risk of developing type II diabetes increases later and if the baby weighing more 4 kilograms birth, also has a danger of type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Fletcher</Author><Year>2002</Year><RecNum>275</RecNum><DisplayText><style face=”bold”>(Fletcher et al., 2002)</style></DisplayText><record><rec-number>275</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>275</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Fletcher, B.

</author><author>Gulanick, M.</author><author>Lamendola, C.</author></authors></contributors><auth-address>University of North Florida, Department of Nursing Jacksonville Beach, USA.</auth-address><titles><title>Risk factors for type 2 diabetes mellitus</title><secondary-title>J Cardiovasc Nurs</secondary-title><alt-title>The Journal of cardiovascular nursing</alt-title></titles><periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></periodical><alt-periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></alt-periodical><pages>17-23</pages><volume>16</volume><number>2</number><edition>2002/01/22</edition><keywords><keyword>Age Factors</keyword><keyword>Diabetes Mellitus, Type 2/*etiology/genetics/nursing/*prevention &amp; control</keyword><keyword>Genetic Predisposition to Disease</keyword><keyword>Humans</keyword><keyword>Insulin Resistance</keyword><keyword>Obesity</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2002</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0889-4655 (Print) 0889-4655</isbn><accession-num>11800065</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Fletcher et al., 2002).3.2.1.

7- Polycystic ovary syndrome;  For women, having polycystic ovary illness a common provision characterized by asymmetrical menstrual periods, numerous cysts variety in the ovaries, excess hair growth, obesity and one hopeful reason is insulin resistance that increases the possibility of type II diabetes 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 ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HYW1iaW5lcmk8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxSZWNOdW0+Mjc2PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oR2FtYmluZXJpIGV0IGFsLiwgMjAxMik8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yNzY8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjI3Njwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+R2FtYmluZXJpLCBBLjwvYXV0aG9yPjxhdXRob3I+UGF0dG9uLCBMLjwvYXV0aG9yPjxhdXRob3I+QWx0aWVyaSwgUC48L2F1dGhvcj48YXV0aG9yPlBhZ290dG8sIFUuPC9hdXRob3I+PGF1dGhvcj5QaXp6aSwgQy48L2F1dGhvcj48YXV0aG9yPk1hbnpvbGksIEwuPC9hdXRob3I+PGF1dGhvcj5QYXNxdWFsaSwgUi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5FbmRvY3Jpbm9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgTWVkaWNpbmUsIFN0IE9yc29sYS1NYWxwaWdoaSBIb3NwaXRhbCwgQWxtYSBNYXRlciBTdHVkaW9ydW0gVW5pdmVyc2l0eSBvZiBCb2xvZ25hLCBCb2xvZ25hLCBJdGFseS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Qb2x5Y3lzdGljIG92YXJ5IHN5bmRyb21lIGlzIGEgcmlzayBmYWN0b3IgZm9yIHR5cGUgMiBkaWFiZXRlczogcmVzdWx0cyBmcm9tIGEgbG9uZy10ZXJtIHByb3NwZWN0aXZlIHN0dWR5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkRpYWJldGVzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5EaWFiZXRlczwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkRpYWJldGVzPC9mdWxsLXRpdGxlPjxhYmJyLTE+RGlhYmV0ZXM8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkRpYWJldGVzPC9mdWxsLXRpdGxlPjxhYmJyLTE+RGlhYmV0ZXM8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4yMzY5LTc0PC9wYWdlcz48dm9sdW1lPjYxPC92b2x1bWU+PG51bWJlcj45PC9udW1iZXI+PGVkaXRpb24+MjAxMi8wNi8xNjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgR2x1Y29zZS9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPkJvZHkgTWFzcyBJbmRleDwva2V5d29yZD48a2V5d29yZD5EaWFiZXRlcyBNZWxsaXR1cywgVHlwZSAyL2VwaWRlbWlvbG9neS8qZXRpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JdGFseS9lcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TG9uZ2l0dWRpbmFsIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UG9seWN5c3RpYyBPdmFyeSBTeW5kcm9tZS8qY29tcGxpY2F0aW9uczwva2V5d29yZD48a2V5d29yZD5QcmV2YWxlbmNlPC9rZXl3b3JkPjxrZXl3b3JkPlByb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmlzayBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPlNleCBIb3Jtb25lLUJpbmRpbmcgR2xvYnVsaW4vbWV0YWJvbGlzbTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEyPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+U2VwPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAxMi0xNzk3PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIyNjk4OTIxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48Y3VzdG9tMj5QbWMzNDI1NDEzPC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4yMzM3L2RiMTEtMTM2MDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB= ADDIN EN.CITE.DATA (Gambineri et al., 2012).

3.2.1.8-High blood pressure; Having blood pressure over 140/90 millimeters of mercury (mm Hg) is associated to an amplified jeopardy of type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Gress</Author><Year>2000</Year><RecNum>278</RecNum><DisplayText><style face=”bold”>(Gress et al.

, 2000)</style></DisplayText><record><rec-number>278</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>278</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Gress, Todd W</author><author>Nieto, F Javier</author><author>Shahar, Eyal</author><author>Wofford, Marion R</author><author>Brancati, Frederick L</author></authors></contributors><titles><title>Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>905-912</pages><volume>342</volume><number>13</number><dates><year>2000</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite></EndNote>(Gress et al., 2000).3.

2.1.9-Abnormal cholesterol and triglyceride levels; Have squat levels of high-density lipoprotein (HDL), or “fine,” cholesterol; the danger of type II diabetes is elevated. Triglycerides are a dissimilar type of fat accepted in the blood, group with elevated levels of triglycerides have an augmented danger of type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Boden</Author><Year>2004</Year><RecNum>279</RecNum><DisplayText><style face=”bold”>(Boden and Laakso, 2004)</style></DisplayText><record><rec-number>279</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>279</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Boden, Guenther</author><author>Laakso, Markku</author></authors></contributors><titles><title>Lipids and glucose in type 2 diabetes: what is the cause and effect?</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>2253-2259</pages><volume>27</volume><number>9</number><dates><year>2004</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Boden and Laakso, 2004).3.3- Gestational diabetes mellitus (GDM) (diabetes diagnosed in the next or third trimester of pregnancy that was not clearly overt diabetes prior to gestation). It risks to the pregnancy itself comprise innate malformations, increased incarceration weight, an imperative risk of perinatal mortality and augmented hazard to woman of increasing diabetes type II afterward in living ADDIN EN.

CITE <EndNote><Cite><Author>Bellamy</Author><Year>2009</Year><RecNum>281</RecNum><DisplayText><style face=”bold”>(Bellamy et al., 2009)</style></DisplayText><record><rec-number>281</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>281</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bellamy, Leanne</author><author>Casas, Juan-Pablo</author><author>Hingorani, Aroon D</author><author>Williams, David</author></authors></contributors><titles><title>Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis</title><secondary-title>The Lancet</secondary-title></titles><periodical><full-title>The Lancet</full-title></periodical><pages>1773-1779</pages><volume>373</volume><number>9677</number><dates><year>2009</year></dates><isbn>0140-6736</isbn><urls></urls></record></Cite></EndNote>(Bellamy et al., 2009).

3.3.1-Risk factors for gestational diabetes Any expectant female preserve enlarge gestational diabetes, but various women at better risk than others. danger factors for gestational diabetes comprise ADDIN EN.

CITE <EndNote><Cite><Author>Buchanan</Author><Year>2005</Year><RecNum>280</RecNum><DisplayText><style face=”bold”>(Buchanan and Xiang, 2005)</style></DisplayText><record><rec-number>280</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>280</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Buchanan, T. A.</author><author>Xiang, A. H.

</author></authors></contributors><auth-address>Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California 90089-9317, USA. [email protected]</auth-address><titles><title>Gestational diabetes mellitus</title><secondary-title>J Clin Invest</secondary-title><alt-title>The Journal of clinical investigation</alt-title></titles><alt-periodical><full-title>The Journal of clinical investigation</full-title></alt-periodical><pages>485-91</pages><volume>115</volume><number>3</number><edition>2005/03/15</edition><keywords><keyword>Blood Glucose/analysis</keyword><keyword>*Diabetes, Gestational/classification/etiology/physiopathology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Insulin/blood</keyword><keyword>Insulin Resistance/physiology</keyword><keyword>Islets of Langerhans/metabolism</keyword><keyword>Mass Screening</keyword><keyword>Pregnancy</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2005</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0021-9738 (Print) 0021-9738</isbn><accession-num>15765129</accession-num><urls></urls><custom2>Pmc1052018</custom2><electronic-resource-num>10.

1172/jci24531</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Buchanan and Xiang, 2005);3.3.1.1-Age: Women adult than age 25 are at amplified risk.3.3.

1.2-Family or personal history; the danger increases for type II diabetes if a lock relatives constituent such as a parent or sibling, has type II diabetes. 3.

3.1.1-Weight; Being obese before pregnancy increases the peril of GDM3.3.1.4-Race: For reasons that aren’t obvious, women who are black, Hispanic, American Indian or Asian are extra probable to enlarge gestational diabetes.3.

4- Specific types of diabetes (owing other reasons, e.g., monogenic diabetes syndromes (such as neonatal diabetes and maturity-onset diabetes of the young MODY), diseases of the exocrine pancreas (such as cystic fibrosis), and treatment- or chemical-induced diabetes (such as with glucocorticoid use, in the behavior of HIV/AIDS, or after organ transplantation) ADDIN EN.CITE <EndNote><Cite><Author>Association</Author><Year>2017</Year><RecNum>82</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2017)</style></DisplayText><record><rec-number>82</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>82</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>2. Classification and diagnosis of diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S11-S24</pages><volume>40</volume><number>Supplement 1</number><dates><year>2017</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2017).4-Criteria for the finding of prediabetes and diabetesPrediabetes DiabetesA1C 5.

7-6.4% ?6.5%**FPG 100–125 mg/dl (5.6-6.9 mmol/L) ?126 mg/dl (7.0 mmol/L)**OGTT* 140-199 mg/dl( 7.8-11.0 mmol/L) ?200 mg/dl (11.

1 mmol/L)**RPG ?200 mg/dl (11.1 mmol/L)***Table (1) diagnosis of diabetes ADDIN EN.CITE <EndNote><Cite><Author>Association</Author><Year>2017</Year><RecNum>82</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2017)</style></DisplayText><record><rec-number>82</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>82</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>2.

Classification and diagnosis of diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S11-S24</pages><volume>40</volume><number>Supplement 1</number><dates><year>2017</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2017)**verify outcome with duplicate testing.***Diagnostic in patients with recognized symptoms of hyperglycemiaA1C, glycated hemoglobin; FPG, fasting plasma glucose; OGTT, oral glucose tolerance test, RPG, random plasma glucose5-Signs and symptoms of diabetes Diabetes type II Diabetes type I BMI is in the overweight or obese range. Body mass index (BMI)is mostly within the normal range or low. Common physical attributesSlow, sometimes taking years and often presenting without early symptoms Rapid, often presenting acutely with ketoacidosis Onsetsever thirst and hunger,Frequent urination, Nausea, Rapid weight loss, fatigue,sever weakness, Vomiting,Irritability, Blurred vision,Skin infections, Sores healed slowly, Dry, itchy skin, Feet pins, needles or numbness Sever thirst and hungerFrequent urination, Nausea, Rapid weight loss, fatigue,sever weakness, vomiting and IrritabilityWarning signsTable (2) some signs and symptoms of possible complications of type I and type II diabetes mellitus diabetes announced by the American Diabetes Association in 2015.6-Complications of diabetes On one occasion hyperglycemia happens, patients with all types of diabetes are at hazard for developing the same complications, even though rates of sequence may change. Hyperglycemia owing to insulin insufficiency or insulin thoughtlessness as an outcome of insulin resistance or on the way out insulin building can lead to a reduce in glucose transport into the liver, muscle cells, and fat cells, causing diabetes complications. People accessible with category II DM are extra subject to dissimilar forms of both little- and long-term complications, which routinely lead to their impulsive decease as of delicate initiation, not on time approval and mainly resource-poor growing countries similar to Africa ADDIN EN.CITE <EndNote><Cite><Author>Azevedo</Author><Year>2008</Year><RecNum>83</RecNum><DisplayText><style face=”bold”>(Azevedo and Alla, 2008)</style></DisplayText><record><rec-number>83</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>83</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Azevedo, Mario</author><author>Alla, Sridevi</author></authors></contributors><titles><title>Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia</title><secondary-title>International journal of diabetes in developing countries</secondary-title></titles><periodical><full-title>International journal of diabetes in developing countries</full-title></periodical><pages>101</pages><volume>28</volume><number>4</number><dates><year>2008</year></dates><urls></urls></record></Cite></EndNote>(Azevedo and Alla, 2008).

Complications of Diabetes can be divided into two main parts ADDIN EN.CITE <EndNote><Cite><Author>Marcovecchio</Author><Year>2017</Year><RecNum>283</RecNum><DisplayText><style face=”bold”>(Marcovecchio, 2017)</style></DisplayText><record><rec-number>283</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>283</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marcovecchio, L</author></authors></contributors><titles><title>Complications of acute and chronic hyperglycaemia</title><secondary-title>US Endocrinology</secondary-title></titles><periodical><full-title>US Endocrinology</full-title></periodical><dates><year>2017</year></dates><urls></urls></record></Cite></EndNote>(Marcovecchio, 2017):6.1- Short-Term Complications (severe Complications) 6.1.

1- Diabetic Ketoacidosis;DKA rarely occurs impulsively in type II diabetes; when seen, it typically arises in connection with the stress of another disease such as infection or with the use of definite drugs (e.g., corticosteroids, atypical antipsychotics, and sodium–glucose cotransporter 2 inhibitors) 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 ADDIN EN.

CITE 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 ADDIN EN.CITE.DATA (Umpierrez and Korytkowski, 2016;Fadini et al., 2017). Ketoacidosis is mainly a complication of type I diabetes. Earlier than the sighting of insulin, more than 50 % of diabetic patients die’s of ketoacidosis. Nowadays, even if it is avoidable, after that also virtually 2% diabetic patients die of ketoacidosis.

Patient has ketoacidosis requires an imperative treatment. Diabetic ketoacidosis occurs in patients with provide insulin deficiency collective with glucagon overload. This leads to the release of free fatty acids into plasma. These free fatty acids are in use up by the liver where the enzyme acetyl co-enzyme –A, oxidizes the free fatty acid into ketone bodies.  6.1.2- Hyperosmolar Nonketotic ComaHyperosmolar nonketotic coma is chiefly seen in patients anguish from Type II diabetes with extreme hyperglycemia and lack of fluids but no ketoacidosis ADDIN EN.CITE <EndNote><Cite><Author>Rosenbloom</Author><Year>1996</Year><RecNum>285</RecNum><DisplayText><style face=”bold”>(Rosenbloom and Hanas, 1996)</style></DisplayText><record><rec-number>285</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>285</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rosenbloom, Arlan L</author><author>Hanas, Ragnar</author></authors></contributors><titles><title>Diabetic ketoacidosis (DKA): treatment guidelines</title><secondary-title>Clinical pediatrics</secondary-title></titles><periodical><full-title>Clinical pediatrics</full-title></periodical><pages>261-266</pages><volume>35</volume><number>5</number><dates><year>1996</year></dates><isbn>0009-9228</isbn><urls></urls></record></Cite></EndNote>(Rosenbloom and Hanas, 1996).

It is caused by strict lack of fluids due to permanent deletion of sugar in urine known as hyperglycemic dieresis. The loss of glucose in urine is force that the patient is incapable to drink enough water to preserve urinary fluid loss. The usual clinical features of ketoacidosis like acetone smelling breath are lacking. But there are major central nervous system symbols present. Blood sugar is particularly high.

The mortality rate in hyperosmolar non-kenotic coma is more than 50% ADDIN EN.CITE <EndNote><Cite><Author>Liamis</Author><Year>2000</Year><RecNum>284</RecNum><DisplayText><style face=”bold”>(Liamis et al., 2000)</style></DisplayText><record><rec-number>284</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>284</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Liamis, G</author><author>Gianoutsos, C</author><author>Elisaf, MS</author></authors></contributors><titles><title>Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment?</title></titles><dates><year>2000</year></dates><isbn>1262-3636</isbn><urls></urls></record></Cite></EndNote>(Liamis et al., 2000).6.1.

3- HypoglycemiaHypoglycemia is usually seen in patients anguish from Type I diabetes. It may happen when excessive quantity of insulin is administered to tolerant, leading to fall in blood glucose level. The symptoms of Hypoglycemia are weakness, intense starvation, sweating, palpitation, headache, nervousness, irritability, cold skin, high beat speed, diplopia and mind misunderstanding. Yet if Hypoglycemia is not treated, person’s death can take place ADDIN EN.CITE <EndNote><Cite><Author>Kalra</Author><Year>2013</Year><RecNum>286</RecNum><DisplayText><style face=”bold”>(Kalra et al., 2013)</style></DisplayText><record><rec-number>286</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>286</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kalra, S.</author><author>Mukherjee, J. J.

</author><author>Venkataraman, S.</author><author>Bantwal, G.</author><author>Shaikh, S.</author><author>Saboo, B.</author><author>Das, A. K.

</author><author>Ramachandran, A.</author></authors></contributors><auth-address>Bharti Research Institute of Diabetes and Endocrinology, Karnal, Haryana, India.</auth-address><titles><title>Hypoglycemia: The neglected complication</title><secondary-title>Indian J Endocrinol Metab</secondary-title><alt-title>Indian journal of endocrinology and metabolism</alt-title></titles><periodical><full-title>Indian J Endocrinol Metab</full-title><abbr-1>Indian journal of endocrinology and metabolism</abbr-1></periodical><alt-periodical><full-title>Indian J Endocrinol Metab</full-title><abbr-1>Indian journal of endocrinology and metabolism</abbr-1></alt-periodical><pages>819-34</pages><volume>17</volume><number>5</number><edition>2013/10/02</edition><dates><year>2013</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>2230-8210 (Print) 2230-9500</isbn><accession-num>24083163</accession-num><urls></urls><custom2>Pmc3784865</custom2><electronic-resource-num>10.

4103/2230-8210.117219</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Kalra et al., 2013).6.

2- Long-Term Complications (persistent complications)Long-term complications can be avoided by maintaining blood glucose level in a hale and hearty range throughout food planning, physical activity, and medications. These complications increase over a lot of years and they all relate to how blood glucose levels can involve blood vessels. By the time, high blood glucose can break the body’s blood vessels, both small and large. Demolish up the small blood vessels causes microvascular complications; smash up the large vessels causes macrovascular complications 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 ADDIN EN.

CITE 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 ADDIN EN.CITE.DATA (Sarwar et al.

, 2010). 6.2.1-Macrovascular Complications (Including: Heart, Brain, and Blood Vessels), type II diabetes can also involve the large blood vessels, causing plaque to ultimately construct up and potentially leading to a heart attack, stroke or vessel blockage in the legs (peripheral vascular disease). Heart sickness and stroke as a result of diabetes can be prevented by running diabetes well; blood stress should be below control, and take attention to cholesterol level. 6.

2.2-Microvascular Complications(Including: damage to Eye, Kidney, and Nerve), tiny blood vessels can be injured by always high blood glucose over time. Smashed blood vessels don’t deliver blood as well as they should, so that leads to other problems, exclusively with the eyes, kidneys, and nerves.6.2.2.1-Eyes; Blood glucose levels out of range for a long period of instance can source cataracts and or retinopathy in the eyes. Both can cause blindness.

To avoid eye problems linked to diabetes; maintenance blood glucose level within range and have annual eye check-up.6.2.2.2-Nerves; Nerve injury caused by diabetes is also known as diabetic neuropathy. at what time blood vessels are injured, the nerves will eventually be smashed. In type II diabetes, some people will already demonstrate signs of nerve injure when they are diagnosed.

Maintaining blood glucose level under control can avoid further nerve injury.6.2.2.

3-Kidneys; elevated blood glucose level for extended time can cause kidney illness (diabetic nephropathy) leads to impaired kidney function, dialysis and/or kidney transplant. Uncontrolled (or badly controlled) diabetes can cause kidneys damage then develop into not capable of cleaning the blood appropriately.Diabetic nephropathyDefinition of diabetic nephropathyDiabetic nephropathy (DN) represents an imperative reason of persistent kidney disease (CKD) that frequently leads to end-stage renal illness (ESRD). Diabetes mellitus (DM) is a numerous disease and DN is one of its chief complications. It is respected that up to 40% of the patients with type I and type II DM presents DN ADDIN EN.CITE <EndNote><Cite><Author>MacIsaac</Author><Year>2014</Year><RecNum>88</RecNum><DisplayText><style face=”bold”>(MacIsaac et al.

, 2014)</style></DisplayText><record><rec-number>88</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>88</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>MacIsaac, Richard J</author><author>Ekinci, Elif I</author><author>Jerums, George</author></authors></contributors><titles><title>Markers of and risk factors for the development and progression of diabetic kidney disease</title><secondary-title>American journal of kidney diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>S39-S62</pages><volume>63</volume><number>2</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(MacIsaac et al., 2014). Diabetic nephropathy is a clinical disease characterized by the following ADDIN EN.CITE <EndNote><Cite><Author>Tang</Author><Year>2016</Year><RecNum>28</RecNum><DisplayText><style face=”bold”>(Tang et al., 2016)</style></DisplayText><record><rec-number>28</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>28</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tang, S.

C.</author><author>Chan, G. C.

</author><author>Lai, K. N.</author></authors></contributors><auth-address>Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong. Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong; Nephrology Department, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.</auth-address><titles><title>Recent advances in managing and understanding diabetic nephropathy</title><secondary-title>F1000Res</secondary-title><alt-title>F1000Research</alt-title></titles><periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></periodical><alt-periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></alt-periodical><volume>5</volume><edition>2016/06/16</edition><dates><year>2016</year></dates><isbn>2046-1402 (Print) 2046-1402</isbn><accession-num>27303648</accession-num><urls></urls><custom2>Pmc4892357</custom2><electronic-resource-num>10.12688/f1000research.

7693.1</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Tang et al., 2016):Persistent albuminuria (>300 mg/day or >200 ?g/min) that is inveterate at least 2 occasions 3-6 months apart Progressive decrease in the glomerular filtration rate (GFR) High arterial blood pressure Proteinuria was primary documented in diabetes mellitus in the tardy 18th century. In the 1930s, Kimmelstiel and Wilson described the typical lesions of nodular glomerulosclerosis in diabetes linked with proteinuria and hypertension.

Early treatment can stop or avoid the inception of diabetic nephropathy. This has time after time been revealed in both type I and type II diabetes mellitus, so standard follow-up for diabetic patients is a retort in managing diabetic nephropathy productively.Recently, it is renowned that microalbuminuria is not always projecting of diabetic nephropathy 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 ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Fa2luY2k8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxSZWNOdW0+ODk8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihFa2luY2kgZXQgYWwuLCAyMDEzKTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjg5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj44OTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RWtpbmNpLCBFLiBJLjwvYXV0aG9yPjxhdXRob3I+SmVydW1zLCBHLjwvYXV0aG9yPjxhdXRob3I+U2tlbmUsIEEuPC9hdXRob3I+PGF1dGhvcj5DcmFtbWVyLCBQLjwvYXV0aG9yPjxhdXRob3I+UG93ZXIsIEQuPC9hdXRob3I+PGF1dGhvcj5DaGVvbmcsIEsuIFkuPC9hdXRob3I+PGF1dGhvcj5QYW5hZ2lvdG9wb3Vsb3MsIFMuPC9hdXRob3I+PGF1dGhvcj5NY05laWwsIEsuPC9hdXRob3I+PGF1dGhvcj5CYWtlciwgUy4gVC48L2F1dGhvcj48YXV0aG9yPkZpb3JldHRvLCBQLjwvYXV0aG9yPjxhdXRob3I+TWFjaXNhYWMsIFIuIEouPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+Q29ycmVzcG9uZGluZyBhdXRob3I6IEVsaWYgSS4gRWtpbmNpLCBlbGlmLmVraW5jaUB1bmltZWxiLmVkdS5hdS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5SZW5hbCBzdHJ1Y3R1cmUgaW4gbm9ybW9hbGJ1bWludXJpYyBhbmQgYWxidW1pbnVyaWMgcGF0aWVudHMgd2l0aCB0eXBlIDIgZGlhYmV0ZXMgYW5kIGltcGFpcmVkIHJlbmFsIGZ1bmN0aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkRpYWJldGVzIENhcmU8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkRpYWJldGVzIGNhcmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5EaWFiZXRlcyBDYXJlPC9mdWxsLXRpdGxlPjxhYmJyLTE+RGlhYmV0ZXMgY2FyZTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RGlhYmV0ZXMgQ2FyZTwvZnVsbC10aXRsZT48YWJici0xPkRpYWJldGVzIGNhcmU8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zNjIwLTY8L3BhZ2VzPjx2b2x1bWU+MzY8L3ZvbHVtZT48bnVtYmVyPjExPC9udW1iZXI+PGVkaXRpb24+MjAxMy8wNy8xMDwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BbGJ1bWludXJpYS9ldGlvbG9neS8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkJpb3BzeTwva2V5d29yZD48a2V5d29yZD5EaWFiZXRlcyBNZWxsaXR1cywgVHlwZSAyLypjb21wbGljYXRpb25zLypwYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0aWMgTmVwaHJvcGF0aGllcy9ldGlvbG9neS8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HbG9tZXJ1bGFyIEZpbHRyYXRpb24gUmF0ZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5IEdsb21lcnVsdXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPlJlbmFsIEluc3VmZmljaWVuY3kvZXRpb2xvZ3kvKnBhdGhvbG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+Tm92PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDE0OS01OTkyPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzODM1NjkwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48Y3VzdG9tMj5QbWMzODE2ODU0PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4yMzM3L2RjMTItMjU3MjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn== ADDIN EN.CITE.

DATA (Ekinci et al., 2013). All the same, a majority of the cases of diabetic nephropathy presents with proteinuria, which gradually gets not as good as as the disease progresses, and is roughly regularly linked with hypertension.Etiology of diabetic nephropathyThe correct reason of diabetic nephropathy is unknown, but various postulated mechanisms are hyperglycemia (causing hyperfiltration and renal injury), advanced glycation products, and activation of cytokines. Glycemic control reflects the balance between food intake, gluconeogenesis, tissue uptake or employment through storage as glycogen or fat and oxidation. This equilibrium is keeping up by insulin making from the ? cells in the pancreas. Insulin regulates serum glucose during its actions on the liver, skeletal muscle and fat tissue. While there is insulin confrontation, insulin cannot repress hepatic gluconeogenesis which guides to hyperglycemia, amplified lipolysis and decrease in the disposal of glucose causing hyperlipidemia.

At what time there is insulin conflict, the pancreas is obligatory to amplify its insulin production, which stresses the ? cells, eventually resultant in ?-cell tiredness. The elevated blood glucose levels and high levels of drenched fatty acids create an inflammatory average, causing activation of the instinctive immune system, which consequences induction of the nuclear transcription factor-kappa B (NF-?B), and liberate of inflammatory mediators, counting, interleukin (IL)-1 and tumor necrosis factor alpha (TNF-?), promoting systemic insulin resistance and ?-cell destroy as a result of autoimmune insulitis. Hyperglycemia, high serum levels of free fatty acids and IL-1 lead to glucotoxicity, lipotoxicity, and IL-1 toxicity, consequential in apoptotic ?-cell death.Hyperglycemia also increases the appearance of transforming growth factor-beta (TGF-?) in the glomeruli and of matrix proteins, particularly encouraged via this cytokine. TGF-? and vascular endothelial growth factor (VEGF) may distribute to the cellular hypertrophy, improved collagen synthesis and may stimulate the vascular changes observed in people with diabetic nephropathy 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 ADDIN EN.CITE 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 ADDIN EN.CITE.

DATA (Chiarelli et al., 2009;Rask-Madsen and King, 2010).  Hyperglycemia also can activate protein kinase C (PKC), which may distribute in renal disease and other vascular complications of diabetes ADDIN EN.

CITE <EndNote><Cite><Author>Ziyadeh</Author><Year>2004</Year><RecNum>92</RecNum><DisplayText><style face=”bold”>(Ziyadeh, 2004)</style></DisplayText><record><rec-number>92</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>92</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Mediators of diabetic renal disease: the case for TGF-? as the major mediator</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>S55-S57</pages><volume>15</volume><number>1 suppl</number><dates><year>2004</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite></EndNote>(Ziyadeh, 2004). Familial or maybe yet genetic factors as well take in a role. Definite ethnic groups, mainly African Americans, persons of Hispanic source, and American Indians, may be mainly inclined to renal disease as a complication of diabetes. It has been argued that the heritable tendency to diabetes is so common in Western societies and even more so in minorities. Some evidence has accrued for a polymorphism in the gene for the angiotensin-converting enzyme (ACE) in also predisposing to nephropathy or accelerating its way; however, perfect inherited markers have up till now to be recognized.

Lately, the role of epigenetic alteration in the pathogenesis of diabetic nephropathy has been elucidated ADDIN EN.CITE <EndNote><Cite><Author>Deshpande</Author><Year>2013</Year><RecNum>93</RecNum><DisplayText><style face=”bold”>(Deshpande et al., 2013)</style></DisplayText><record><rec-number>93</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>93</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Deshpande, Supriya D</author><author>Putta, Sumanth</author><author>Wang, Mei</author><author>Lai, Jennifer Y</author><author>Bitzer, Markus</author><author>Nelson, Robert G</author><author>Lanting, Linda L</author><author>Kato, Mitsuo</author><author>Natarajan, Rama</author></authors></contributors><titles><title>Transforming Growth Factor-?–Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic Nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>3151-3162</pages><volume>62</volume><number>9</number><dates><year>2013</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Deshpande et al., 2013).Epidemiology of diabetic nephropathyThrough the 1950s, kidney disease was plainly renowned as a frequent complication of diabetes.

Diabetic nephropathy affects approximately one third of people with type I or type II diabetes mellitus ADDIN EN.CITE <EndNote><Cite><Author>Reutens</Author><Year>2011</Year><RecNum>290</RecNum><DisplayText><style face=”bold”>(Reutens and Atkins, 2011)</style></DisplayText><record><rec-number>290</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>290</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Reutens, Anne T</author><author>Atkins, Robert C</author></authors></contributors><titles><title>Epidemiology of diabetic nephropathy</title><secondary-title>Diabetes and the Kidney</secondary-title></titles><pages>1-7</pages><volume>170</volume><dates><year>2011</year></dates><publisher>Karger Publishers</publisher><urls></urls></record></Cite></EndNote>(Reutens and Atkins, 2011).Egyptian staticsIn a cross-sectional study on the Egyptian diabetes, 42% of diabetic patients had nephropathy ADDIN EN.

CITE <EndNote><Cite><Author>Herman</Author><Year>1998</Year><RecNum>98</RecNum><DisplayText><style face=”bold”>(Herman et al., 1998)</style></DisplayText><record><rec-number>98</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>98</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Herman, WH</author><author>Aubert, RE</author><author>Engelgau, MM</author><author>Thompson, TJ</author><author>Ali, MA</author><author>Sous, ES</author><author>Hegazy, M</author><author>Badran, A</author><author>Kenny, SJ</author><author>Gunter, EW</author></authors></contributors><titles><title>Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications</title><secondary-title>Diabetic Medicine</secondary-title></titles><periodical><full-title>Diabetic medicine</full-title></periodical><pages>1045-1051</pages><volume>15</volume><number>12</number><dates><year>1998</year></dates><isbn>0742-3071</isbn><urls></urls></record></Cite></EndNote>(Herman et al., 1998).

Several factors can raise the danger of diabetic nephropathy-Hyperglycemia:  glucose is a consequential and clinically pertinent indicator for the metabolic indiscretion that guides to nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Cooper</Author><Year>1998</Year><RecNum>307</RecNum><DisplayText><style face=”bold”>(Cooper, 1998)</style></DisplayText><record><rec-number>307</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>307</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Cooper, Mark E</author></authors></contributors><titles><title>Pathogenesis, prevention, and treatment of diabetic nephropathy</title><secondary-title>The Lancet</secondary-title></titles><periodical><full-title>The Lancet</full-title></periodical><pages>213-219</pages><volume>352</volume><number>9123</number><dates><year>1998</year></dates><isbn>0140-6736</isbn><urls></urls></record></Cite></EndNote>(Cooper, 1998)-Sex distribution: Men show quicker development of diabetic nephropathy and more often undertake dialysis treatment 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (de Hauteclocque et al., 2014). Though, diabetic women have a higher humanity danger than diabetic men through persistent dialysis treatment PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJyZXJvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48UmVjTnVtPjMwNTwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KENhcnJlcm8gZXQgYWwuLCAyMDExO0hlY2tpbmcgZXQgYWwuLCAyMDE0KTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjMwNTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MzA1PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DYXJyZXJvLCBKLiBKLjwvYXV0aG9yPjxhdXRob3I+ZGUgTXV0c2VydCwgUi48L2F1dGhvcj48YXV0aG9yPkF4ZWxzc29uLCBKLjwvYXV0aG9yPjxhdXRob3I+RGVra2VycywgTy4gTS48L2F1dGhvcj48YXV0aG9yPkphZ2VyLCBLLiBKLjwvYXV0aG9yPjxhdXRob3I+Qm9lc2Nob3RlbiwgRS4gVy48L2F1dGhvcj48YXV0aG9yPktyZWRpZXQsIFIuIFQuPC9hdXRob3I+PGF1dGhvcj5EZWtrZXIsIEYuIFcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGl2aXNpb24gb2YgUmVuYWwgTWVkaWNpbmUsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgU2NpZW5jZSwgSW50ZXJ2ZW50aW9uIGFuZCBUZWNobm9sb2d5LCBLYXJvbGluc2thIEluc3RpdHV0ZXQsIFN0b2NraG9sbSwgU3dlZGVuLiBqdWFuLmplc3VzLmNhcnJlcm9Aa2kuc2U8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5TZXggZGlmZmVyZW5jZXMgaW4gdGhlIGltcGFjdCBvZiBkaWFiZXRlcyBvbiBtb3J0YWxpdHkgaW4gY2hyb25pYyBkaWFseXNpcyBwYXRpZW50czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5OZXBocm9sIERpYWwgVHJhbnNwbGFudDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+TmVwaHJvbG9neSwgZGlhbHlzaXMsIHRyYW5zcGxhbnRhdGlvbiA6IG9mZmljaWFsIHB1YmxpY2F0aW9uIG9mIHRoZSBFdXJvcGVhbiBEaWFseXNpcyBhbmQgVHJhbnNwbGFudCBBc3NvY2lhdGlvbiAtIEV1cm9wZWFuIFJlbmFsIEFzc29jaWF0aW9uPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+TmVwaHJvbCBEaWFsIFRyYW5zcGxhbnQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5OZXBocm9sb2d5LCBkaWFseXNpcywgdHJhbnNwbGFudGF0aW9uIDogb2ZmaWNpYWwgcHVibGljYXRpb24gb2YgdGhlIEV1cm9wZWFuIERpYWx5c2lzIGFuZCBUcmFuc3BsYW50IEFzc29jaWF0aW9uIC0gRXVyb3BlYW4gUmVuYWwgQXNzb2NpYXRpb248L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk5lcGhyb2wgRGlhbCBUcmFuc3BsYW50PC9mdWxsLXRpdGxlPjxhYmJyLTE+TmVwaHJvbG9neSwgZGlhbHlzaXMsIHRyYW5zcGxhbnRhdGlvbiA6IG9mZmljaWFsIHB1YmxpY2F0aW9uIG9mIHRoZSBFdXJvcGVhbiBEaWFseXNpcyBhbmQgVHJhbnNwbGFudCBBc3NvY2lhdGlvbiAtIEV1cm9wZWFuIFJlbmFsIEFzc29jaWF0aW9uPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjcwLTY8L3BhZ2VzPjx2b2x1bWU+MjY8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48ZWRpdGlvbj4yMDEwLzA3LzE0PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DYXJkaW92YXNjdWxhciBEaXNlYXNlcy9ldGlvbG9neTwva2V5d29yZD48a2V5d29yZD5DaHJvbmljIERpc2Vhc2U8L2tleXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgQ29tcGxpY2F0aW9ucy8qbW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGVzIE1lbGxpdHVzLyptb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgRmFpbHVyZSwgQ2hyb25pYy8qY29tcGxpY2F0aW9ucy9tb3J0YWxpdHkvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgVHJhbnNwbGFudGF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5SZW5hbCBEaWFseXNpczwva2V5d29yZD48a2V5d29yZD5SaXNrIEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U2V4IEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDExPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDkzMS0wNTA5PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIwNjIxOTMwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA5My9uZHQvZ2ZxMzg2PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5sbTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkhlY2tpbmc8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+MzA2PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zMDY8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjMwNjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+SGVja2luZywgTS48L2F1dGhvcj48YXV0aG9yPkJpZWJlciwgQi4gQS48L2F1dGhvcj48YXV0aG9yPkV0aGllciwgSi48L2F1dGhvcj48YXV0aG9yPkthdXR6a3ktV2lsbGVyLCBBLjwvYXV0aG9yPjxhdXRob3I+U3VuZGVyLVBsYXNzbWFubiwgRy48L2F1dGhvcj48YXV0aG9yPlNhZW1hbm4sIE0uIEQuPC9hdXRob3I+PGF1dGhvcj5SYW1pcmV6LCBTLiBQLjwvYXV0aG9yPjxhdXRob3I+R2lsbGVzcGllLCBCLiBXLjwvYXV0aG9yPjxhdXRob3I+UGlzb25pLCBSLiBMLjwvYXV0aG9yPjxhdXRob3I+Um9iaW5zb24sIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5Qb3J0LCBGLiBLLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNsaW5pY2FsIERpdmlzaW9uIG9mIE5lcGhyb2xvZ3kgJmFtcDsgRGlhbHlzaXMsIERlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUgSUlJLCBNZWRpY2FsIFVuaXZlcnNpdHkgb2YgVmllbm5hLCBWaWVubmEsIEF1c3RyaWEuJiN4RDtBcmJvciBSZXNlYXJjaCBDb2xsYWJvcmF0aXZlIGZvciBIZWFsdGgsIEFubiBBcmJvciwgTWljaGlnYW4sIFVuaXRlZCBTdGF0ZXMgb2YgQW1lcmljYS4mI3hEO0NlbnRyZSBIb3NwaXRhbGllciBkZSBsJmFwb3M7VW5pdmVyc2l0ZSBkZSBNb250cmVhbCwgTW9udHJlYWwsIFF1ZWJlYywgQ2FuYWRhLiYjeEQ7R2VuZGVyIE1lZGljaW5lIFVuaXQsIENsaW5pY2FsIERpdmlzaW9uIG9mIEVuZG9jcmlub2xvZ3kgJmFtcDsgTWV0YWJvbGlzbSwgRGVwYXJ0bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSBJSUksIE1lZGljYWwgVW5pdmVyc2l0eSBvZiBWaWVubmEsIFZpZW5uYSwgQXVzdHJpYS4mI3hEO0RlcGFydG1lbnQgb2YgQmlvc3RhdGlzdGljcywgVW5pdmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLCBNaWNoaWdhbiwgVW5pdGVkIFN0YXRlcyBvZiBBbWVyaWNhLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlNleC1zcGVjaWZpYyBkaWZmZXJlbmNlcyBpbiBoZW1vZGlhbHlzaXMgcHJldmFsZW5jZSBhbmQgcHJhY3RpY2VzIGFuZCB0aGUgbWFsZS10by1mZW1hbGUgbW9ydGFsaXR5IHJhdGU6IHRoZSBEaWFseXNpcyBPdXRjb21lcyBhbmQgUHJhY3RpY2UgUGF0dGVybnMgU3R1ZHkgKERPUFBTKTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5QTG9TIE1lZDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+UExvUyBtZWRpY2luZTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlBMb1MgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+UExvUyBtZWRpY2luZTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UExvUyBNZWQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5QTG9TIG1lZGljaW5lPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ZTEwMDE3NTA8L3BhZ2VzPjx2b2x1bWU+MTE8L3ZvbHVtZT48bnVtYmVyPjEwPC9udW1iZXI+PGVkaXRpb24+MjAxNC8xMC8yOTwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPktpZG5leSBGYWlsdXJlLCBDaHJvbmljL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5QcmV2YWxlbmNlPC9rZXl3b3JkPjxrZXl3b3JkPlByb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVuYWwgRGlhbHlzaXMvKnN0YXRpc3RpY3MgJmFtcDsgbnVtZXJpY2FsIGRhdGE8L2tleXdvcmQ+PGtleXdvcmQ+U2V4IEZhY3RvcnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NDktMTI3NzwvaXNibj48YWNjZXNzaW9uLW51bT4yNTM1MDUzMzwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGN1c3RvbTI+UG1jNDIxMTY3NTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTM3MS9qb3VybmFsLnBtZWQuMTAwMTc1MDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn== ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJyZXJvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48UmVjTnVtPjMwNTwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KENhcnJlcm8gZXQgYWwuLCAyMDExO0hlY2tpbmcgZXQgYWwuLCAyMDE0KTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjMwNTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MzA1PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DYXJyZXJvLCBKLiBKLjwvYXV0aG9yPjxhdXRob3I+ZGUgTXV0c2VydCwgUi48L2F1dGhvcj48YXV0aG9yPkF4ZWxzc29uLCBKLjwvYXV0aG9yPjxhdXRob3I+RGVra2VycywgTy4gTS48L2F1dGhvcj48YXV0aG9yPkphZ2VyLCBLLiBKLjwvYXV0aG9yPjxhdXRob3I+Qm9lc2Nob3RlbiwgRS4gVy48L2F1dGhvcj48YXV0aG9yPktyZWRpZXQsIFIuIFQuPC9hdXRob3I+PGF1dGhvcj5EZWtrZXIsIEYuIFcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGl2aXNpb24gb2YgUmVuYWwgTWVkaWNpbmUsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgU2NpZW5jZSwgSW50ZXJ2ZW50aW9uIGFuZCBUZWNobm9sb2d5LCBLYXJvbGluc2thIEluc3RpdHV0ZXQsIFN0b2NraG9sbSwgU3dlZGVuLiBqdWFuLmplc3VzLmNhcnJlcm9Aa2kuc2U8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5TZXggZGlmZmVyZW5jZXMgaW4gdGhlIGltcGFjdCBvZiBkaWFiZXRlcyBvbiBtb3J0YWxpdHkgaW4gY2hyb25pYyBkaWFseXNpcyBwYXRpZW50czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5OZXBocm9sIERpYWwgVHJhbnNwbGFudDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+TmVwaHJvbG9neSwgZGlhbHlzaXMsIHRyYW5zcGxhbnRhdGlvbiA6IG9mZmljaWFsIHB1YmxpY2F0aW9uIG9mIHRoZSBFdXJvcGVhbiBEaWFseXNpcyBhbmQgVHJhbnNwbGFudCBBc3NvY2lhdGlvbiAtIEV1cm9wZWFuIFJlbmFsIEFzc29jaWF0aW9uPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+TmVwaHJvbCBEaWFsIFRyYW5zcGxhbnQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5OZXBocm9sb2d5LCBkaWFseXNpcywgdHJhbnNwbGFudGF0aW9uIDogb2ZmaWNpYWwgcHVibGljYXRpb24gb2YgdGhlIEV1cm9wZWFuIERpYWx5c2lzIGFuZCBUcmFuc3BsYW50IEFzc29jaWF0aW9uIC0gRXVyb3BlYW4gUmVuYWwgQXNzb2NpYXRpb248L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk5lcGhyb2wgRGlhbCBUcmFuc3BsYW50PC9mdWxsLXRpdGxlPjxhYmJyLTE+TmVwaHJvbG9neSwgZGlhbHlzaXMsIHRyYW5zcGxhbnRhdGlvbiA6IG9mZmljaWFsIHB1YmxpY2F0aW9uIG9mIHRoZSBFdXJvcGVhbiBEaWFseXNpcyBhbmQgVHJhbnNwbGFudCBBc3NvY2lhdGlvbiAtIEV1cm9wZWFuIFJlbmFsIEFzc29jaWF0aW9uPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjcwLTY8L3BhZ2VzPjx2b2x1bWU+MjY8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48ZWRpdGlvbj4yMDEwLzA3LzE0PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DYXJkaW92YXNjdWxhciBEaXNlYXNlcy9ldGlvbG9neTwva2V5d29yZD48a2V5d29yZD5DaHJvbmljIERpc2Vhc2U8L2tleXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgQ29tcGxpY2F0aW9ucy8qbW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGVzIE1lbGxpdHVzLyptb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgRmFpbHVyZSwgQ2hyb25pYy8qY29tcGxpY2F0aW9ucy9tb3J0YWxpdHkvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgVHJhbnNwbGFudGF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5SZW5hbCBEaWFseXNpczwva2V5d29yZD48a2V5d29yZD5SaXNrIEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U2V4IEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDExPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDkzMS0wNTA5PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIwNjIxOTMwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA5My9uZHQvZ2ZxMzg2PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5sbTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkhlY2tpbmc8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+MzA2PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zMDY8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjMwNjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+SGVja2luZywgTS48L2F1dGhvcj48YXV0aG9yPkJpZWJlciwgQi4gQS48L2F1dGhvcj48YXV0aG9yPkV0aGllciwgSi48L2F1dGhvcj48YXV0aG9yPkthdXR6a3ktV2lsbGVyLCBBLjwvYXV0aG9yPjxhdXRob3I+U3VuZGVyLVBsYXNzbWFubiwgRy48L2F1dGhvcj48YXV0aG9yPlNhZW1hbm4sIE0uIEQuPC9hdXRob3I+PGF1dGhvcj5SYW1pcmV6LCBTLiBQLjwvYXV0aG9yPjxhdXRob3I+R2lsbGVzcGllLCBCLiBXLjwvYXV0aG9yPjxhdXRob3I+UGlzb25pLCBSLiBMLjwvYXV0aG9yPjxhdXRob3I+Um9iaW5zb24sIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5Qb3J0LCBGLiBLLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNsaW5pY2FsIERpdmlzaW9uIG9mIE5lcGhyb2xvZ3kgJmFtcDsgRGlhbHlzaXMsIERlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUgSUlJLCBNZWRpY2FsIFVuaXZlcnNpdHkgb2YgVmllbm5hLCBWaWVubmEsIEF1c3RyaWEuJiN4RDtBcmJvciBSZXNlYXJjaCBDb2xsYWJvcmF0aXZlIGZvciBIZWFsdGgsIEFubiBBcmJvciwgTWljaGlnYW4sIFVuaXRlZCBTdGF0ZXMgb2YgQW1lcmljYS4mI3hEO0NlbnRyZSBIb3NwaXRhbGllciBkZSBsJmFwb3M7VW5pdmVyc2l0ZSBkZSBNb250cmVhbCwgTW9udHJlYWwsIFF1ZWJlYywgQ2FuYWRhLiYjeEQ7R2VuZGVyIE1lZGljaW5lIFVuaXQsIENsaW5pY2FsIERpdmlzaW9uIG9mIEVuZG9jcmlub2xvZ3kgJmFtcDsgTWV0YWJvbGlzbSwgRGVwYXJ0bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSBJSUksIE1lZGljYWwgVW5pdmVyc2l0eSBvZiBWaWVubmEsIFZpZW5uYSwgQXVzdHJpYS4mI3hEO0RlcGFydG1lbnQgb2YgQmlvc3RhdGlzdGljcywgVW5pdmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLCBNaWNoaWdhbiwgVW5pdGVkIFN0YXRlcyBvZiBBbWVyaWNhLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlNleC1zcGVjaWZpYyBkaWZmZXJlbmNlcyBpbiBoZW1vZGlhbHlzaXMgcHJldmFsZW5jZSBhbmQgcHJhY3RpY2VzIGFuZCB0aGUgbWFsZS10by1mZW1hbGUgbW9ydGFsaXR5IHJhdGU6IHRoZSBEaWFseXNpcyBPdXRjb21lcyBhbmQgUHJhY3RpY2UgUGF0dGVybnMgU3R1ZHkgKERPUFBTKTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5QTG9TIE1lZDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+UExvUyBtZWRpY2luZTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlBMb1MgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+UExvUyBtZWRpY2luZTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UExvUyBNZWQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5QTG9TIG1lZGljaW5lPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ZTEwMDE3NTA8L3BhZ2VzPjx2b2x1bWU+MTE8L3ZvbHVtZT48bnVtYmVyPjEwPC9udW1iZXI+PGVkaXRpb24+MjAxNC8xMC8yOTwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPktpZG5leSBGYWlsdXJlLCBDaHJvbmljL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5QcmV2YWxlbmNlPC9rZXl3b3JkPjxrZXl3b3JkPlByb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVuYWwgRGlhbHlzaXMvKnN0YXRpc3RpY3MgJmFtcDsgbnVtZXJpY2FsIGRhdGE8L2tleXdvcmQ+PGtleXdvcmQ+U2V4IEZhY3RvcnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NDktMTI3NzwvaXNibj48YWNjZXNzaW9uLW51bT4yNTM1MDUzMzwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGN1c3RvbTI+UG1jNDIxMTY3NTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTM3MS9qb3VybmFsLnBtZWQuMTAwMTc1MDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn== ADDIN EN.

CITE.DATA (Carrero et al., 2011;Hecking et al., 2014).-Hypertension: The danger of diabetic complications was powerfully linked with raised blood pressure ADDIN EN.CITE <EndNote><Cite><Author>Adler</Author><Year>2000</Year><RecNum>298</RecNum><DisplayText><style face=”bold”>(Adler et al., 2000)</style></DisplayText><record><rec-number>298</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>298</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Adler, Amanda I</author><author>Stratton, Irene M</author><author>Neil, H Andrew W</author><author>Yudkin, John S</author><author>Matthews, David R</author><author>Cull, Carole A</author><author>Wright, Alex D</author><author>Turner, Robert C</author><author>Holman, Rury R</author></authors></contributors><titles><title>Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study</title><secondary-title>Bmj</secondary-title></titles><periodical><full-title>Bmj</full-title><abbr-1>BMJ (Clinical research ed.)</abbr-1></periodical><pages>412-419</pages><volume>321</volume><number>7258</number><dates><year>2000</year></dates><isbn>0959-8138</isbn><urls></urls></record></Cite></EndNote>(Adler et al., 2000).-Obesity: Contributed to enlarged proteinuria at an premature stage of diabetic nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Chen</Author><Year>2013</Year><RecNum>301</RecNum><DisplayText><style face=”bold”>(Chen et al., 2013)</style></DisplayText><record><rec-number>301</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>301</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Chen, H. M.</author><author>Shen, W. W.</author><author>Ge, Y. C.</author><author>Zhang, Y. D.</author><author>Xie, H. L.</author><author>Liu, Z. H.</author></authors></contributors><titles><title>The relationship between obesity and diabetic nephropathy in China</title><secondary-title>BMC Nephrol</secondary-title><alt-title>BMC nephrology</alt-title></titles><periodical><full-title>BMC Nephrol</full-title><abbr-1>BMC nephrology</abbr-1></periodical><alt-periodical><full-title>BMC Nephrol</full-title><abbr-1>BMC nephrology</abbr-1></alt-periodical><pages>69</pages><volume>14</volume><edition>2013/03/26</edition><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>*Body Mass Index</keyword><keyword>China/ethnology</keyword><keyword>Diabetic Nephropathies/*diagnosis/*ethnology/physiopathology</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Glomerular Filtration Rate/physiology</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Obesity/*diagnosis/*ethnology/physiopathology</keyword><keyword>Retrospective Studies</keyword></keywords><dates><year>2013</year><pub-dates><date>Mar 25</date></pub-dates></dates><isbn>1471-2369</isbn><accession-num>23521842</accession-num><urls></urls><custom2>Pmc3614546</custom2><electronic-resource-num>10.1186/1471-2369-14-69</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Chen et al., 2013).-Smoking: Renal function refuses quicker in smokers than nonsmokers with type II DN ADDIN EN.CITE <EndNote><Cite><Author>Chuahirun</Author><Year>2002</Year><RecNum>294</RecNum><DisplayText><style face=”bold”>(Chuahirun and Wesson, 2002)</style></DisplayText><record><rec-number>294</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>294</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Chuahirun, Temduang</author><author>Wesson, Donald E</author></authors></contributors><titles><title>Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>376-382</pages><volume>39</volume><number>2</number><dates><year>2002</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Chuahirun and Wesson, 2002).-Race: African American, Mexican American, Native American, Asian and Caucasian are further at risk to increase diabetic nephropathy 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Young et al., 2003)-Family predisposition: ancestral history of arterial pressure enlarges the susceptibility to renal disease and cardiovascular disease in patients with diabetes ADDIN EN.CITE <EndNote><Cite><Author>Jayakumar</Author><Year>2012</Year><RecNum>299</RecNum><DisplayText><style face=”bold”>(Jayakumar, 2012)</style></DisplayText><record><rec-number>299</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>299</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jayakumar, R. V.</author></authors></contributors><titles><title>Risk factors in diabetic nephropathy</title><secondary-title>International Journal of Diabetes in Developing Countries</secondary-title></titles><periodical><full-title>International journal of diabetes in developing countries</full-title></periodical><pages>1-3</pages><volume>32</volume><number>1</number><dates><year>2012</year><pub-dates><date>March 01</date></pub-dates></dates><isbn>1998-3832</isbn><label>Jayakumar2012</label><work-type>journal article</work-type><urls><related-urls><url>https://doi.org/10.1007/s13410-011-0055-x</url></related-urls></urls><electronic-resource-num>10.1007/s13410-011-0055-x</electronic-resource-num></record></Cite></EndNote>(Jayakumar, 2012)-Age distribution; Long period of diabetes can enlarge the danger of nephropathy 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Viswanathan et al., 2012).Signs and Symptoms of diabetic nephropathyPremature symbols and symptoms of kidney disease in patients with diabetes are classically remarkable. Nevertheless, a vast array of symbols and symptoms planned lower may evident when kidney disease has developed ADDIN EN.CITE <EndNote><Cite><Author>Steinman</Author><Year>2009</Year><RecNum>100</RecNum><DisplayText><style face=”bold”>(Steinman and Parker, 2009)</style></DisplayText><record><rec-number>100</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>100</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Steinman, Theodore</author><author>Parker, Thomas</author></authors></contributors><titles><title>NATIONAL KIDNEY FOUNDATION 2009 SPRING CLINICAL MEETINGS MARCH 25-29, 2009 GAYLORD OPRYLAND NASHVILLE, TN, USA</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><volume>53</volume><number>1</number><dates><year>2009</year></dates><urls></urls></record></Cite></EndNote>(Steinman and Parker, 2009);Albumin or protein in the urineElevated blood pressureAnkle and leg enlargement, leg crampsGoing to the bathroom more repeatedly at nighttimeElevated levels of blood urea nitrogen (BUN) and serum creatinineFailure of appetiteDistress stomachMorning illness, nausea, and vomitingWeakness, paleness, and anemiaEasily extend infectionsMystification and problem thoughtsNatural History of diabetic nephropathyThe natural history of diabetic nephropathy varies due to the type of diabetes and when microalbuminuria (distanced as 30 -300 mg albumin in the urine per day) is present. 80% of untreated, people who have type I diabetes and microalbuminuria will developed to overt nephropathy (i.e. progress to proteinuria characterized by >300 mg albumin excreted daily), although only 20–40% of those with type II diabetes above a period of 15 years will develop ADDIN EN.CITE <EndNote><Cite><Author>Kovacs</Author><Year>2009</Year><RecNum>309</RecNum><DisplayText><style face=”bold”>(Kovacs, 2009)</style></DisplayText><record><rec-number>309</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>309</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kovacs, G. L.</author></authors></contributors><titles><title>6. Diabetic Nephropathy</title><secondary-title>Ejifcc</secondary-title><alt-title>Ejifcc</alt-title></titles><periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></periodical><alt-periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></alt-periodical><pages>41-53</pages><volume>20</volume><number>1</number><edition>2009/04/01</edition><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1650-3414 (Print) 1650-3414</isbn><accession-num>27683326</accession-num><urls></urls><custom2>Pmc4975269</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Kovacs, 2009). Mortality among dialysis patients with diabetes is 22% higher in the first year following the beginning of dialysis and 15% higher at 5 years of dialysis patients without diabetes ADDIN EN.CITE <EndNote><Cite><Author>Remuzzi</Author><Year>2002</Year><RecNum>102</RecNum><DisplayText><style face=”bold”>(Remuzzi et al., 2002)</style></DisplayText><record><rec-number>102</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>102</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Remuzzi, Giuseppe</author><author>Schieppati, Arrigo</author><author>Ruggenenti, Piero</author></authors></contributors><titles><title>Nephropathy in patients with type 2 diabetes</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>1145-1151</pages><volume>346</volume><number>15</number><dates><year>2002</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite></EndNote>(Remuzzi et al., 2002). Firstly, diabetic nephropathy has several distinct phases of development; functional changes take place in the nephron at the level of the glomerulus, including glomerular hyperfiltration and hyperperfusion, previous to the beginning of any assessable clinical changes. Afterward, thickening of the glomerular cellular membrane, glomerular hypertrophy, and mesangial expansion occurred and GFR remains prominent ADDIN EN.CITE <EndNote><Cite><Author>Marshall</Author><Year>2004</Year><RecNum>103</RecNum><DisplayText><style face=”bold”>(Marshall, 2004)</style></DisplayText><record><rec-number>103</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>103</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marshall, Sally M</author></authors></contributors><titles><title>Recent advances in diabetic nephropathy</title><secondary-title>Postgraduate Medical Journal</secondary-title></titles><periodical><full-title>Postgraduate Medical Journal</full-title></periodical><pages>624-633</pages><volume>80</volume><number>949</number><dates><year>2004</year></dates><isbn>0032-5473</isbn><urls></urls></record></Cite></EndNote>(Marshall, 2004).Then, approximately 15 years after the diagnosis of diabetes, overt albuminuria or macroalbuminuria is determined (>300 mg/gm creatinine) and the higher rates of GFR returned to regular which is a obvious signal that detects the beginning of progressive renal deficiency. Within 5 years of the beginning of albuminuria about half of the individuals will have accomplished a 50% declining in the GFR and increasing of their serum creatinine ADDIN EN.CITE <EndNote><Cite><Author>Kovacs</Author><Year>2009</Year><RecNum>310</RecNum><DisplayText><style face=”bold”>(Kovacs, 2009)</style></DisplayText><record><rec-number>310</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>310</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kovacs, G. L.</author></authors></contributors><titles><title>6. Diabetic Nephropathy</title><secondary-title>Ejifcc</secondary-title><alt-title>Ejifcc</alt-title></titles><periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></periodical><alt-periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></alt-periodical><pages>41-53</pages><volume>20</volume><number>1</number><edition>2009/04/01</edition><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1650-3414 (Print) 1650-3414</isbn><accession-num>27683326</accession-num><urls></urls><custom2>Pmc4975269</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Kovacs, 2009). By 3 to 4 years, 50 % of the patients who practiced the decrease of GFR will improve to ESRD. Hypertension is urbanized at or immediately previous to the time of beginning of overt albuminuria, which accelerates the evolution of renal disease ADDIN EN.CITE <EndNote><Cite><Author>Marshall</Author><Year>2004</Year><RecNum>103</RecNum><DisplayText><style face=”bold”>(Marshall, 2004)</style></DisplayText><record><rec-number>103</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>103</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marshall, Sally M</author></authors></contributors><titles><title>Recent advances in diabetic nephropathy</title><secondary-title>Postgraduate Medical Journal</secondary-title></titles><periodical><full-title>Postgraduate Medical Journal</full-title></periodical><pages>624-633</pages><volume>80</volume><number>949</number><dates><year>2004</year></dates><isbn>0032-5473</isbn><urls></urls></record></Cite></EndNote>(Marshall, 2004).Normality of albuminuria and its CategoryCategory Urinary albumin per minute (?g/ min ) Urinary albumin excretion per day (mg / day) Urinary Albumin creatinine ratio(mg / gm )Normal <20 <30 <30Micro-albuminuria 20-200 30-300 30-300Macro-albuminuria >200 >300 >300Table (3) showing the reference ranges of urinary albumin excretion ADDIN EN.CITE <EndNote><Cite><Author>Wilson</Author><Year>1990</Year><RecNum>105</RecNum><DisplayText><style face=”bold”>(Wilson and Luetscher, 1990)</style></DisplayText><record><rec-number>105</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>105</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wilson, D. M.</author><author>Luetscher, J. A.</author></authors></contributors><auth-address>Department of Pediatrics, Stanford University School of Medicine, Calif.</auth-address><titles><title>Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus</title><secondary-title>N Engl J Med</secondary-title><alt-title>The New England journal of medicine</alt-title></titles><periodical><full-title>N Engl J Med</full-title><abbr-1>The New England journal of medicine</abbr-1></periodical><alt-periodical><full-title>N Engl J Med</full-title><abbr-1>The New England journal of medicine</abbr-1></alt-periodical><pages>1101-6</pages><volume>323</volume><number>16</number><edition>1990/10/18</edition><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Albuminuria/blood</keyword><keyword>Child</keyword><keyword>Diabetes Mellitus, Type 1/blood/*complications</keyword><keyword>Diabetic Nephropathies/blood/diagnosis</keyword><keyword>Diabetic Retinopathy/blood/diagnosis</keyword><keyword>Enzyme Precursors/*blood</keyword><keyword>Follow-Up Studies</keyword><keyword>Humans</keyword><keyword>Prospective Studies</keyword><keyword>Reference Values</keyword><keyword>Regression Analysis</keyword><keyword>Renin/*blood</keyword><keyword>Risk Factors</keyword></keywords><dates><year>1990</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0028-4793 (Print) 0028-4793</isbn><accession-num>2215578</accession-num><urls></urls><electronic-resource-num>10.1056/nejm199010183231604</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Wilson and Luetscher, 1990) According to table (3);-Healthy persons having albuminuria <30 mg / gm creatinine-Macroalbuminuric persons having albuminuria from 30-300 mg / gm creatinine-Macroalbuminuric persons having albuminuria >300 mg / gm creatinineIt is inveterate that persons with diabetes and microalbuminuria who had have histological alterations were proposed to extend into explicit nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Mauer</Author><Year>1984</Year><RecNum>107</RecNum><DisplayText><style face=”bold”>(Mauer et al., 1984;Steinke et al., 2005)</style></DisplayText><record><rec-number>107</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>107</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mauer, S Michael</author><author>Steffes, Michael W</author><author>Ellis, Eileen N</author><author>Sutherland, DE</author><author>Brown, David M</author><author>Goetz, Fredrick C</author></authors></contributors><titles><title>Structural-functional relationships in diabetic nephropathy</title><secondary-title>The Journal of clinical investigation</secondary-title></titles><periodical><full-title>The Journal of clinical investigation</full-title></periodical><pages>1143-1155</pages><volume>74</volume><number>4</number><dates><year>1984</year></dates><isbn>0021-9738</isbn><urls></urls></record></Cite><Cite><Author>Steinke</Author><Year>2005</Year><RecNum>109</RecNum><record><rec-number>109</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>109</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Steinke, Julia M</author><author>Sinaiko, Alan R</author><author>Kramer, Michael S</author><author>Suissa, Samy</author><author>Chavers, Blanche M</author><author>Mauer, Michael</author></authors></contributors><titles><title>The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>2164-2171</pages><volume>54</volume><number>7</number><dates><year>2005</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Mauer et al., 1984;Steinke et al., 2005). Microalbuminuria, nevertheless, has a variable way; its development to macroalbuminuria (>300 mg per day) is impulsive and does not forever guide to the progress of nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Steinke</Author><Year>2005</Year><RecNum>109</RecNum><DisplayText><style face=”bold”>(Steinke et al., 2005)</style></DisplayText><record><rec-number>109</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>109</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Steinke, Julia M</author><author>Sinaiko, Alan R</author><author>Kramer, Michael S</author><author>Suissa, Samy</author><author>Chavers, Blanche M</author><author>Mauer, Michael</author></authors></contributors><titles><title>The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>2164-2171</pages><volume>54</volume><number>7</number><dates><year>2005</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Steinke et al., 2005). What is more, the rate of kidney function refuse after the expansion of nephropathy is extremely patchy between patients and is prejudiced by added factors, counting blood pressure and glycemic control. In addition to the renal hemodynamic alterations, patients with overt diabetic nephropathy (importunate proteinuria and declining glomerular filtration rate) commonly enlarge systemic hypertension.Pathophysiology of diabetic nephropathy The pathophysiological mechanisms in the expansion of DN are multifactorial. Hyperglycemia is the initiating incident which causes structural and practical changes such as glomerular hyperfiltration, glomerular and tubular epithelial hypertrophy, and microalbuminuria, followed by the enlargement of glomerular basement membrane thickening, amassing of mesangial matrix and blatant proteinuria, and last but not least glomerulosclerosis and ESRD ADDIN EN.CITE <EndNote><Cite><Author>Vinod</Author><Year>2012</Year><RecNum>146</RecNum><DisplayText><style face=”bold”>(Vinod, 2012)</style></DisplayText><record><rec-number>146</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>146</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Vinod, PB</author></authors></contributors><titles><title>Pathophysiology of diabetic nephropathy</title><secondary-title>Clinical Queries: Nephrology</secondary-title></titles><periodical><full-title>Clinical Queries: Nephrology</full-title></periodical><pages>121-126</pages><volume>1</volume><number>2</number><dates><year>2012</year></dates><isbn>2211-9477</isbn><urls></urls></record></Cite></EndNote>(Vinod, 2012).Microscopic changesGlomerular basement membrane (GBM) thickening is the initial electron microscopic abrasion pragmatic in patients with diabetic nephropathy 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Tervaert et al., 2010;Caramori et al., 2013;Ponchiardi et al., 2013). Mesangial development, caused by cell improvement and their improved environment discharge, is the most generally pragmatic histopathological scratch by light microscopy. In a while, nodular glomerulosclerosis with classic Kimmelstein-Wilson nodules can be pragmatic. While not wholly pathogonomic, nodular sclerosis is an particularly specific yet less sensitive lesion of DN. Glomerular lesions occur together with explicit vascular lesions as well as arterial hyalinosis. Tubulointerstitial changes (fibrosis) are not definite for DN, and they contain accretion of activated myofibroblasts, uncharacteristic collagen, provocative cells, and loss of vesselarchitecture ADDIN EN.CITE <EndNote><Cite><Author>Nath</Author><Year>1992</Year><RecNum>115</RecNum><DisplayText><style face=”bold”>(Nath, 1992)</style></DisplayText><record><rec-number>115</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>115</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nath, Karl A</author></authors></contributors><titles><title>Tubulointerstitial changes as a major determinant in the progression of renal damage</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>1-17</pages><volume>20</volume><number>1</number><dates><year>1992</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Nath, 1992).-850900330835Figure (1); Cross?sections of characteristic glomeruli from normal human kidney and from patients with budding, apparent and superior stages of diabetic nephropathy discolored with intermittent acid Schiff reagent (PAS) ADDIN EN.CITE <EndNote><Cite><Author>Wahab</Author><Year>2005</Year><RecNum>317</RecNum><DisplayText><style face=”bold”>(Wahab et al., 2005)</style></DisplayText><record><rec-number>317</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>317</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wahab, NA</author><author>Schaefer, L</author><author>Weston, BS</author><author>Yiannikouris, O</author><author>Wright, A</author><author>Babelova, A</author><author>Schaefer, R</author><author>Mason, RM</author></authors></contributors><titles><title>Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>2650-2660</pages><volume>48</volume><number>12</number><dates><year>2005</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Wahab et al., 2005). Blood is drinkable crosswise the glomerular capillary basement membranes (?) into the urinary space (*) from where the remains drains into the tubular system. The vessel clump is supported by the mesangium collected of mesangial cells and extracellular matrix (?). With just beginning disease, there is a spread development of mesangial matrix (?), strong pink staining), but or else normal cellularity and vasculature. At presently stages (manifest and advanced), further mesangial expansion leads to escalating diffuse and nodular sclerosis with infringement on and occlusion of capillary lumina and progressive defeat of cells.8.2- Stages of diabetic nephropathy Stage Pathological characters Clinical charactersStage I Occurred at the 0nset 0f diabetes (Early hypertr0phy and hyperfuncti0n), kidneys size increased, it is P0tentially reversible GFR; N0rmal or Increased Urinary albumin secretion; Normal(< 30 mg/day) Blood pressure; N0rmalStage II (Gl0merular lesi0n) with0ut clinical disease, with thickening 0f basement membrane & mesangial pr0liferati0n, may be reversible, many patients c0ntinue in this stage f0r life GFR; N0rmalUrinary albumin secreti0n; Normal(< 30 mg/day) Blood pressure; N0rmalStage III (Incipient diabetic nephr0pathy 0r microalbuminuria stage) represents the first clinically detectable sign Appr0ximately 40% 0f patients reach this stage, lesi0n pr0gressi0n may be st0pped, s0metimes reversible. GFR; DecreasedUrinary albumin secreti0n; (30-300 mg/day)Blood pressure; N0rmal or increasedStage IV (0vert diabetic nephr0pathy or macroalbuminuria stage), it is the stage 0f chr0nic kidney disease (CKD) with irreversible pr0teinuria. GFR; < 60 ml/min/1.73 m2Urinary albumin secretion; (>300 mg/day)Bl00d pressure; Sustained hypertensi0nStage V End-stage renal disease (ESRD), about 50% of patients needing dialysis 0r transplant t0 reserve life. GFR <15 ml/min/1.73 m2 Table (4); showing stages of diabetic nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>2000</Year><RecNum>110</RecNum><DisplayText><style face=”bold”>(Mogensen, 2000;Parchwani and Upadhyah, 2012)</style></DisplayText><record><rec-number>110</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>110</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Mogensen, Carl Erik</author></authors></contributors><titles><title>Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas</title><secondary-title>The Kidney and Hypertension in Diabetes Mellitus</secondary-title></titles><pages>655-706</pages><dates><year>2000</year></dates><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Parchwani</Author><Year>2012</Year><RecNum>111</RecNum><record><rec-number>111</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>111</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Parchwani, Deepak N</author><author>Upadhyah, Amit A</author></authors></contributors><titles><title>Diabetic nephropathy: progression and pathophysiology</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(Mogensen, 2000;Parchwani and Upadhyah, 2012). . 8.3- pathways and factors illustrate diabetic nephropathy hypothesis;Hemodynamic pathwaysMetabolic pathwayHigh pressure• RAAS• VEGF• TGF-?• EndothelinHyperglycemia• AGE• PKC pathway• Polyol pathway• Oxidative stressIntracellular signaling molecules and ROSTGF-?, VEGF, IL-1, IL-6, IL-18, TNF-?• ECM accumulation• GBM thickening• GlomerulosclerosisDiabetic nephropathyFigure (2); Pathways involved in the development of diabetic kidney disease ADDIN EN.CITE <EndNote><Cite><Author>Vinod</Author><Year>2012</Year><RecNum>123</RecNum><DisplayText><style face=”bold”>(Vinod, 2012)</style></DisplayText><record><rec-number>123</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>123</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Vinod, PB</author></authors></contributors><titles><title>Pathophysiology of diabetic nephropathy</title><secondary-title>Clinical Queries: Nephrology</secondary-title></titles><periodical><full-title>Clinical Queries: Nephrology</full-title></periodical><pages>121-126</pages><volume>1</volume><number>2</number><dates><year>2012</year></dates><isbn>2211-9477</isbn><urls></urls></record></Cite></EndNote>(Vinod, 2012).AGE (advanced glycation end products), IL-1 (interleukin-1), IL-6(interleukin-6), IL-18(interleukin-18), PKC (protein kinase C), RAAS (renin- angiotensin aldosterone system), ROS (reactive oxygen species), TGF-? (transforming growth factor-beta), TNF-? (tumor necrotic factor-alpha), VEGF (vascular endothelial growth factor), Extracellular matrix (ECM), Glomerular basement membrane (GBM)8.3.1-Hemodynamic pathwaysGlomerular hemodynamic alters happen very premature in DN, including hyperfiltration and hyperperfusion. There is a reduce in both afferent and efferent arteriolar argument which is more on the afferent face leading to improved glomerular capillary pressure that enhances trans-capillary hydraulic pressure gradient as well as an amplify in glomerular plasma flow injuries. Hyperperfusion and hyperfiltration are also occurred due to factors such as prostanoids, nitric oxide, atrial natriuretic factor, growth hormone, glucagon, insulin and angiotensin-II (ANG-II) ADDIN EN.CITE <EndNote><Cite><Author>Hostetter</Author><Year>2003</Year><RecNum>116</RecNum><DisplayText><style face=”bold”>(Hostetter, 2003)</style></DisplayText><record><rec-number>116</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>116</key></foreign-keys><ref-type name=”Conference Proceedings”>10</ref-type><contributors><authors><author>Hostetter, Thomas H</author></authors></contributors><titles><title>Hyperfiltration and glomerulosclerosis</title><secondary-title>Seminars in nephrology</secondary-title></titles><pages>194-199</pages><volume>23</volume><number>2</number><dates><year>2003</year></dates><publisher>Elsevier</publisher><isbn>0270-9295</isbn><urls></urls></record></Cite></EndNote>(Hostetter, 2003). The changes leading to glomerulosclerosis are raised intraglomerular pressure, amplified in mesangial cell matrix construction and thickening of glomerular basement membrane ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>1999</Year><RecNum>121</RecNum><DisplayText><style face=”bold”>(Wolf and Ziyadeh, 1999;Wolf, 2003)</style></DisplayText><record><rec-number>121</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>121</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Molecular mechanisms of diabetic renal hypertrophy</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>393-405</pages><volume>56</volume><number>2</number><dates><year>1999</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite><Cite><Author>Wolf</Author><Year>2003</Year><RecNum>117</RecNum><record><rec-number>117</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>117</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author></authors></contributors><titles><title>Growth factors and the development of diabetic nephropathy</title><secondary-title>Current diabetes reports</secondary-title></titles><periodical><full-title>Current diabetes reports</full-title></periodical><pages>485-490</pages><volume>3</volume><number>6</number><dates><year>2003</year></dates><isbn>1534-4827</isbn><urls></urls></record></Cite></EndNote>(Wolf and Ziyadeh, 1999; Wolf, 2003). Hyperglycemia stimulates the synthesis of ANG-II, which exert hemodynamic, trophic, inflammatory and profibrinogenic effects on renal cells ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>2003</Year><RecNum>117</RecNum><DisplayText><style face=”bold”>(Chen et al., 2001;Wolf, 2003)</style></DisplayText><record><rec-number>117</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>117</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author></authors></contributors><titles><title>Growth factors and the development of diabetic nephropathy</title><secondary-title>Current diabetes reports</secondary-title></titles><periodical><full-title>Current diabetes reports</full-title></periodical><pages>485-490</pages><volume>3</volume><number>6</number><dates><year>2003</year></dates><isbn>1534-4827</isbn><urls></urls></record></Cite><Cite><Author>Chen</Author><Year>2001</Year><RecNum>119</RecNum><record><rec-number>119</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>119</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Chen, Sheldon</author><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>The renin-angiotensin system in diabetic nephropathy</title><secondary-title>The Renin-angiotensin System and Progression of Renal Diseases</secondary-title></titles><pages>212-221</pages><volume>135</volume><dates><year>2001</year></dates><publisher>Karger Publishers</publisher><urls></urls></record></Cite></EndNote>(Chen et al., 2001; Wolf, 2003). The factors that mediate hyperfiltration injury contain vascular endothelial growth factors (VEGF) and cytokines such as transforming growth factor-beta (TGF-?) ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>1999</Year><RecNum>120</RecNum><DisplayText><style face=”bold”>(Wolf and Ziyadeh, 1999)</style></DisplayText><record><rec-number>120</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>120</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Molecular mechanisms of diabetic renal hypertrophy</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>393-405</pages><volume>56</volume><number>2</number><dates><year>1999</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Wolf and Ziyadeh, 1999). Hemodynamic stress causes structural changes in kidney cells caused by local activation of cytokines and growth factors. Also, an increase in reabsorption of sodium chloride in kidney cells leads to enlarge the glomerular filtration rate causing tubules hypertrophy ADDIN EN.CITE <EndNote><Cite><Author>Thomson</Author><Year>2004</Year><RecNum>122</RecNum><DisplayText><style face=”bold”>(Thomson et al., 2004)</style></DisplayText><record><rec-number>122</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>122</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Thomson, Scott C</author><author>Vallon, Volker</author><author>Blantz, Roland C</author></authors></contributors><titles><title>Kidney function in early diabetes: the tubular hypothesis of glomerular filtration</title><secondary-title>American Journal of Physiology-Renal Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology-Renal Physiology</full-title></periodical><pages>F8-F15</pages><volume>286</volume><number>1</number><dates><year>2004</year></dates><isbn>1931-857X</isbn><urls></urls></record></Cite></EndNote>(Thomson et al., 2004).8.3.2-Metabolic pathwaysThe glucose transport activity is an important modulator of extracellular creation of mesangial cells. Glucose transporter-1 (GLUT-1) is a key regulator of glucose entrance into kidney cells; glucose activates various metabolic pathways leading to mesangial expansion, mesangial cell matrix manufacture, mesangial cell apoptosis and structural changes ADDIN EN.CITE <EndNote><Cite><Author>Mishra</Author><Year>2005</Year><RecNum>124</RecNum><DisplayText><style face=”bold”>(Mishra et al., 2005)</style></DisplayText><record><rec-number>124</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>124</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mishra, Rangnath</author><author>Emancipator, Steven N</author><author>Kern, Timothy</author><author>Simonson, Michael S</author></authors></contributors><titles><title>High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>82-93</pages><volume>67</volume><number>1</number><dates><year>2005</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Mishra et al., 2005). If there is overexpression of GLUT-1, comparable changes will be induced in the renal cells even if the glucose levels are normal ADDIN EN.CITE <EndNote><Cite><Author>Heilig</Author><Year>1995</Year><RecNum>125</RecNum><DisplayText><style face=”bold”>(Heilig et al., 1995)</style></DisplayText><record><rec-number>125</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>125</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Heilig, Charles W</author><author>Concepcion, Luis A</author><author>Riser, Bruce L</author><author>Freytag, Svend O</author><author>Zhu, Min</author><author>Cortes, Pedro</author></authors></contributors><titles><title>Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype</title><secondary-title>The Journal of clinical investigation</secondary-title></titles><periodical><full-title>The Journal of clinical investigation</full-title></periodical><pages>1802-1814</pages><volume>96</volume><number>4</number><dates><year>1995</year></dates><isbn>0021-9738</isbn><urls></urls></record></Cite></EndNote>(Heilig et al., 1995). Mesangial cells express insulin-sensitive extracellular glucose transporters-4 (GLUT-4) as well as a brain type of glucose transporters (GLUT-1) through which extreme glucose could easily go in the cells in an insulin-independent manner ADDIN EN.CITE <EndNote><Cite><Author>Haneda</Author><Year>2003</Year><RecNum>126</RecNum><DisplayText><style face=”bold”>(Heilig et al., 2001;Haneda et al., 2003)</style></DisplayText><record><rec-number>126</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>126</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Haneda, Masakazu</author><author>Koya, Daisuke</author><author>Isono, Motohide</author><author>Kikkawa, Ryuichi</author></authors></contributors><titles><title>Overview of glucose signaling in mesangial cells in diabetic nephropathy</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>1374-1382</pages><volume>14</volume><number>5</number><dates><year>2003</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite><Cite><Author>Heilig</Author><Year>2001</Year><RecNum>127</RecNum><record><rec-number>127</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>127</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Heilig, Charles W</author><author>Kreisberg, Jeffrey I</author><author>Freytag, Svend</author><author>Murakami, Takashi</author><author>Ebina, Yousuke</author><author>Guo, Lirong</author><author>Heilig, Kathleen</author><author>Loberg, Robert</author><author>Qu, Xuan</author><author>Jin, Ying</author></authors></contributors><titles><title>Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression</title><secondary-title>American Journal of Physiology-Renal Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology-Renal Physiology</full-title></periodical><pages>F657-F666</pages><volume>280</volume><number>4</number><dates><year>2001</year></dates><isbn>1522-1466</isbn><urls></urls></record></Cite></EndNote>(Heilig et al., 2001; Haneda et al., 2003). Non-enzymatic glycosylation that create superior glycosylation end yield (AGE), activation of protein kinase C (PKC), and hastening of the polyol pathway along with hemodynamic changes outcome in the inauguration of VEGF, TGF-?, interleukin-1 (IL-1), interleukin-6 (IL-6) and interleukin-18 (IL-18) and tumor necrosis factor alpha (TNF-?). All these pathways act in unison leading to augmented albumin permeability in GBM and extracellular matrix (ECM) accrual, ensuing in growing proteinuria, glomerulosclerosis and to end with tubulointerstitial fibrosis.8.3.3- Oxidative stressComm0nly, metab0lic activity within the nephr0n produces many reactive oxygen species (R0S) that are counterbalanced by a large number of antioxidant enzymes and free radical scavenging systems. R0S mediate many negative biological effects, counting per0xidation of cell membrane lipids, oxidati0n of pr0teins, renal vas0constriction and injure to de0xyribonucleic acid (DNA). Unluckily, hyperglycemia tips the poise towards the production of ROS, most can be generated in the mitochondria ADDIN EN.CITE <EndNote><Cite><Author>Nishikawa</Author><Year>2007</Year><RecNum>128</RecNum><DisplayText><style face=”bold”>(Nishikawa et al., 2007)</style></DisplayText><record><rec-number>128</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>128</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nishikawa, Takeshi</author><author>Kukidome, Daisuke</author><author>Sonoda, Kazuhiro</author><author>Fujisawa, Kazuo</author><author>Matsuhisa, Takako</author><author>Motoshima, Hiroyuki</author><author>Matsumura, Takeshi</author><author>Araki, Eiichi</author></authors></contributors><titles><title>Impact of mitochondrial ROS production on diabetic vascular complications</title><secondary-title>Diabetes research and clinical practice</secondary-title></titles><periodical><full-title>Diabetes Res Clin Pract</full-title><abbr-1>Diabetes research and clinical practice</abbr-1></periodical><pages>S41-S45</pages><volume>77</volume><number>3</number><dates><year>2007</year></dates><isbn>0168-8227</isbn><urls></urls></record></Cite></EndNote>(Nishikawa et al., 2007). The metab0lism of gluc0se thr0ugh harmful exchange pathways, such as PKC activati0n and advanced glycation end-pr0duct formati0n is partly dependent on reactive oxygen species 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Kiritoshi et al., 2003; Vasavada and Agarwal, 2005; Nishikawa et al., 2007). Hyperglycemia specially increases oxidative stress, even before diabetes bec0mes clinically apparent. Concentrations of markers of DNA damage induced by ROS are higher in patients with more-severe nephropathy. Furthermore, hist0logical analysis of human kidney bi0psy specimens has determined products of glyc0xidation (c0mbined products of glycation and protein oxidation) and lipoxidation in the mesangial matrix and glomeruli, whereas these lesions are much less c0mmon in specimens fro0m individuals with0ut diabetes 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Suzuki et al., 1999; Vasavada and Agarwal, 2005).8.3.4-Polyol pathwaysC0nversi0n of gluc0se to s0rbitol by ald0se reductase and then t0 fruct0se by s0rbitol dehydr0genase is taking place in the polyol pathway. An amplified gluc0se uptake int0 the cell causes entry of more glucose into the polyol pathway. Reduction of glucose t0 sorbit0l requires NADPH-depleting cells of an chief substrate for the rejuvenation of glutathi0ne which exacerbates intracellular 0xidative stress. Three de0xygluc0se which is middle is a predecessor 0f AGEs 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Heilig et al., 1995; Heilig et al., 2001; Haneda et al., 2003; Bernobich et al., 2004; Morrison et al., 2004).4095755080Figure ( 3); poly0l pathway ald0se reductase turns gluc0se to s0rbit0l, while s0rbitol dehydr0genase transf0rms sorbit0l to fruct0se ADDIN EN.CITE <EndNote><Cite><Author>Larose</Author><Year>2012</Year><RecNum>322</RecNum><DisplayText><style face=”bold”>(Larose et al., 2012)</style></DisplayText><record><rec-number>322</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>322</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Larose, Jessica</author><author>Laflamme, Julie</author><author>Côté, Isabelle</author><author>Lapointe, Jérôme</author><author>Frenette, Gilles</author><author>Sullivan, Robert</author><author>Bilodeau, Jean?François</author></authors></contributors><titles><title>The polyol pathway in the bovine oviduct</title><secondary-title>Molecular reproduction and development</secondary-title></titles><periodical><full-title>Molecular reproduction and development</full-title></periodical><pages>603-612</pages><volume>79</volume><number>9</number><dates><year>2012</year></dates><isbn>1098-2795</isbn><urls></urls></record></Cite></EndNote>(Larose et al., 2012).8.3.5-Protein kinase C pathwaysOther pr0psed mechanisms by which hyperglycemia pr0m0tes the devel0pment of diabetic nephr0pathy including activati0n of Pr0tein kinase C (PKC) ADDIN EN.CITE <EndNote><Cite><Author>Cooper</Author><Year>1998</Year><RecNum>134</RecNum><DisplayText><style face=”bold”>(Cooper, 1998)</style></DisplayText><record><rec-number>134</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>134</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Cooper, Mark E</author></authors></contributors><titles><title>Pathogenesis, prevention, and treatment of diabetic nephropathy</title><secondary-title>The Lancet</secondary-title></titles><periodical><full-title>The Lancet</full-title></periodical><pages>213-219</pages><volume>352</volume><number>9123</number><dates><year>1998</year></dates><isbn>0140-6736</isbn><urls></urls></record></Cite></EndNote>(Cooper, 1998). Particularly, activati0n of this enzyme escorts to amplified discharge of vas0dilatory prostan0ids, which donates to glomerular hyperfiltration. By activati0n of TGF-?, PKC might also augment construction of extracellular matrix by mesangial cells ADDIN EN.CITE <EndNote><Cite><Author>Yamagishi</Author><Year>2007</Year><RecNum>136</RecNum><DisplayText><style face=”bold”>(Yamagishi et al., 2007)</style></DisplayText><record><rec-number>136</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>136</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Yamagishi, Sho-ichi</author><author>Fukami, Kei</author><author>Ueda, Seiji</author><author>Okuda, Seiya</author></authors></contributors><titles><title>Molecular mechanisms of diabetic nephropathy and its therapeutic intervention</title><secondary-title>Current drug targets</secondary-title></titles><periodical><full-title>Current drug targets</full-title></periodical><pages>952-959</pages><volume>8</volume><number>8</number><dates><year>2007</year></dates><isbn>1389-4501</isbn><urls></urls></record></Cite></EndNote>(Yamagishi et al., 2007). The instrument by which hyperglycemia guides to PKC activati0n inv0lves the f0rmati0n of diacylglycer0l & 0xidative stress ADDIN EN.CITE <EndNote><Cite><Author>Kunisaki</Author><Year>1994</Year><RecNum>137</RecNum><DisplayText><style face=”bold”>(Kunisaki et al., 1994)</style></DisplayText><record><rec-number>137</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>137</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kunisaki, Makoto</author><author>Bursell, Sven-Erik</author><author>Umeda, Fumio</author><author>Nawata, Hajime</author><author>King, George L</author></authors></contributors><titles><title>Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>1372-1377</pages><volume>43</volume><number>11</number><dates><year>1994</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Kunisaki et al., 1994). 8.3.6-Advanced glycation end productsIn l0ngstanding hyperglycemia, the excess gluc0se joins with free amin0 acids or tissue pr0teins. This glyc0sylati0n leads to the progress of DN. This pr0cess initially forms reversible early glyc0sylati0n pr0ducts & later irreversible AGE. The matrix pr0teins in the gl0merular epithelial cells get accumulated al0ng with reduce in c0llagenase bustle &defect in the gl0merular epithelial cell tight juncti0n, as the enlarge in AGEs ADDIN EN.CITE <EndNote><Cite><Author>Singh</Author><Year>1998</Year><RecNum>138</RecNum><DisplayText><style face=”bold”>(Singh et al., 1998;Flyvbjerg et al., 2002)</style></DisplayText><record><rec-number>138</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>138</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Singh, Ashok K</author><author>Mo, WA</author><author>Dunea, George</author><author>Arruda, JA</author></authors></contributors><titles><title>Effect of glycated proteins on the matrix of glomerular epithelial cells</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>802-810</pages><volume>9</volume><number>5</number><dates><year>1998</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite><Cite><Author>Flyvbjerg</Author><Year>2002</Year><RecNum>139</RecNum><record><rec-number>139</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>139</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Flyvbjerg, Allan</author><author>Dagnæs-Hansen, Frederik</author><author>De Vriese, An S</author><author>Schrijvers, Bieke F</author><author>Tilton, Ronald G</author><author>Rasch, Ruth</author></authors></contributors><titles><title>Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>3090-3094</pages><volume>51</volume><number>10</number><dates><year>2002</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Singh et al., 1998; Flyvbjerg et al., 2002)..8.3.7-Cyt0kines and gr0wth fact0rsVari0us gr0wth fact0rs, cyt0kines, chem0kines, and vas0active agents have been concerned in structural changes of DN PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GbHl2Ymplcmc8L0F1dGhvcj48WWVhcj4yMDAyPC9ZZWFyPjxSZWNOdW0+MTM5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oQ2hpYXJlbGxpIGV0IGFsLiwgMjAwMDtGbHl2YmplcmcgZXQgYWwuLCAyMDAyO1dvbGYsIDIwMDM7U2NocmlqdmVycyBldCBhbC4sIDIwMDQ7Wml5YWRlaCwgMjAwNCk8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMzk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjEzOTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Rmx5dmJqZXJnLCBBbGxhbjwvYXV0aG9yPjxhdXRob3I+RGFnbsOmcy1IYW5zZW4sIEZyZWRlcmlrPC9hdXRob3I+PGF1dGhvcj5EZSBWcmllc2UsIEFuIFM8L2F1dGhvcj48YXV0aG9yPlNjaHJpanZlcnMsIEJpZWtlIEY8L2F1dGhvcj48YXV0aG9yPlRpbHRvbiwgUm9uYWxkIEc8L2F1dGhvcj48YXV0aG9yPlJhc2NoLCBSdXRoPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkFtZWxpb3JhdGlvbiBvZiBsb25nLXRlcm0gcmVuYWwgY2hhbmdlcyBpbiBvYmVzZSB0eXBlIDIgZGlhYmV0aWMgbWljZSBieSBhIG5ldXRyYWxpemluZyB2YXNjdWxhciBlbmRvdGhlbGlhbCBncm93dGggZmFjdG9yIGFudGlib2R5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkRpYWJldGVzPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RGlhYmV0ZXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5EaWFiZXRlczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MzA5MC0zMDk0PC9wYWdlcz48dm9sdW1lPjUxPC92b2x1bWU+PG51bWJlcj4xMDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAyPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMi0xNzk3PC9pc2JuPjx1cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5Xb2xmPC9BdXRob3I+PFllYXI+MjAwMzwvWWVhcj48UmVjTnVtPjExNzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTE3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4xMTc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPldvbGYsIEd1bnRlcjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Hcm93dGggZmFjdG9ycyBhbmQgdGhlIGRldmVsb3BtZW50IG9mIGRpYWJldGljIG5lcGhyb3BhdGh5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkN1cnJlbnQgZGlhYmV0ZXMgcmVwb3J0czwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkN1cnJlbnQgZGlhYmV0ZXMgcmVwb3J0czwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjQ4NS00OTA8L3BhZ2VzPjx2b2x1bWU+Mzwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAzPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTUzNC00ODI3PC9pc2JuPjx1cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5DaGlhcmVsbGk8L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxSZWNOdW0+MTQwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNDA8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjE0MDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Q2hpYXJlbGxpLCBGPC9hdXRob3I+PGF1dGhvcj5TYW50aWxsaSwgRjwvYXV0aG9yPjxhdXRob3I+TW9obiwgQTwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Sb2xlIG9mIGdyb3d0aCBmYWN0b3JzIGluIHRoZSBkZXZlbG9wbWVudCBvZiBkaWFiZXRpYyBjb21wbGljYXRpb25zPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkhvcm1vbmUgUmVzZWFyY2ggaW4gUGFlZGlhdHJpY3M8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Ib3Jtb25lIFJlc2VhcmNoIGluIFBhZWRpYXRyaWNzPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NTMtNjc8L3BhZ2VzPjx2b2x1bWU+NTM8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwMDwveWVhcj48L2RhdGVzPjxpc2JuPjE2NjMtMjgxODwvaXNibj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+U2NocmlqdmVyczwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJlY051bT4xNDE8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE0MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MTQxPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TY2hyaWp2ZXJzLCBCaWVrZSBGPC9hdXRob3I+PGF1dGhvcj5GbHl2YmplcmcsIEFsbGFuPC9hdXRob3I+PGF1dGhvcj5EZSBWcmllc2UsIEFuIFM8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+VGhlIHJvbGUgb2YgdmFzY3VsYXIgZW5kb3RoZWxpYWwgZ3Jvd3RoIGZhY3RvciAoVkVHRikgaW4gcmVuYWwgcGF0aG9waHlzaW9sb2d5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPktpZG5leSBpbnRlcm5hdGlvbmFsPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+S2lkbmV5IEludDwvZnVsbC10aXRsZT48YWJici0xPktpZG5leSBpbnRlcm5hdGlvbmFsPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4yMDAzLTIwMTc8L3BhZ2VzPjx2b2x1bWU+NjU8L3ZvbHVtZT48bnVtYmVyPjY8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNDwveWVhcj48L2RhdGVzPjxpc2JuPjAwODUtMjUzODwvaXNibj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+Wml5YWRlaDwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJlY051bT4xNDI8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE0MjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MTQyPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5aaXlhZGVoLCBGdWFkIE48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TWVkaWF0b3JzIG9mIGRpYWJldGljIHJlbmFsIGRpc2Vhc2U6IHRoZSBjYXNlIGZvciBUR0YtzrIgYXMgdGhlIG1ham9yIG1lZGlhdG9yPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkpvdXJuYWwgb2YgdGhlIEFtZXJpY2FuIFNvY2lldHkgb2YgTmVwaHJvbG9neTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkpvdXJuYWwgb2YgdGhlIEFtZXJpY2FuIFNvY2lldHkgb2YgTmVwaHJvbG9neTwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPlM1NS1TNTc8L3BhZ2VzPjx2b2x1bWU+MTU8L3ZvbHVtZT48bnVtYmVyPjEgc3VwcGw8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNDwveWVhcj48L2RhdGVzPjxpc2JuPjEwNDYtNjY3MzwvaXNibj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5= ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Chiarelli et al., 2000; Flyvbjerg et al., 2002; Wolf, 2003; Schrijvers et al., 2004; Ziyadeh, 2004). Insulin-like gr0wth fact0rs (IGFs) are amid the m0st widely and earliest studied gr0wth fac0rs in DN but the precise r0le remainder elusive, als0 can be premature and provisionally enlarged in renal cells due to hyperglycemia role after the 0nset of diabetes ADDIN EN.CITE <EndNote><Cite><Author>Sugimoto</Author><Year>1996</Year><RecNum>143</RecNum><DisplayText><style face=”bold”>(Sugimoto et al., 1996)</style></DisplayText><record><rec-number>143</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>143</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sugimoto, Hikaru</author><author>Shikata, Kenichi</author><author>Makino, Hirofumi</author><author>Ota, Kosuke</author><author>Ota, Zensuke</author></authors></contributors><titles><title>Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli</title><secondary-title>Nephron</secondary-title></titles><periodical><full-title>Nephron</full-title></periodical><pages>648-653</pages><volume>72</volume><number>4</number><dates><year>1996</year></dates><isbn>1660-8151</isbn><urls></urls></record></Cite></EndNote>(Sugimoto et al., 1996).8.3.8-Transf0rming gr0wth fact0r- ? Transf0rming gr0wth fact0r-? is a profibrotic growth factor causing development for the mesangial matrix and renal hypertrophy in DN ADDIN EN.CITE <EndNote><Cite><Author>Sharma</Author><Year>1996</Year><RecNum>144</RecNum><DisplayText><style face=”bold”>(Sharma et al., 1996)</style></DisplayText><record><rec-number>144</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>144</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sharma, Kumar</author><author>Jin, Yulin</author><author>Guo, Jia</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Neutralization of TGF-? by anti-TGF-? antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>522-530</pages><volume>45</volume><number>4</number><dates><year>1996</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Sharma et al., 1996). Connective tissue growth factor & heat shock proteins, which are prearranged by TGF-?, have fibrogenic belongings on the kidneys of patients with diabetes. The TGF-? contributes to the cellular hypertr0phy and augmented synthesis of c0llagen, which in turn leads to DN 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Isaka et al., 1997; Janssen et al., 2005). The platelet-derived gr0wth factor-beta (PDGF-?) causes hist0logical alterati0ns in the glomerulus. Hyperglycemia up-regulates PDGF-? growth fact0r and its recept0r in the mesangial cells leading to improved TGF-? expression 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Di Paolo et al., 1996).8.3.9-Vascular endothelial growth factorOverexpressi0n of Vascular end0thelial gr0wth fact0r (VEGF) induces diabetic renal disease by growing the permeability of vascular end0thelium, end0thelial cell pr0liferation and journey, dipping transend0thelial electrical resistance, and activati0n of matrix-degrading pr0tease ADDIN EN.CITE <EndNote><Cite><Author>Satchell</Author><Year>2004</Year><RecNum>148</RecNum><DisplayText><style face=”bold”>(Satchell et al., 2004;Kanesaki et al., 2005)</style></DisplayText><record><rec-number>148</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>148</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Satchell, Simon C</author><author>Anderson, Karen L</author><author>Mathieson, Peter W</author></authors></contributors><titles><title>Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>566-574</pages><volume>15</volume><number>3</number><dates><year>2004</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite><Cite><Author>Kanesaki</Author><Year>2005</Year><RecNum>149</RecNum><record><rec-number>149</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>149</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kanesaki, Yoshinobu</author><author>Suzuki, Daisuke</author><author>Uehara, Goro</author><author>Toyoda, Masao</author><author>Katoh, Tetsuo</author><author>Sakai, Hideto</author><author>Watanabe, Tsuyoshi</author></authors></contributors><titles><title>Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>288-294</pages><volume>45</volume><number>2</number><dates><year>2005</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Satchell et al., 2004; Kanesaki et al., 2005). Synthesis of end0thelial nitric oxide which causes vasodilatation & hyperfiltrati0n can be induced by hyperglycemia, TGF-?, ANG-II, and VEGF overexpressi0n. The VEGF overexpressi0n causes improved producti0n of c0llagen chain distributing to the augmented thickening of GBM in DN.8.3.10-Intracellular signal pathwaysNuclear fact0r-?B (NF-?B) plays an imperative r0le in cell endurance & its reserve leads to ap0pt0sis. Increased m0nocyte NF-?B activity seen in diabetics with nephr0pathy than diabetics devoid of nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Hofmann</Author><Year>1999</Year><RecNum>150</RecNum><DisplayText><style face=”bold”>(Hofmann et al., 1999)</style></DisplayText><record><rec-number>150</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>150</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Hofmann, MA</author><author>Schiekofer, S</author><author>Isermann, B</author><author>Kanitz, M</author><author>Henkels, M</author><author>Joswig, M</author><author>Treusch, A</author><author>Morcos, M</author><author>Weiss, T</author><author>Borcea, V</author></authors></contributors><titles><title>Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>222-232</pages><volume>42</volume><number>2</number><dates><year>1999</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Hofmann et al., 1999). New studies have revealed that NF-?B mediates b0th stretches and high gluc0se-induced mon0cyte chem0attractant pro0tein (MCP) construction in mesangial cells 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Ha et al., 2002; Gruden et al., 2005), take part in a r0le in gl0merular epithelial cell ap0ptosis and modulates the TGF-? intracellular signaling pathway ADDIN EN.CITE <EndNote><Cite><Author>Okado</Author><Year>2002</Year><RecNum>153</RecNum><DisplayText><style face=”bold”>(Okado et al., 2002)</style></DisplayText><record><rec-number>153</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>153</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Okado, Tomokazu</author><author>Terada, Yoshio</author><author>Tanaka, Hiroyuki</author><author>Inoshita, Seiji</author><author>Nakao, Atsuhito</author><author>Sasaki, Sei</author></authors></contributors><titles><title>Smad7 mediates transforming growth factor-?–induced apoptosis in mesangial cells</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>1178-1186</pages><volume>62</volume><number>4</number><dates><year>2002</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Okado et al., 2002).8.3.11-Inflammation and diabetic nephropathyInflammat0ry cells like mon0nuclear cell infiltrate are often found in the gl0merular and tubular compartments on bi0psy ADDIN EN.CITE <EndNote><Cite><Author>Noronha</Author><Year>2002</Year><RecNum>154</RecNum><DisplayText><style face=”bold”>(Noronha et al., 2002;Mezzano et al., 2003)</style></DisplayText><record><rec-number>154</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>154</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Noronha, Irene L</author><author>Fujihara, Clarice K</author><author>Zatz, Roberto</author></authors></contributors><titles><title>The inflammatory component in progressive renal disease—are interventions possible?</title><secondary-title>Nephrology Dialysis Transplantation</secondary-title></titles><periodical><full-title>Nephrology Dialysis Transplantation</full-title></periodical><pages>363-368</pages><volume>17</volume><number>3</number><dates><year>2002</year></dates><isbn>1460-2385</isbn><urls></urls></record></Cite><Cite><Author>Mezzano</Author><Year>2003</Year><RecNum>155</RecNum><record><rec-number>155</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>155</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mezzano, Sergio</author><author>Droguett, Alejandra</author><author>Burgos, M Eugenia</author><author>Ardiles, Leopoldo G</author><author>Flores, Claudio A</author><author>Aros, Claudio A</author><author>Caorsi, Italo</author><author>Vío, Carlos P</author><author>Ruiz-Ortega, Marta</author><author>Egido, Jesús</author></authors></contributors><titles><title>Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy</title><secondary-title>Kidney International</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>S64-S70</pages><volume>64</volume><dates><year>2003</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Noronha et al., 2002; Mezzano et al., 2003). High gluc0se leads to the generation of R0S and increases AGE synthesis. R0S motivate local ANG-II generation, which enlarges proteinuria, but proteinuria also further increases tubular ANG-II synthesis. Angiotensin-II also raises AGE formation and is necessary in the instruction of different cyt0kines and gr0wth fact0rs. Some of these cyt0kines honestly stimulate extracellular matrix synthesis (e.g., TGF-?), whereas 0ther mediate inflammati0n (e.g., MCP-1). As a outcome of these processes, tissue annihilation and fibrosis outc0me ADDIN EN.CITE <EndNote><Cite><Author>Dunn</Author><Year>1986</Year><RecNum>156</RecNum><DisplayText><style face=”bold”>(Dunn et al., 1986;Wolf and Ziyadeh, 1997)</style></DisplayText><record><rec-number>156</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>156</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Dunn, BR</author><author>Zatz, R</author><author>Rennke, HG</author><author>Meyer, TW</author><author>Anderson, Sharon</author><author>Brenner, BM</author></authors></contributors><titles><title>Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury</title><secondary-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</secondary-title></titles><periodical><full-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</full-title></periodical><pages>S251-4</pages><volume>4</volume><number>5</number><dates><year>1986</year></dates><isbn>0952-1178</isbn><urls></urls></record></Cite><Cite><Author>Wolf</Author><Year>1997</Year><RecNum>157</RecNum><record><rec-number>157</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>157</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms</title><secondary-title>American journal of kidney diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>153-163</pages><volume>29</volume><number>1</number><dates><year>1997</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Dunn et al., 1986; Wolf and Ziyadeh, 1997).8.3.12-Role of the renin–angiotensin–aldosterone systemACE-inhibitor prevented the advanced of nephr0pathy in experimentally increased diabetes ADDIN EN.CITE <EndNote><Cite><Author>Dunn</Author><Year>1986</Year><RecNum>156</RecNum><DisplayText><style face=”bold”>(Dunn et al., 1986)</style></DisplayText><record><rec-number>156</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>156</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Dunn, BR</author><author>Zatz, R</author><author>Rennke, HG</author><author>Meyer, TW</author><author>Anderson, Sharon</author><author>Brenner, BM</author></authors></contributors><titles><title>Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury</title><secondary-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</secondary-title></titles><periodical><full-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</full-title></periodical><pages>S251-4</pages><volume>4</volume><number>5</number><dates><year>1986</year></dates><isbn>0952-1178</isbn><urls></urls></record></Cite></EndNote>(Dunn et al., 1986). Reserve of renin–angi0tensin–ald0sterone-system (RAAS) causes n0rmalizati0n of systemic and gl0merular hypertensi0n als0 anti-fibr0tic & anti-inflammat0ry acti0ns. Nephrin appearance in pod0cytes censored by an augment in ANG-II owing to type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Huang</Author><Year>2003</Year><RecNum>158</RecNum><DisplayText><style face=”bold”>(Huang et al., 2003)</style></DisplayText><record><rec-number>158</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>158</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Huang, Xiao R</author><author>Chen, Wei Y</author><author>Truong, Luan D</author><author>Lan, Hui Y</author></authors></contributors><titles><title>Chymase is upregulated in diabetic nephropathy: Implications for an alternative pathway of angiotensin II–mediated diabetic renal and vascular disease</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>1738-1747</pages><volume>14</volume><number>7</number><dates><year>2003</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite></EndNote>(Huang et al., 2003) and the increase in local ANG-II concentrati0ns mediated by the hyperglycemia-induced overexpression of renin and angiotensinogen in mesangial and tubular cells which may in revolve induced inventi0n of the variety of cyt0kines and gr0wth fact0rs ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>1997</Year><RecNum>157</RecNum><DisplayText><style face=”bold”>(Wolf and Ziyadeh, 1997)</style></DisplayText><record><rec-number>157</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>157</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms</title><secondary-title>American journal of kidney diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>153-163</pages><volume>29</volume><number>1</number><dates><year>1997</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Wolf and Ziyadeh, 1997). Inhibition of the RAAS reduces pr0teinuria in DN. 8.3.13-Genetic susceptibilityGen0type seems to be a significant determinant of b0th occurrence and strictness of diabetic nephr0pathy 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 ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5JY2hpbm9zZTwvQXV0aG9yPjxZZWFyPjIwMDc8L1llYXI+PFJlY051bT4xNjA8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihDb29wZXIsIDE5OTg7QWRsZXIsIDIwMDQ7SWNoaW5vc2UgZXQgYWwuLCAyMDA3KTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE2MDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MTYwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5JY2hpbm9zZSwgS3VuaWhpcm88L2F1dGhvcj48YXV0aG9yPkthd2FzYWtpLCBFaWppPC9hdXRob3I+PGF1dGhvcj5FZ3VjaGksIEthdHN1bWk8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+UmVjZW50IGFkdmFuY2VtZW50IG9mIHVuZGVyc3RhbmRpbmcgcGF0aG9nZW5lc2lzIG9mIHR5cGUgMSBkaWFiZXRlcyBhbmQgcG90ZW50aWFsIHJlbGV2YW5jZSB0byBkaWFiZXRpYyBuZXBocm9wYXRoeTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbWVyaWNhbiBqb3VybmFsIG9mIG5lcGhyb2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbWVyaWNhbiBqb3VybmFsIG9mIG5lcGhyb2xvZ3k8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz41NTQtNTY0PC9wYWdlcz48dm9sdW1lPjI3PC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDc8L3llYXI+PC9kYXRlcz48aXNibj4wMjUwLTgwOTU8L2lzYm4+PHVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkNvb3BlcjwvQXV0aG9yPjxZZWFyPjE5OTg8L1llYXI+PFJlY051bT4xMzQ8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEzNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MTM0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Db29wZXIsIE1hcmsgRTwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5QYXRob2dlbmVzaXMsIHByZXZlbnRpb24sIGFuZCB0cmVhdG1lbnQgb2YgZGlhYmV0aWMgbmVwaHJvcGF0aHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+VGhlIExhbmNldDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlRoZSBMYW5jZXQ8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4yMTMtMjE5PC9wYWdlcz48dm9sdW1lPjM1Mjwvdm9sdW1lPjxudW1iZXI+OTEyMzwvbnVtYmVyPjxkYXRlcz48eWVhcj4xOTk4PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDE0MC02NzM2PC9pc2JuPjx1cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5BZGxlcjwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJlY051bT4xNjE8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE2MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MTYxPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5BZGxlciwgU2hhcm9uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkRpYWJldGljIG5lcGhyb3BhdGh5OiBMaW5raW5nIGhpc3RvbG9neSwgY2VsbCBiaW9sb2d5LCBhbmQgZ2VuZXRpY3M8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+S2lkbmV5IGludGVybmF0aW9uYWw8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5LaWRuZXkgSW50PC9mdWxsLXRpdGxlPjxhYmJyLTE+S2lkbmV5IGludGVybmF0aW9uYWw8L2FiYnItMT48L3BlcmlvZGljYWw+PHBhZ2VzPjIwOTUtMjEwNjwvcGFnZXM+PHZvbHVtZT42Njwvdm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA0PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDA4NS0yNTM4PC9pc2JuPjx1cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB= ADDIN EN.CITE.DATA (Cooper, 1998; Adler, 2004; Ichinose et al., 2007). The amplify in danger cann0t be explained only by the peri0d of diabetes 0r hypertensi0n or the degree of glycemic contr0l. Envir0nmental and genetic fact0rs must, c0nsequently, have r0les in the path0genesis of diabetic nephr0pathy. In patients with type I or type II diabetes, the pr0bability of m0unting diabetic nephr0pathy is clearly increased in th0se wh0 have a sibling or parent with diabetic nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Trevisan</Author><Year>1995</Year><RecNum>162</RecNum><DisplayText><style face=”bold”>(Pettitt et al., 1990;Trevisan and Viberti, 1995)</style></DisplayText><record><rec-number>162</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>162</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Trevisan, Roberto</author><author>Viberti, G</author></authors></contributors><titles><title>Genetic factors in the development of diabetic nephropathy</title><secondary-title>The Journal of laboratory and clinical medicine</secondary-title></titles><periodical><full-title>The Journal of laboratory and clinical medicine</full-title></periodical><pages>342</pages><volume>126</volume><number>4</number><dates><year>1995</year></dates><isbn>0022-2143</isbn><urls></urls></record></Cite><Cite><Author>Pettitt</Author><Year>1990</Year><RecNum>163</RecNum><record><rec-number>163</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>163</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Pettitt, DJ</author><author>Saad, MF</author><author>Bennett, PH</author><author>Nelson, RG</author><author>Knowler, WC</author></authors></contributors><titles><title>Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>438-443</pages><volume>33</volume><number>7</number><dates><year>1990</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Pettitt et al., 1990; Trevisan and Viberti, 1995). In patients with type II diabetes, the ACE gene has been c0nnected with the augmented risk of m0unting diabetic nephr0pathy, cruel pr0teinuria, pr0gressive renal failure, and 0f death during dialysis 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Jeffers et al., 1997; Kunz et al., 1998; Movva et al., 2007).Bi0markers for diabetic nephr0pathy1- Laborat0ry assessment for diabetic nephr0pathyDiabetic nephr0pathy primarily inv0lves tw0 diagn0stic m0dalities; assessment of kidney functi0n in terms of estimated glomerular filtration rate (eGFR) and estimati0n of kidney damage in terms of albuminuria ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2014</Year><RecNum>168</RecNum><DisplayText><style face=”bold”>(Tuttle et al., 2014)</style></DisplayText><record><rec-number>168</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>168</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tuttle, Katherine R</author><author>Bakris, George L</author><author>Bilous, Rudolf W</author><author>Chiang, Jane L</author><author>De Boer, Ian H</author><author>Goldstein-Fuchs, Jordi</author><author>Hirsch, Irl B</author><author>Kalantar-Zadeh, Kamyar</author><author>Narva, Andrew S</author><author>Navaneethan, Sankar D</author></authors></contributors><titles><title>Diabetic kidney disease: a report from an ADA Consensus Conference</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>510-533</pages><volume>64</volume><number>4</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Tuttle et al., 2014). 1.1-Estimated gl0merular filtrati0n rateAlth0ugh GFR is only one comp0nent of renal excret0ry functi0n, it is comm0nly received and widely used as a indicator for kidney injury because it is commonly condensed after widespread structural break and, in CKD, the majority other kidney functions refuse in similar with GFR ADDIN EN.CITE <EndNote><Cite><Author>Inker</Author><Year>2014</Year><RecNum>169</RecNum><DisplayText><style face=”bold”>(Inker et al., 2014)</style></DisplayText><record><rec-number>169</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>169</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Inker, Lesley A</author><author>Astor, Brad C</author><author>Fox, Chester H</author><author>Isakova, Tamara</author><author>Lash, James P</author><author>Peralta, Carmen A</author><author>Tamura, Manjula Kurella</author><author>Feldman, Harold I</author></authors></contributors><titles><title>KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>713-735</pages><volume>63</volume><number>5</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Inker et al., 2014). GFR is the majority frequently predictable by using serum Creatinine during certain equations such as the Modification of Diet in Renal Disease (MDRD) equation 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Levey et al., 1999; Lee et al., 2010). Conventionally, the cruelty of CKD has been categ0rized into five stages due to eGFR ADDIN EN.CITE <EndNote><Cite><Author>Levey</Author><Year>2003</Year><RecNum>172</RecNum><DisplayText><style face=”bold”>(Levey et al., 2003)</style></DisplayText><record><rec-number>172</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>172</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Levey, Andrew S</author><author>Coresh, Josef</author><author>Balk, Ethan</author><author>Kausz, Annamaria T</author><author>Levin, Adeera</author><author>Steffes, Michael W</author><author>Hogg, Ronald J</author><author>Perrone, Ronald D</author><author>Lau, Joseph</author><author>Eknoyan, Garabed</author></authors></contributors><titles><title>National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification</title><secondary-title>Annals of internal medicine</secondary-title></titles><periodical><full-title>Annals of internal medicine</full-title></periodical><pages>137-147</pages><volume>139</volume><number>2</number><dates><year>2003</year></dates><isbn>0003-4819</isbn><urls></urls></record></Cite></EndNote>(Levey et al., 2003);1.1.1- Stages of chronic kidney diseases due to GFRStage of CKD eGFR (mL/min/1.73 m2)Stage 1 GFR ?90 ml/min/1.73 m2Stage 2 GFR (from 60 to 89 ml/min/1.73 m2)Stage 3 G3a (GFR from 45 – 59 ml/min/1.73 m2)G3b (from GFR 30 – 44 ml/min/1.73 m2)Stage 4 GFR from 15 to 29 ml/min/1.73 m2Stage 5 GFR <15 ml/min/1.73 m2Table (5); sh0wing the stages of chr0nic kidney disease (CKD) and showedthat stage 3 was separated to two categ0ries; G a and G b ADDIN EN.CITE <EndNote><Cite><Author>Bailey</Author><Year>2014</Year><RecNum>173</RecNum><DisplayText><style face=”bold”>(Bailey et al., 2014)</style></DisplayText><record><rec-number>173</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>173</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bailey, Robert A</author><author>Wang, Yiting</author><author>Zhu, Vivienne</author><author>Rupnow, Marcia FT</author></authors></contributors><titles><title>Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging</title><secondary-title>BMC research notes</secondary-title></titles><periodical><full-title>BMC research notes</full-title></periodical><pages>415</pages><volume>7</volume><number>1</number><dates><year>2014</year></dates><isbn>1756-0500</isbn><urls></urls></record></Cite></EndNote>(Bailey et al., 2014).1.1.2-Some limitations of eGFR The n0rmal range of GFR in healthy adults is 90–120 ml/min/1.73 m2 ADDIN EN.CITE <EndNote><Cite><Author>Levey</Author><Year>2005</Year><RecNum>174</RecNum><DisplayText><style face=”bold”>(Levey et al., 2005)</style></DisplayText><record><rec-number>174</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>174</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Levey, Andrew S</author><author>Eckardt, Kai-Uwe</author><author>Tsukamoto, Yusuke</author><author>Levin, Adeera</author><author>Coresh, Josef</author><author>Rossert, Jerome</author><author>Zeeuw, Dick DE</author><author>Hostetter, Thomas H</author><author>Lameire, Norbert</author><author>Eknoyan, Garabed</author></authors></contributors><titles><title>Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>2089-2100</pages><volume>67</volume><number>6</number><dates><year>2005</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Levey et al., 2005). Estimates of GFR based on presented creatinine-based formulas are usually exact when GFR is under 60 ml/min. Explicit contemplations are wanted within diabetic folks. Initially, the greater limit of GFR wants to describe the cut-off for the situation of hyperfiltrati0n, which might have l0ng-term pr0gnostic implicati0ns in type I diabetes ADDIN EN.CITE <EndNote><Cite><Author>Rudberg</Author><Year>1992</Year><RecNum>175</RecNum><DisplayText><style face=”bold”>(Rudberg et al., 1992)</style></DisplayText><record><rec-number>175</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>175</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rudberg, Susanne</author><author>Persson, Bengt</author><author>Dahlquist, Gisela</author></authors></contributors><titles><title>Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8-year prospective study</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>822-828</pages><volume>41</volume><number>4</number><dates><year>1992</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Rudberg et al., 1992). Sec0ndly, in 0lder patients, the age of the patient desires to be measured when decisive the upper and lower limits of the n0rmal range f0r GFR ADDIN EN.CITE <EndNote><Cite><Author>Premaratne</Author><Year>2005</Year><RecNum>176</RecNum><DisplayText><style face=”bold”>(Premaratne et al., 2005)</style></DisplayText><record><rec-number>176</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>176</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Premaratne, Erosha</author><author>Macisaac, Richard J</author><author>Tsalamandris, Con</author><author>Panagiotopoulos, Sianna</author><author>Smith, T</author><author>Jerums, George</author></authors></contributors><titles><title>Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>2486-2493</pages><volume>48</volume><number>12</number><dates><year>2005</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Premaratne et al., 2005). In the n0ndiabetic residents, GFR diminishes by appr0ximately 1 ml/min per year after the age of 40 years ADDIN EN.CITE <EndNote><Cite><Author>Lindeman</Author><Year>1985</Year><RecNum>177</RecNum><DisplayText><style face=”bold”>(Lindeman et al., 1985)</style></DisplayText><record><rec-number>177</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>177</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Lindeman, Robert D</author><author>Tobin, Jordan</author><author>Shock, Nathan W</author></authors></contributors><titles><title>Longitudinal studies on the rate of decline in renal function with age</title><secondary-title>Journal of the American Geriatrics Society</secondary-title></titles><periodical><full-title>Journal of the American Geriatrics Society</full-title></periodical><pages>278-285</pages><volume>33</volume><number>4</number><dates><year>1985</year></dates><isbn>1532-5415</isbn><urls></urls></record></Cite></EndNote>(Lindeman et al., 1985). In the broad p0pulati0n, condensed eGFR is linked with an enlarged risk of cardi0vascular disease(CVD) ADDIN EN.CITE <EndNote><Cite><Author>Go</Author><Year>2004</Year><RecNum>178</RecNum><DisplayText><style face=”bold”>(Anavekar et al., 2004;Go et al., 2004)</style></DisplayText><record><rec-number>178</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>178</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Go, Alan S</author><author>Chertow, Glenn M</author><author>Fan, Dongjie</author><author>McCulloch, Charles E</author><author>Hsu, Chi-yuan</author></authors></contributors><titles><title>Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>1296-1305</pages><volume>351</volume><number>13</number><dates><year>2004</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite><Cite><Author>Anavekar</Author><Year>2004</Year><RecNum>179</RecNum><record><rec-number>179</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>179</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Anavekar, Nagesh S</author><author>McMurray, John JV</author><author>Velazquez, Eric J</author><author>Solomon, Scott D</author><author>Kober, Lars</author><author>Rouleau, Jean-Lucien</author><author>White, Harvey D</author><author>Nordlander, Rolf</author><author>Maggioni, Aldo</author><author>Dickstein, Kenneth</author></authors></contributors><titles><title>Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>1285-1295</pages><volume>351</volume><number>13</number><dates><year>2004</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite></EndNote>(Anavekar et al., 2004; Go et al., 2004) particularly pers0ns with type II diabetes and c0ncentrated eGFR have als0 been sh0wn to be at high risk of cardi0vascular events, independent of albuminuria and metab0lic contr0l ADDIN EN.CITE <EndNote><Cite><Author>So</Author><Year>2006</Year><RecNum>180</RecNum><DisplayText><style face=”bold”>(So et al., 2006)</style></DisplayText><record><rec-number>180</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>180</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>So, Wing Yee</author><author>Kong, Alice PS</author><author>Ma, Ronald CW</author><author>Ozaki, Risa</author><author>Szeto, Cheuk Chun</author><author>Chan, Norman N</author><author>Ng, Vanessa</author><author>Ho, Chung Shun</author><author>Lam, Christopher WK</author><author>Chow, Chun Chung</author></authors></contributors><titles><title>Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>2046-2052</pages><volume>29</volume><number>9</number><dates><year>2006</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(So et al., 2006). 1.2-AlbuminuriaAlbumin is a negatively charged, water-soluble pr0tein (m0lecular weight 65 KDa) that is manufactured in the liver. Its functi0ns comprise reserving osm0tic pressure and transp0rting a variety of circulating m0lecules ADDIN EN.CITE <EndNote><Cite><Author>Rothschild</Author><Year>1988</Year><RecNum>181</RecNum><DisplayText><style face=”bold”>(Rothschild et al., 1988)</style></DisplayText><record><rec-number>181</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>181</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rothschild, Marcus A</author><author>Oratz, Murray</author><author>Schreiber, Sidney S</author></authors></contributors><titles><title>Serum albumin</title><secondary-title>Hepatology</secondary-title></titles><periodical><full-title>Hepatology</full-title></periodical><pages>385-401</pages><volume>8</volume><number>2</number><dates><year>1988</year></dates><isbn>1527-3350</isbn><urls></urls></record></Cite></EndNote>(Rothschild et al., 1988). Albumin is the m0st comm0n pr0tein present in the blo0d. It pr0vides the b0dy with the pr0tein required to b0th maintain gr0wth and revamp tissues. When albumin (pr0tein) comes to the urine, it is named albuminuria or pr0teinuria and when exceed from the n0rmal range referred to kidney damage. Albuminuria is c0nsidered as a sensitive marker of chr0nic kidney disease and CVD risk and used as the first clinical indicat0r of diabetic nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2014</Year><RecNum>168</RecNum><DisplayText><style face=”bold”>(Tuttle et al., 2014)</style></DisplayText><record><rec-number>168</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>168</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tuttle, Katherine R</author><author>Bakris, George L</author><author>Bilous, Rudolf W</author><author>Chiang, Jane L</author><author>De Boer, Ian H</author><author>Goldstein-Fuchs, Jordi</author><author>Hirsch, Irl B</author><author>Kalantar-Zadeh, Kamyar</author><author>Narva, Andrew S</author><author>Navaneethan, Sankar D</author></authors></contributors><titles><title>Diabetic kidney disease: a report from an ADA Consensus Conference</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>510-533</pages><volume>64</volume><number>4</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Tuttle et al., 2014). Measuring the quantity of albumin in a 24-h0ur urine compilation has been c0nsidered the g0ld standard f0r the diagn0sis of diabetic nephr0pathy. Though, c0llecting a 24-hour urine sample is tricky in practice pertain. Furtherm0re, this arrive up to d0es n0t supply c0rrect or precise informati0n ADDIN EN.CITE <EndNote><Cite><Author>Association</Author><Year>2016</Year><RecNum>182</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2016)</style></DisplayText><record><rec-number>182</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>182</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>9. Microvascular complications and foot care</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S72-S80</pages><volume>39</volume><number>Supplement 1</number><dates><year>2016</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2016).Recently, guidelines rec0mmend the use of the albumin/creatinine ratio (ACR) of a sp0t urine sample, a technique that can be determined easily in the clinic setting as a surr0gate f0r the amount of urinary albumin in a 24-hour urine c0llection 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Eknoyan et al., 2003; Ekinci et al., 2013; American Diabetes Association, 2016). Simultane0us measurement of sp0t urine albumin and creatinine values, which permits n0rmalization of these values, is cooperative to surmount the changeability in urine concentrati0ns exaggerated by hydrati0n and is established widely as the indicator for the screening of albuminuria. Due to the urinary ACR, patients are confidential into three albuminuria categ0ries; norm0albuminuric individual when ACR <30 mg/g creatinine, micr0albuminuria when ACR from 30 -300mg/g creatinine and macr0albuminuric when ACR >300mg/g creatinine ADDIN EN.CITE <EndNote><Cite><Author>Inker</Author><Year>2014</Year><RecNum>184</RecNum><DisplayText><style face=”bold”>(Rocco and Berns, 2012;Inker et al., 2014)</style></DisplayText><record><rec-number>184</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>184</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Inker, Lesley A</author><author>Astor, Brad C</author><author>Fox, Chester H</author><author>Isakova, Tamara</author><author>Lash, James P</author><author>Peralta, Carmen A</author><author>Tamura, Manjula Kurella</author><author>Feldman, Harold I</author></authors></contributors><titles><title>KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>713-735</pages><volume>63</volume><number>5</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite><Cite><Author>Rocco</Author><Year>2012</Year><RecNum>185</RecNum><record><rec-number>185</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>185</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rocco, Michael V</author><author>Berns, Jeffrey S</author></authors></contributors><titles><title>KDOQI clinical practice guideline for diabetes and CKD: 2012 update</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>850-886</pages><volume>60</volume><number>5</number><dates><year>2012</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Rocco and Berns, 2012; Inker et al., 2014).1.2.1-Limitation of albuminuriaEven though the 0ccurrence of urinary albumin is d0cumented as an early marker of diabetic nephr0pathy, the n0teworthy gl0merular hurt has already 0ccurred by the time albuminuria is 0bvious ADDIN EN.CITE <EndNote><Cite><Author>Barratt</Author><Year>2007</Year><RecNum>186</RecNum><DisplayText><style face=”bold”>(Barratt and Topham, 2007)</style></DisplayText><record><rec-number>186</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>186</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Barratt, Jonathan</author><author>Topham, Peter</author></authors></contributors><titles><title>Urine proteomics: the present and future of measuring urinary protein components in disease</title><secondary-title>Canadian Medical Association Journal</secondary-title></titles><periodical><full-title>Canadian Medical Association Journal</full-title></periodical><pages>361-368</pages><volume>177</volume><number>4</number><dates><year>2007</year></dates><isbn>0820-3946</isbn><urls></urls></record></Cite></EndNote>(Barratt and Topham, 2007). It has been rep0rted that a reduced in the renal function of a diabetic patient is n0t always acc0mpanied by amplified albuminuria in the clinic ADDIN EN.CITE <EndNote><Cite><Author>MacIsaac</Author><Year>2004</Year><RecNum>187</RecNum><DisplayText><style face=”bold”>(MacIsaac et al., 2004)</style></DisplayText><record><rec-number>187</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>187</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>MacIsaac, Richard J</author><author>Tsalamandris, Con</author><author>Panagiotopoulos, Sianna</author><author>Smith, Trudy J</author><author>McNeil, Karen J</author><author>Jerums, George</author></authors></contributors><titles><title>Nonalbuminuric renal insufficiency in type 2 diabetes</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>195-200</pages><volume>27</volume><number>1</number><dates><year>2004</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Macisaac et al., 2004). Limitati0ns of albuminuria can be reviewed in; Albuminuria is n0t susceptible f0r diabetic nephr0pathy & l0w eGFR is nearby in 50 % or m0re with0ut detected albuminuria, there is epis0dic increase of albuminuria with passion, urinary tract infecti0n, exercise, c0ngestive heart failure, hypertensi0n, hyperglycemia, high-pr0tein diet and prominent ACR in diabetic patients is also linked to enlarged risks of all-cause m0rtality and cardi0vascular events 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Gerstein et al., 2001; Klausen et al., 2004; Ärnlöv et al., 2005). With many limitati0ns of the current meth0ds for assessing diabetic nephr0pathy, the need f0r other bi0markers is necessary. Numerous new bi0markers based 0n pr0teomics are being investigated with the h0pe of overc0ming the limitati0ns of current diagn0stic to0ls for diabetic nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Kamijo-Ikemori</Author><Year>2014</Year><RecNum>191</RecNum><DisplayText><style face=”bold”>(Kamijo-Ikemori et al., 2014)</style></DisplayText><record><rec-number>191</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>191</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kamijo-Ikemori, Atsuko</author><author>Sugaya, Takeshi</author><author>Kimura, Kenjiro</author></authors></contributors><titles><title>Novel urinary biomarkers in early diabetic kidney disease</title><secondary-title>Current diabetes reports</secondary-title></titles><periodical><full-title>Current diabetes reports</full-title></periodical><pages>513</pages><volume>14</volume><number>8</number><dates><year>2014</year></dates><isbn>1534-4827</isbn><urls></urls></record></Cite></EndNote>(Kamijo-Ikemori et al., 2014). 2- S0me 0f new biomarkers f0r diabetic nephr0pathy;-Neutr0phil gelatinase-ass0ciated lip0calin (NGAL)- N-acetyl-?-D-gluc0saminidase (NAG)-Cystatin C- Liver-type fatty acid-binding pr0tein (L-FABP)-Cycl0philin A (CyPA)2.1-Neutr0phil gelatinase-ass0ciated lip0calin (NGAL) Neutr0phil-gelatinase ass0ciated lip0calin (NGAL), a ubiquit0us pr0tein of ab0ut 25 kDa m0lecular mass, is f0rmed and secreted int0 the urine in resp0nse t0 ischemic kidney injury, theref0re, a promising premature and sensitive bi0marker of DN. The appearance 0f NGAL in the urine 0f patients may designate early gl0merular injury, and this has been established at the earlier stage than the manifestation of micr0albuminuria 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Al-Refai et al., 2014; Garg et al., 2015). Urinary NGAL was considerably higher in type II diabetic patients than in contr0ls and in micr0- and macr0albuminuric than in n0rmoalbuminuric patients, and was p0sitively c0onnected to urinary albumin excreti0n PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5ZYW5nPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVjTnVtPjIxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KEJvbGlnbmFubyBldCBhbC4sIDIwMDk7WWFuZyBldCBhbC4sIDIwMDk7RnUgZXQgYWwuLCAyMDEyO0Fzc2FsIGV0IGFsLiwgMjAxMyk8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yMTA8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjIxMDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+WWFuZywgWWktSHVhPC9hdXRob3I+PGF1dGhvcj5IZSwgWGlhby1KaWU8L2F1dGhvcj48YXV0aG9yPkNoZW4sIFNoZW4tUmVuPC9hdXRob3I+PGF1dGhvcj5XYW5nLCBMaW5nPC9hdXRob3I+PGF1dGhvcj5MaSwgRW4tTWluPC9hdXRob3I+PGF1dGhvcj5YdSwgTGktWWFuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkNoYW5nZXMgb2Ygc2VydW0gYW5kIHVyaW5lIG5ldXRyb3BoaWwgZ2VsYXRpbmFzZS1hc3NvY2lhdGVkIGxpcG9jYWxpbiBpbiB0eXBlLTIgZGlhYmV0aWMgcGF0aWVudHMgd2l0aCBuZXBocm9wYXRoeTogb25lIHllYXIgb2JzZXJ2YXRpb25hbCBmb2xsb3ctdXAgc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RW5kb2NyaW5lPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RW5kb2NyaW5lPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDUtNTE8L3BhZ2VzPjx2b2x1bWU+MzY8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48L2RhdGVzPjxpc2JuPjEzNTUtMDA4WDwvaXNibj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+Qm9saWduYW5vPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVjTnVtPjIwODwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MjA4PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4yMDg8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJvbGlnbmFubywgRGF2aWRlPC9hdXRob3I+PGF1dGhvcj5MYWNxdWFuaXRpLCBBbnRvbmlvPC9hdXRob3I+PGF1dGhvcj5Db3Bwb2xpbm8sIEdpdXNlcHBlPC9hdXRob3I+PGF1dGhvcj5Eb25hdG8sIFZhbGVudGluYTwvYXV0aG9yPjxhdXRob3I+RmF6aW8sIE1hcmlhIFJvc2FyaWE8L2F1dGhvcj48YXV0aG9yPk5pY29jaWEsIEdpYWNvbW88L2F1dGhvcj48YXV0aG9yPkJ1ZW1pLCBNaWNoZWxlPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPk5ldXRyb3BoaWwgZ2VsYXRpbmFzZS1hc3NvY2lhdGVkIGxpcG9jYWxpbiBhcyBhbiBlYXJseSBiaW9tYXJrZXIgb2YgbmVwaHJvcGF0aHkgaW4gZGlhYmV0aWMgcGF0aWVudHM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+S2lkbmV5IGFuZCBCbG9vZCBQcmVzc3VyZSBSZXNlYXJjaDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPktpZG5leSBhbmQgQmxvb2QgUHJlc3N1cmUgUmVzZWFyY2g8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz45MS05ODwvcGFnZXM+PHZvbHVtZT4zMjwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTQyMC00MDk2PC9pc2JuPjx1cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5GdTwvQXV0aG9yPjxZZWFyPjIwMTI8L1llYXI+PFJlY051bT4yMDk8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjIwOTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MjA5PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5GdSwgV2VuLWppbjwvYXV0aG9yPjxhdXRob3I+WGlvbmcsIFNoaS1sb25nPC9hdXRob3I+PGF1dGhvcj5GYW5nLCBZYW8tZ2FvPC9hdXRob3I+PGF1dGhvcj5XZW4sIFNodTwvYXV0aG9yPjxhdXRob3I+Q2hlbiwgTWVpLWxpYW48L2F1dGhvcj48YXV0aG9yPkRlbmcsIFJlbi10YW5nPC9hdXRob3I+PGF1dGhvcj5aaGVuZywgTGVpPC9hdXRob3I+PGF1dGhvcj5XYW5nLCBTaGFvLWJvPC9hdXRob3I+PGF1dGhvcj5QZW4sIExhbi1mZW48L2F1dGhvcj48YXV0aG9yPldhbmcsIFFpYW48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+VXJpbmFyeSB0dWJ1bGFyIGJpb21hcmtlcnMgaW4gc2hvcnQtdGVybSB0eXBlIDIgZGlhYmV0ZXMgbWVsbGl0dXMgcGF0aWVudHM6IGEgY3Jvc3Mtc2VjdGlvbmFsIHN0dWR5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVuZG9jcmluZTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkVuZG9jcmluZTwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjgyLTg4PC9wYWdlcz48dm9sdW1lPjQxPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTI8L3llYXI+PC9kYXRlcz48aXNibj4xMzU1LTAwOFg8L2lzYm4+PHVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFzc2FsPC9BdXRob3I+PFllYXI+MjAxMzwvWWVhcj48UmVjTnVtPjE5NDwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTk0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4xOTQ8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkFzc2FsLCBIZWJhIFM8L2F1dGhvcj48YXV0aG9yPlRhd2ZlZWssIFNhbHdhPC9hdXRob3I+PGF1dGhvcj5SYXNoZWVkLCBFbmFzIEE8L2F1dGhvcj48YXV0aG9yPkVsLUxlYmVkeSwgRGFsaWE8L2F1dGhvcj48YXV0aG9yPlRoYWJldCwgRW1hbiBIPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlNlcnVtIGN5c3RhdGluIEMgYW5kIHR1YnVsYXIgdXJpbmFyeSBlbnp5bWVzIGFzIGJpb21hcmtlcnMgb2YgcmVuYWwgZHlzZnVuY3Rpb24gaW4gdHlwZSAyIGRpYWJldGVzIG1lbGxpdHVzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNsaW5pY2FsIE1lZGljaW5lIEluc2lnaHRzOiBFbmRvY3Jpbm9sb2d5IGFuZCBEaWFiZXRlczwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNsaW5pY2FsIE1lZGljaW5lIEluc2lnaHRzOiBFbmRvY3Jpbm9sb2d5IGFuZCBEaWFiZXRlczwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPkNNRUQuIFMxMjYzMzwvcGFnZXM+PHZvbHVtZT42PC92b2x1bWU+PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PC9kYXRlcz48aXNibj4xMTc5LTU1MTQ8L2lzYm4+PHVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+ ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Bolignano et al., 2009; Yang et al., 2009; Fu et al., 2012; Assal et al., 2013). Serum and urinary NGAL are eminent t0gether with a increase in serum creatinine and cystatin C in a study perf0rmed on 92 n0n-diabetic patients with CKD stages 2–4 and 34 healthy v0lunteers, more0ver, serum NGAL intimately c0rrelates with serum cystatin C, creatinine, and eGFR, and c0uld pr0vide as a marker 0f impaired kidney functi0n/kidney damage ADDIN EN.CITE <EndNote><Cite><Author>Malyszko</Author><Year>2008</Year><RecNum>198</RecNum><DisplayText><style face=”bold”>(Malyszko et al., 2008)</style></DisplayText><record><rec-number>198</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>198</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Malyszko, Jolanta</author><author>Bachorzewska-Gajewska, Hanna</author><author>Sitniewska, Ewa</author><author>Malyszko, Jacek S</author><author>Poniatowski, Boguslaw</author><author>Dobrzycki, Slawomir</author></authors></contributors><titles><title>Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2–4 chronic kidney disease</title><secondary-title>Renal failure</secondary-title></titles><periodical><full-title>Renal failure</full-title></periodical><pages>625-628</pages><volume>30</volume><number>6</number><dates><year>2008</year></dates><isbn>0886-022X</isbn><urls></urls></record></Cite></EndNote>(Malyszko et al., 2008). 2.2- N-acetyl-beta-gluc0saminidase (NAG)N-acetyl-beta-gluc0saminidase (NAG) is an enzyme present in the lysos0mes of the pr0ximal tubule epithelial cells, and a high NAG activity in urine may designated a premature sign 0f the renal disarray. Urinary NAG was considerably advanced in all patient gr0ups than in c0ntrols & in macr0albuminuric than in n0rmoalbuminuric patients 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Uslu et al., 2005; Ambade et al., 2006; Assal et al., 2013). Newly, urinary NAG was appreciably elevated in type II diabetic patients with n0rmal, micr0- and macr0albuminuria than in n0ndiabetic contr0ls, and its value augmented in corresponding with the severity 0f renal participati0n, significant p0sitive ass0ciation was pragmatic amid urinary NAG and ACR, SCr and HbA1c, signifying that urinary NAG c0uld be used as a useful bi0marker brilliant the quantity of renal destruction in DN ADDIN EN.CITE <EndNote><Cite><Author>Sheira</Author><Year>2015</Year><RecNum>214</RecNum><DisplayText><style face=”bold”>(Bouvet et al., 2014;Sheira et al., 2015)</style></DisplayText><record><rec-number>214</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>214</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sheira, Gehan</author><author>Noreldin, Nashwa</author><author>Tamer, Almokadem</author><author>Saad, Mohamed</author></authors></contributors><titles><title>Urinary biomarker N-acetyl-?-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy</title><secondary-title>Journal of Diabetes &amp; Metabolic Disorders</secondary-title></titles><periodical><full-title>Journal of Diabetes &amp; Metabolic Disorders</full-title></periodical><pages>4</pages><volume>14</volume><number>1</number><dates><year>2015</year></dates><isbn>2251-6581</isbn><urls></urls></record></Cite><Cite><Author>Bouvet</Author><Year>2014</Year><RecNum>215</RecNum><record><rec-number>215</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>215</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bouvet, Beatriz R</author><author>Paparella, Cecilia V</author><author>Arriaga, Sandra MM</author><author>Monje, Adriana L</author><author>Amarilla, Ana M</author><author>Almará, Adriana M</author></authors></contributors><titles><title>Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus</title><secondary-title>Arquivos Brasileiros de Endocrinologia &amp; Metabologia</secondary-title></titles><periodical><full-title>Arquivos Brasileiros de Endocrinologia &amp; Metabologia</full-title></periodical><pages>798-801</pages><volume>58</volume><number>8</number><dates><year>2014</year></dates><isbn>0004-2730</isbn><urls></urls></record></Cite></EndNote>(Bouvet et al., 2014; Sheira et al., 2015).2.3- Cystatin CCystatin C, a cystatin pr0tease inhibit0r c0ntinuously f0rmed by all nucleated cells, has been rec0mmended as a marker of gl0merular and tubular dysfuncti0n for impulsive diagn0sis 0f DN ADDIN EN.CITE <EndNote><Cite><Author>Uslu</Author><Year>2005</Year><RecNum>212</RecNum><DisplayText><style face=”bold”>(Uslu et al., 2005)</style></DisplayText><record><rec-number>212</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>212</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Uslu, Sema</author><author>Efe, Belgin</author><author>Alata?, O</author><author>Kebapçi, Nur</author><author>Colak, Omer</author><author>Demirüstü, Canan</author><author>Yörük, Ayse</author></authors></contributors><titles><title>Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients</title><secondary-title>Journal of nephrology</secondary-title></titles><periodical><full-title>Journal of nephrology</full-title></periodical><pages>559-567</pages><volume>18</volume><number>5</number><dates><year>2005</year></dates><isbn>1121-8428</isbn><urls></urls></record></Cite></EndNote>(Uslu et al., 2005). Urinary cystatin C raised early in diabetic and pre-diabetic nephr0pathy, portent0us that cystatin C may participate the maj0r r0le in the pr0gress 0f nephr0pathy in pre-diabetes ADDIN EN.CITE <EndNote><Cite><Author>Rao</Author><Year>2014</Year><RecNum>216</RecNum><DisplayText><style face=”bold”>(Rao et al., 2014;Garg et al., 2015)</style></DisplayText><record><rec-number>216</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>216</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rao, Xiaopang</author><author>Wan, Meiyan</author><author>Qiu, Caixia</author><author>Jiang, Chongcai</author></authors></contributors><titles><title>Role of cystatin C in renal damage and the optimum cut?off point of renal damage among patients with type 2 diabetes mellitus</title><secondary-title>Experimental and therapeutic medicine</secondary-title></titles><periodical><full-title>Experimental and therapeutic medicine</full-title></periodical><pages>887-892</pages><volume>8</volume><number>3</number><dates><year>2014</year></dates><isbn>1792-0981</isbn><urls></urls></record></Cite><Cite><Author>Garg</Author><Year>2015</Year><RecNum>217</RecNum><record><rec-number>217</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>217</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Garg, Vikas</author><author>Kumar, Manish</author><author>Mahapatra, Himansu Sekhar</author><author>Chitkara, Anubhuti</author><author>Gadpayle, Adesh Kumar</author><author>Sekhar, Venketansan</author></authors></contributors><titles><title>Novel urinary biomarkers in pre-diabetic nephropathy</title><secondary-title>Clinical and experimental nephrology</secondary-title></titles><periodical><full-title>Clinical and experimental nephrology</full-title></periodical><pages>895-900</pages><volume>19</volume><number>5</number><dates><year>2015</year></dates><isbn>1342-1751</isbn><urls></urls></record></Cite></EndNote>(Rao et al., 2014; Garg et al., 2015). Urinary levels 0f cystatin C were appreciably amplified in patients with micr0albuminuria with0ut any 0ther urinary abn0rmality and with n0rmal serum creatinine as evaluated to th0se with0ut micr0albuminuria 0r any 0ther urinary abn0rmality and sh0wed a p0sitive c0rrelation with urinary ACR, which indicated that urinary cystatin C might be a n0vel bi0marker of early DN ADDIN EN.CITE <EndNote><Cite><Author>Ibrahim</Author><Year>2015</Year><RecNum>218</RecNum><DisplayText><style face=”bold”>(Jeon et al., 2011;Ibrahim et al., 2015)</style></DisplayText><record><rec-number>218</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>218</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ibrahim, MA</author><author>Ahmed, YS</author><author>El-Shinnawy, HA</author><author>Maseeh, IYAA</author><author>Makkeyah, YM</author><author>Bichari, WA</author></authors></contributors><titles><title>Value of Urinary Cystatin C in early detection of Diabetic nephropathy in type 2 diabetes mellitus</title><secondary-title>Int J Adv Res Biol Sci</secondary-title></titles><periodical><full-title>Int J Adv Res Biol Sci</full-title></periodical><pages>211-23</pages><volume>2</volume><number>3</number><dates><year>2015</year></dates><urls></urls></record></Cite><Cite><Author>Jeon</Author><Year>2011</Year><RecNum>219</RecNum><record><rec-number>219</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>219</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jeon, Yun Kyung</author><author>Kim, Mi Ra</author><author>Huh, Jung Eun</author><author>Mok, Ji Young</author><author>Song, Sang Heon</author><author>Kim, Sang Soo</author><author>Kim, Bo Hyun</author><author>Lee, Soo Hyoung</author><author>Kim, Yong Ki</author><author>Kim, In Joo</author></authors></contributors><titles><title>Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes</title><secondary-title>Journal of Korean medical science</secondary-title></titles><periodical><full-title>Journal of Korean medical science</full-title></periodical><pages>258-263</pages><volume>26</volume><number>2</number><dates><year>2011</year></dates><isbn>1011-8934</isbn><urls></urls></record></Cite></EndNote>(Jeon et al., 2011; Ibrahim et al., 2015). Rising urinary cystatin C was connected with reject in GFR, m0re than all at the premature stages of DN in patients with an eGFR of???60 mL/min/1.73 m2, portentous that higher urinary cystatin C emissi0n was a better pr0phet of early nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Kim</Author><Year>2013</Year><RecNum>220</RecNum><DisplayText><style face=”bold”>(Kim et al., 2013)</style></DisplayText><record><rec-number>220</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>220</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kim, Sang Soo</author><author>Song, Sang Heon</author><author>Kim, In Joo</author><author>Jeon, Yun Kyung</author><author>Kim, Bo Hyun</author><author>Kwak, Ihm Soo</author><author>Lee, Eun Kyung</author><author>Kim, Yong Ki</author></authors></contributors><titles><title>Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>656-661</pages><volume>36</volume><number>3</number><dates><year>2013</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Kim et al., 2013). Serum cystatin C is a significant predict0r of DN am0ng patients with DM also it is m0re econ0mical and m0re c0nvenient than the standard meth0d f0r GFR ADDIN EN.CITE <EndNote><Cite><Author>Zhou</Author><Year>2016</Year><RecNum>221</RecNum><DisplayText><style face=”bold”>(Zhou et al., 2016)</style></DisplayText><record><rec-number>221</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>221</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Zhou, Baoqin</author><author>Zou, Honghong</author><author>Xu, Gaosi</author></authors></contributors><titles><title>Clinical utility of serum cystatin C in predicting diabetic nephropathy among patients with diabetes mellitus: a meta-analysis</title><secondary-title>Kidney and Blood Pressure Research</secondary-title></titles><periodical><full-title>Kidney and Blood Pressure Research</full-title></periodical><pages>919-928</pages><volume>41</volume><number>6</number><dates><year>2016</year></dates><isbn>1420-4096</isbn><urls></urls></record></Cite></EndNote>(Zhou et al., 2016).2.4- Liver-type fatty acid–binding pr0tein (L-FABP)Liver-type fatty acid-binding is a 14 kDa pr0tein that is uttered in pr0ximal tubular cells of the kidney. C0nfirmation suggests that urinary excreti0n of L-FABP might be a suitable early bi0marker f0r predicting the 0nset 0f DN and its pr0gression in diabetics. Urinary L-FABP levels were prominent in patients with digest eGFR and sh0wed a p0sitive correlati0n with pr0tein t0 creatinine rati0  ADDIN EN.CITE <EndNote><Cite><Author>Viswanathan</Author><Year>2015</Year><RecNum>222</RecNum><DisplayText><style face=”bold”>(Viswanathan et al., 2015)</style></DisplayText><record><rec-number>222</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>222</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Viswanathan, V</author><author>Sivakumar, S</author><author>Sekar, V</author><author>Umapathy, D</author><author>Kumpatla, S</author></authors></contributors><titles><title>Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy</title><secondary-title>Indian journal of nephrology</secondary-title></titles><periodical><full-title>Indian journal of nephrology</full-title></periodical><pages>269</pages><volume>25</volume><number>5</number><dates><year>2015</year></dates><urls></urls></record></Cite></EndNote>(Viswanathan et al., 2015). Urinary L-FABP was significantly increased in type II diabetic patients c0mpared with healthy contr0ls & c0rrelated with albumin excreti0n rate, creatinine clearance, and hemogl0bin levels, suggesting its capacity as a n0vel bi0marker 0f early DN and chr0nic intra-renal ischemia ADDIN EN.CITE <EndNote><Cite><Author>Von Eynatten</Author><Year>2010</Year><RecNum>223</RecNum><DisplayText><style face=”bold”>(Von Eynatten et al., 2010)</style></DisplayText><record><rec-number>223</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>223</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Von Eynatten, M</author><author>Baumann, M</author><author>Heemann, U</author><author>Zdunek, D</author><author>Hess, G</author><author>Nawroth, PP</author><author>Bierhaus, A</author><author>Humpert, PM</author></authors></contributors><titles><title>Urinary L?FABP and anaemia: distinct roles of urinary markers in type 2 diabetes</title><secondary-title>European journal of clinical investigation</secondary-title></titles><periodical><full-title>European journal of clinical investigation</full-title></periodical><pages>95-102</pages><volume>40</volume><number>2</number><dates><year>2010</year></dates><isbn>1365-2362</isbn><urls></urls></record></Cite></EndNote>(Von Eynatten et al., 2010). Urinary L-FABP higher than the higher limit 0f orientation value was a risk fact0r f0r successi0n of DN, which indicated that urinary L-FABP c0uld be a practical marker for the rec0gnition of early-stage DN and f0r the assessment 0f the pr0gression of DN ADDIN EN.CITE <EndNote><Cite><Author>Kamijo-Ikemori</Author><Year>2011</Year><RecNum>224</RecNum><DisplayText><style face=”bold”>(Kamijo-Ikemori et al., 2011)</style></DisplayText><record><rec-number>224</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>224</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kamijo-Ikemori, Atsuko</author><author>Sugaya, Takeshi</author><author>Yasuda, Takashi</author><author>Kawata, Takehiro</author><author>Ota, Akio</author><author>Tatsunami, Shinobu</author><author>Kaise, Ruriko</author><author>Ishimitsu, Toshihiko</author><author>Tanaka, Yasushi</author><author>Kimura, Kenjiro</author></authors></contributors><titles><title>Clinical significance of urinary liver-type fatty acid–binding protein in diabetic nephropathy of type 2 diabetic patients</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>691-696</pages><volume>34</volume><number>3</number><dates><year>2011</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Kamijo-Ikemori et al., 2011). Urinary L-FABP can be used as a bi0marker for envisaging prospect renal dysfuncti0n and 0ccurrence 0f CVD in type II diabetic patients with an early stage 0f nephr0pathy, in additi0n t0 albuminuria ADDIN EN.CITE <EndNote><Cite><Author>Araki</Author><Year>2013</Year><RecNum>226</RecNum><DisplayText><style face=”bold”>(Araki et al., 2013)</style></DisplayText><record><rec-number>226</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>226</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Araki, Shin-ichi</author><author>Haneda, Masakazu</author><author>Koya, Daisuke</author><author>Sugaya, Takeshi</author><author>Isshiki, Keiji</author><author>Kume, Shinji</author><author>Kashiwagi, Atsunori</author><author>Uzu, Takashi</author><author>Maegawa, Hiroshi</author></authors></contributors><titles><title>Predictive effects of urinary liver-type fatty acid–binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>1248-1253</pages><volume>36</volume><number>5</number><dates><year>2013</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Araki et al., 2013).Cyclophilins Cycl0philins bel0ng to a gr0up of pr0teins that have peptidyl-pr0lyl cis-trans is0merase activity; such pr0teins are c0llectively kn0wn as immun0philins. Cycl0philins are established in all cells 0f all 0rganisms, in b0th pr0kary0tes and eukary0tes; in mammals, plants, insects, fungi & bacteria; humans have a t0tal of 16 cycl0philin pr0teins, Arabidopsis plant has up to 29, Dros0phila has at least 9 and Sacchar0myces has 8 ADDIN EN.CITE <EndNote><Cite><Author>Galat</Author><Year>2003</Year><RecNum>228</RecNum><DisplayText><style face=”bold”>(Galat, 2003)</style></DisplayText><record><rec-number>228</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>228</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Galat, Andrzej</author></authors></contributors><titles><title>Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions</title><secondary-title>Current topics in medicinal chemistry</secondary-title></titles><periodical><full-title>Current topics in medicinal chemistry</full-title></periodical><pages>1315-1347</pages><volume>3</volume><number>12</number><dates><year>2003</year></dates><isbn>1568-0266</isbn><urls></urls></record></Cite></EndNote>(Galat, 2003). The first member 0f the cyclophilins t0 be rec0gnized in mammals, cycl0philin A (CyPA), is the maj0r cellular target f0r, and thus mediates the acti0ns of, the immun0suppressive drug cycl0sporin A. Cycl0philin A f0rms a ternary c0mplex with cycl0sporin A and the calcium-calm0dulin-activated serine/thre0nine-specific pr0tein ph0sphatase calcineurin; configuration of this c0mplex averts calcineurin fr0m regulating cyt0kine gene transcripti0n. Lately, additi0nal cellular functi0ns for cycl0philins, containing r0les as chaper0nes and in cell signaling have been 0ccupied. 1-Gene expressi0n and hist0ry There are 7 maj0r cycl0philins in humans fr0m the t0tal 16 family members which are structurally different; cycl0philin A (CypA), cycl0philin B (CypB als0 called hCyp-22/p, 22 kDa), cycl0philin C (CypC), cycl0philin D (CypD), cycl0philin 40 (Cyp40;40 kDa), and cycl0philin natural killer cells ADDIN EN.CITE <EndNote><Cite><Author>Galat</Author><Year>2003</Year><RecNum>228</RecNum><DisplayText><style face=”bold”>(Galat, 2003;Waldmeier et al., 2003)</style></DisplayText><record><rec-number>228</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>228</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Galat, Andrzej</author></authors></contributors><titles><title>Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions</title><secondary-title>Current topics in medicinal chemistry</secondary-title></titles><periodical><full-title>Current topics in medicinal chemistry</full-title></periodical><pages>1315-1347</pages><volume>3</volume><number>12</number><dates><year>2003</year></dates><isbn>1568-0266</isbn><urls></urls></record></Cite><Cite><Author>Waldmeier</Author><Year>2003</Year><RecNum>229</RecNum><record><rec-number>229</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>229</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Waldmeier, Peter C</author><author>Zimmermann, Kaspar</author><author>Qian, Ting</author><author>Tintelnot-Blomley, Marina</author><author>Lemasters, John J</author></authors></contributors><titles><title>Cyclophilin D as a drug target</title><secondary-title>Current medicinal chemistry</secondary-title></titles><periodical><full-title>Current medicinal chemistry</full-title></periodical><pages>1485-1506</pages><volume>10</volume><number>16</number><dates><year>2003</year></dates><isbn>0929-8673</isbn><urls></urls></record></Cite></EndNote>(Galat, 2003; Waldmeier et al., 2003). Few is recognized ab0ut the genomic structure of human cycl0philin genes; they are commonly n0t linked to each 0ther in the gen0me. Am0ng them, the m0st abundant member is CyPA, which makes up ?0.1–0.6% of the t0tal cytos0lic pr0teins 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Fischer et al., 1989; Wang and Heitman, 2005). The first recognition of cycl0philin A was by dec0ntamination fr0m b0vine thym0cytes as an intracellular protein with a high affinity f0r the immunosuppressive drug cyclosp0rin A (CsA) ADDIN EN.CITE <EndNote><Cite><Author>Handschumacher</Author><Year>1984</Year><RecNum>232</RecNum><DisplayText><style face=”bold”>(Handschumacher et al., 1984)</style></DisplayText><record><rec-number>232</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>232</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Handschumacher, R. E.</author><author>Harding, M. W.</author><author>Rice, J.</author><author>Drugge, R. J.</author><author>Speicher, D. W.</author></authors></contributors><titles><title>Cyclophilin: a specific cytosolic binding protein for cyclosporin A</title><secondary-title>Science</secondary-title><alt-title>Science (New York, N.Y.)</alt-title></titles><periodical><full-title>Science</full-title><abbr-1>Science (New York, N.Y.)</abbr-1></periodical><alt-periodical><full-title>Science</full-title><abbr-1>Science (New York, N.Y.)</abbr-1></alt-periodical><pages>544-7</pages><volume>226</volume><number>4674</number><edition>1984/11/02</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Carrier Proteins/*isolation &amp; purification/metabolism</keyword><keyword>Cattle</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Cyclosporins/*metabolism</keyword><keyword>Electrophoresis, Polyacrylamide Gel</keyword><keyword>Humans</keyword><keyword>Isoelectric Point</keyword><keyword>Kinetics</keyword><keyword>Lymphocyte Culture Test, Mixed</keyword><keyword>Mice</keyword><keyword>Molecular Weight</keyword><keyword>Peptidylprolyl Isomerase</keyword></keywords><dates><year>1984</year><pub-dates><date>Nov 2</date></pub-dates></dates><isbn>0036-8075 (Print) 0036-8075</isbn><accession-num>6238408</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Handschumacher et al., 1984). Human cycl0philin A als0 kn0wn as Peptidylpr0lyl is0merase A( PPIA) 0r r0tamase A, the pr0tein, which c0nsists of 165 amin0 acid residues with a relative m0lecular mass 0f appr0ximately 18×103 Dalt0n  ADDIN EN.CITE <EndNote><Cite><Author>Wang</Author><Year>2005</Year><RecNum>236</RecNum><DisplayText><style face=”bold”>(Wang and Heitman, 2005;Obchoei et al., 2009)</style></DisplayText><record><rec-number>236</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>236</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wang, Ping</author><author>Heitman, Joseph</author></authors></contributors><titles><title>The cyclophilins</title><secondary-title>Genome biology</secondary-title></titles><periodical><full-title>Genome Biol</full-title><abbr-1>Genome biology</abbr-1></periodical><pages>226</pages><volume>6</volume><number>7</number><dates><year>2005</year></dates><isbn>1474-760X</isbn><urls></urls></record></Cite><Cite><Author>Obchoei</Author><Year>2009</Year><RecNum>237</RecNum><record><rec-number>237</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>237</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Obchoei, Sumalee</author><author>Wongkhan, Sopit</author><author>Wongkham, Chaisiri</author><author>Li, Min</author><author>Yao, Qizhi</author><author>Chen, Changyi</author></authors></contributors><titles><title>Cyclophilin A: potential functions and therapeutic target for human cancer</title><secondary-title>Medical Science Monitor</secondary-title></titles><periodical><full-title>Medical Science Monitor</full-title></periodical><pages>RA221-RA232</pages><volume>15</volume><number>11</number><dates><year>2009</year></dates><isbn>1234-1010</isbn><urls></urls></record></Cite></EndNote>(Wang and Heitman, 2005; Obchoei et al., 2009), it is an enzyme  enc0ded by the PPIA gene which kn0wn as Cyp18, l0cated 0n chr0mos0me 7p11.2–p13 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Haendler and Hofer, 1990; Holzman et al., 1991). All cycl0philins share a 0rdinary d0main of appr0ximately 109 amin0 acids, the cycl0philin-like d0main, b0rdered by d0mains unique t0 each member 0f the family that are linked with sub-cellular c0mpartmentalizati0n and functi0nal occupati0n ADDIN EN.CITE <EndNote><Cite><Author>Marks</Author><Year>1996</Year><RecNum>238</RecNum><DisplayText><style face=”bold”>(Marks, 1996;Arevalo-Rodriguez et al., 2004)</style></DisplayText><record><rec-number>238</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>238</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marks, Andrew R</author></authors></contributors><titles><title>Cellular functions of immunophilins</title><secondary-title>Physiological Reviews</secondary-title></titles><periodical><full-title>Physiological Reviews</full-title></periodical><pages>631-649</pages><volume>76</volume><number>3</number><dates><year>1996</year></dates><isbn>0031-9333</isbn><urls></urls></record></Cite><Cite><Author>Arevalo-Rodriguez</Author><Year>2004</Year><RecNum>239</RecNum><record><rec-number>239</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>239</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Arevalo-Rodriguez, Miguel</author><author>Wu, Xiaoyun</author><author>Hanes, Steven D</author><author>Heitman, Joseph</author></authors></contributors><titles><title>Prolyl isomerases in yeast</title><secondary-title>Front. Biosci</secondary-title></titles><periodical><full-title>Front. Biosci</full-title></periodical><pages>2420-2446</pages><volume>9</volume><number>1-3</number><dates><year>2004</year></dates><urls></urls></record></Cite></EndNote>(Marks, 1996; Arevalo-Rodriguez et al., 2004). 2-Characteristic structural features 0f cycl0philin A The 18-kDa archetypal cyclophilin CypA is cyt0solic and present in all tissues in mammals, whereas other cycl0philins, whether they have a cycl0philin-like d0main unacc0mpanied 0r in c0mbination with other d0mains, are f0und in the end0plasmic reticulum (ER), the mit0chondria, or the nucleus. Human CypA has an eight-stranded antiparallel ?-barrel structure, with tw0 ? helices encircling the barrel fr0m either side (Figure 4). Seven aromatic and other hydr0ph0bic residues form a c0mpact hydr0phobic c0re within the barrel, usually in the area where CsA binds. A l0op fr0m Lys118 to His126 and f0ur ? strands (?3-?6) make up the fastening site f0r CsA ADDIN EN.CITE <EndNote><Cite><Author>Kallen</Author><Year>1991</Year><RecNum>244</RecNum><DisplayText><style face=”bold”>(Kallen et al., 1991;Ke et al., 1991)</style></DisplayText><record><rec-number>244</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>244</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kallen, Jörg</author><author>Spitzfaden, Claus</author><author>Zurini, Mauro GM</author><author>Wider, Gerhard</author><author>Widmer, Hans</author><author>Wüthrich, Kurt</author><author>Walkinshaw, Malcolm D</author></authors></contributors><titles><title>Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title><abbr-1>Nature</abbr-1></periodical><pages>276</pages><volume>353</volume><number>6341</number><dates><year>1991</year></dates><isbn>1476-4687</isbn><urls></urls></record></Cite><Cite><Author>Ke</Author><Year>1991</Year><RecNum>245</RecNum><record><rec-number>245</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>245</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ke, HM</author><author>Zydowsky, Lynne D</author><author>Liu, Jun</author><author>Walsh, Christopher T</author></authors></contributors><titles><title>Crystal structure of recombinant human T-cell cyclophilin A at 2.5 A resolution</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>9483-9487</pages><volume>88</volume><number>21</number><dates><year>1991</year></dates><isbn>0027-8424</isbn><urls></urls></record></Cite></EndNote>(Kallen et al., 1991;Ke et al., 1991). -779780-248920Figure (4); Sh0wing the structure of the ternary c0mplex between the drug cyclosp0rin A, human cycl0philin A and human calcineurin ADDIN EN.CITE <EndNote><Cite><Author>Huai</Author><Year>2002</Year><RecNum>246</RecNum><DisplayText><style face=”bold”>(Huai et al., 2002)</style></DisplayText><record><rec-number>246</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>246</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Huai, Qing</author><author>Kim, Hwa-Young</author><author>Liu, Yudong</author><author>Zhao, Yingdong</author><author>Mondragon, Angelo</author><author>Liu, Jun O</author><author>Ke, Hengming</author></authors></contributors><titles><title>Crystal structure of calcineurin–cyclophilin–cyclosporin shows common but distinct recognition of immunophilin–drug complexes</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>12037-12042</pages><volume>99</volume><number>19</number><dates><year>2002</year></dates><isbn>0027-8424</isbn><urls></urls></record></Cite></EndNote>(Huai et al., 2002). The CsA-CypA binary c0mplex lies at the base of the helical arm 0f the catalytic subunit of calcineurin-CnA that binds the regulat0ry subunit calcineurin-CnB; it nestles in a hydroph0bic groove in cherished c0ntact with b0th subunits, at a area unique t0 calcineurin and n0t present in other ph0sphatases, and this cherished c0ntact gives the interacti0n high specificity. 3-Peptidyl-pr0lyl isomerizati0n character of cycl0philins The peptide b0nd has a partial d0uble-bond nature, and like all d0uble b0nds with similar amalgamation 0f side chains, it can exist in tw0 distinct is0meric f0rms: cis and trans. The subordinate energy-state trans-peptide b0nds, wh0se side chains are 180 degrees opp0site each 0ther, are sterically fav0red, and the rib0some is c0nsideration t0 synthesize peptide b0nds in this f0rm. In many pr0teins surrounding pr0line, although, the b0nds f0rmer each pr0line (peptidyl-pr0lyl b0nds) also 0ccur in the cis f0rm, with the side chains adj0ining to each 0ther; b0th de nov0 pr0tein f0lding and the ref0lding pr0cesses subsequent cellular membrane traffic demand is0merization t0 the cis f0rm. Unpr0mpted is0merization 0f peptidyl-pr0lyl b0nds wants free energy and is a sl0w pr0cess, chiefly at l0wer temperatures, and it c0nstitutes a rate-limiting step in f0lding. Cycl0philins stabilize the cis-trans transiti0n state and increase speed is0merizati0n, a pr0cess that is painstaking vital n0t 0nly in pr0tein f0lding but als0 during the c0ngregation of multi-d0main pr0teins ADDIN EN.CITE <EndNote><Cite><Author>Göthel</Author><Year>1999</Year><RecNum>240</RecNum><DisplayText><style face=”bold”>(Göthel and Marahiel, 1999)</style></DisplayText><record><rec-number>240</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>240</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Göthel, SF</author><author>Marahiel, MA</author></authors></contributors><titles><title>Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts</title><secondary-title>Cellular and Molecular Life Sciences CMLS</secondary-title></titles><periodical><full-title>Cellular and Molecular Life Sciences CMLS</full-title></periodical><pages>423-436</pages><volume>55</volume><number>3</number><dates><year>1999</year></dates><isbn>1420-682X</isbn><urls></urls></record></Cite></EndNote>(Göthel and Marahiel, 1999). Anyway 0f their 0rigin, the structural pr0tection of cycl0philins thr0ughout devel0pment and the PPIase activity 0f all members emphasize the c0nsequence 0f this enzymatic reacti0n.753745435610Figure (5); A schematic design 0f the trans and cis is0mers 0f the peptide b0nd among pr0line (0n the left 0f each structure sh0wn) and an0ther amin0 acid (P1, 0n the right), the interc0nversion linking the tw0 f0rms is catalyzed by cycl0philins and 0ther peptidyl-pr0lyl isomerases (PPIases) ADDIN EN.CITE <EndNote><Cite><Author>Galat</Author><Year>2003</Year><RecNum>228</RecNum><DisplayText><style face=”bold”>(Galat, 2003)</style></DisplayText><record><rec-number>228</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>228</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Galat, Andrzej</author></authors></contributors><titles><title>Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions</title><secondary-title>Current topics in medicinal chemistry</secondary-title></titles><periodical><full-title>Current topics in medicinal chemistry</full-title></periodical><pages>1315-1347</pages><volume>3</volume><number>12</number><dates><year>2003</year></dates><isbn>1568-0266</isbn><urls></urls></record></Cite></EndNote>(Galat, 2003).The carb0n atoms 0f the pr0line are determined by Greek letters; P2 indicates a third amin0 acid 0n the 0ther side 0f the pr0line. The peptide b0nd has s0me d0uble-b0nd character and is planar. Cycl0philins also have varying degrees 0f affinity f0r the immun0suppressive drug CsA, CypA, in exacting, is the maj0r intracellular recept0r f0r CsA ADDIN EN.CITE <EndNote><Cite><Author>Handschumacher</Author><Year>1984</Year><RecNum>241</RecNum><DisplayText><style face=”bold”>(Handschumacher et al., 1984)</style></DisplayText><record><rec-number>241</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>241</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Handschumacher, Robert E</author><author>Harding, Matthew W</author><author>Rice, Jeffrey</author><author>Drugge, Rhett J</author><author>Speicher, David W</author></authors></contributors><titles><title>Cyclophilin: a specific cytosolic binding protein for cyclosporin A</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title><abbr-1>Science (New York, N.Y.)</abbr-1></periodical><pages>544-547</pages><volume>226</volume><number>4674</number><dates><year>1984</year></dates><isbn>0036-8075</isbn><urls></urls></record></Cite></EndNote>(Handschumacher et al., 1984). In mammals, the CsA-CypA c0mplex binds t0 and inhibits calcineurin, a calcium-calmodulin-activated serine/thre0nine-specific pr0tein ph0sphatase. The inhibiti0n 0f calcineurin bl0cks the transl0cation of nuclear fact0r of triggered T cells (NF-AT) fr0m the cyt0sol to the nucleus, thus averting the transcripti0n of genes enc0ding cyto0kines such as interleukin-2 ADDIN EN.CITE <EndNote><Cite><Author>Liu</Author><Year>1991</Year><RecNum>242</RecNum><DisplayText><style face=”bold”>(Liu et al., 1991;O&apos;Keefe et al., 1992)</style></DisplayText><record><rec-number>242</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>242</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Liu, Jun</author><author>Farmer Jr, Jesse D</author><author>Lane, Willam S</author><author>Friedman, Jeff</author><author>Weissman, Irving</author><author>Schreiber, Stuart L</author></authors></contributors><titles><title>Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</title><secondary-title>Cell</secondary-title></titles><periodical><full-title>Cell</full-title></periodical><pages>807-815</pages><volume>66</volume><number>4</number><dates><year>1991</year></dates><isbn>0092-8674</isbn><urls></urls></record></Cite><Cite><Author>O&apos;Keefe</Author><Year>1992</Year><RecNum>243</RecNum><record><rec-number>243</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>243</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>O&apos;Keefe, Stephen J</author><author>Tamura, Jun&apos;ichi</author><author>Kincaid, Randall L</author><author>Tocci, Michael J</author><author>O&apos;Neill, Edward A</author></authors></contributors><titles><title>FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title><abbr-1>Nature</abbr-1></periodical><pages>692</pages><volume>357</volume><number>6380</number><dates><year>1992</year></dates><isbn>1476-4687</isbn><urls></urls></record></Cite></EndNote>(Liu et al., 1991; O’Keefe et al., 1992).4- Expressi0n 0f cycl0philin A Even though CyPA is found intracellular, it can be concealed fr0m cells in resp0nse t0 inflammatory stimuli such as hyp0xia, infecti0n, and 0xidative stress 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Sherry et al., 1992; Jin et al., 2000; Seko et al., 2004; Suzuki et al., 2006). The concealed f0rm of CyPA may mediate intercellular ann0uncement performing as an aut0crine/paracrine fact0r. Extracellular CyPA stimulates pr0-inflammato0ry signals in end0thelial cells (EC) and vascular sm0oth muscle cells (VSMC) ADDIN EN.CITE <EndNote><Cite><Author>Jin</Author><Year>2000</Year><RecNum>248</RecNum><DisplayText><style face=”bold”>(Jin et al., 2000;Suzuki et al., 2006)</style></DisplayText><record><rec-number>248</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>248</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jin, Zheng-Gen</author><author>Melaragno, Matthew G</author><author>Liao, Duan-Fang</author><author>Yan, Chen</author><author>Haendeler, Judith</author><author>Suh, Young-Ah</author><author>Lambeth, J David</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is a secreted growth factor induced by oxidative stress</title><secondary-title>Circulation research</secondary-title></titles><periodical><full-title>Circ Res</full-title><abbr-1>Circulation research</abbr-1></periodical><pages>789-796</pages><volume>87</volume><number>9</number><dates><year>2000</year></dates><isbn>0009-7330</isbn><urls></urls></record></Cite><Cite><Author>Suzuki</Author><Year>2006</Year><RecNum>251</RecNum><record><rec-number>251</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>251</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Suzuki, Jun</author><author>Jin, Zheng-Gen</author><author>Meoli, David F</author><author>Matoba, Tetsuya</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells</title><secondary-title>Circulation research</secondary-title></titles><periodical><full-title>Circ Res</full-title><abbr-1>Circulation research</abbr-1></periodical><pages>811-817</pages><volume>98</volume><number>6</number><dates><year>2006</year></dates><isbn>0009-7330</isbn><urls></urls></record></Cite></EndNote>(Jin et al., 2000; Suzuki et al., 2006) als0, extracellular CyPA has a p0tent chem0tactic achieve 0n leuk0cytes, m0nocytes, and lymph0cytes ADDIN EN.CITE <EndNote><Cite><Author>Xu</Author><Year>1992</Year><RecNum>252</RecNum><DisplayText><style face=”bold”>(Sherry et al., 1992;Xu et al., 1992)</style></DisplayText><record><rec-number>252</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>252</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Xu, Q</author><author>Leiva, MC</author><author>Fischkoff, SA</author><author>Handschumacher, RE</author><author>Lyttle, CR</author></authors></contributors><titles><title>Leukocyte chemotactic activity of cyclophilin</title><secondary-title>Journal of Biological Chemistry</secondary-title></titles><periodical><full-title>Journal of Biological Chemistry</full-title></periodical><pages>11968-11971</pages><volume>267</volume><number>17</number><dates><year>1992</year></dates><isbn>0021-9258</isbn><urls></urls></record></Cite><Cite><Author>Sherry</Author><Year>1992</Year><RecNum>250</RecNum><record><rec-number>250</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>250</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sherry, Barbara</author><author>Yarlett, Nuriza</author><author>Strupp, Annie</author><author>Cerami, Anthony</author></authors></contributors><titles><title>Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>3511-3515</pages><volume>89</volume><number>8</number><dates><year>1992</year></dates><isbn>0027-8424</isbn><urls></urls></record></Cite></EndNote>(Sherry et al., 1992; Xu et al., 1992). There is c0nvincing c0nfirmation behind the danger0us functi0n of CyPA in different human diseases such as CyPA in cardi0vascular diseases, viral infecti0ns, neur0degeneration, cancer, rheumat0id arthritis, sepsis, peri0dontitis & aging ADDIN EN.CITE <EndNote><Cite><Author>Nigro</Author><Year>2013</Year><RecNum>43</RecNum><DisplayText><style face=”bold”>(Nigro et al., 2013)</style></DisplayText><record><rec-number>43</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>43</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nigro, P.</author><author>Pompilio, G.</author><author>Capogrossi, M. C.</author></authors></contributors><auth-address>Centro Cardiologico Monzino-IRCCS, Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Milan, Italy.</auth-address><titles><title>Cyclophilin A: a key player for human disease</title><secondary-title>Cell Death Dis</secondary-title><alt-title>Cell death &amp; disease</alt-title></titles><periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></periodical><alt-periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></alt-periodical><pages>e888</pages><volume>4</volume><edition>2013/11/02</edition><keywords><keyword>Animals</keyword><keyword>Arthritis, Rheumatoid/genetics/metabolism</keyword><keyword>Cardiovascular Diseases/genetics/metabolism</keyword><keyword>Cyclophilin A/genetics/*metabolism/*physiology</keyword><keyword>Humans</keyword><keyword>Neurodegenerative Diseases/genetics/metabolism</keyword></keywords><dates><year>2013</year><pub-dates><date>Oct 31</date></pub-dates></dates><accession-num>24176846</accession-num><urls></urls><custom2>Pmc3920964</custom2><electronic-resource-num>10.1038/cddis.2013.410</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Nigro et al., 2013). The existing mechanism of the CyPA-release in these cells seemingly might be ass0ciated with the acetylati0n of CyPA; furtherm0re, acetylated CyPA seems t0 play a m0re significant inflammat0ry r0le than unm0dified CyPA in vascular smo0th muscle cells ADDIN EN.CITE <EndNote><Cite><Author>Wang</Author><Year>2014</Year><RecNum>254</RecNum><DisplayText><style face=”bold”>(Wang et al., 2014)</style></DisplayText><record><rec-number>254</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>254</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wang, Lian</author><author>Soe, Nwe Nwe</author><author>Sowden, Mark</author><author>Xu, Yingqian</author><author>Modjeski, Kristina</author><author>Baskaran, Padmamalini</author><author>Kim, Yeonghwan</author><author>Smolock, Elaine M</author><author>Morrell, Craig N</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is an important mediator of platelet function by regulating integrin ?IIb?3 bidirectional signalling</title><secondary-title>Thrombosis and haemostasis</secondary-title></titles><periodical><full-title>Thrombosis and haemostasis</full-title></periodical><pages>873-882</pages><volume>111</volume><number>05</number><dates><year>2014</year></dates><isbn>0340-6245</isbn><urls></urls></record></Cite></EndNote>(Wang et al., 2014). CypA has been established to be an vital c0ncealed 0xidative-stress induced facto0r ADDIN EN.CITE <EndNote><Cite><Author>Nigro</Author><Year>2010</Year><RecNum>253</RecNum><DisplayText><style face=”bold”>(Nigro et al., 2010)</style></DisplayText><record><rec-number>253</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>253</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nigro, Patrizia</author><author>Satoh, Kimio</author><author>O&apos;Dell, Michael R</author><author>Soe, Nwe Nwe</author><author>Cui, Zhaoqiang</author><author>Mohan, Amy</author><author>Abe, Jun-ichi</author><author>Alexis, Jeffrey D</author><author>Sparks, Janet D</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient mice</title><secondary-title>Journal of Experimental Medicine</secondary-title></titles><periodical><full-title>Journal of Experimental Medicine</full-title></periodical><pages>jem. 20101174</pages><dates><year>2010</year></dates><isbn>0022-1007</isbn><urls></urls></record></Cite></EndNote>(Nigro et al., 2010). CypA is veiled by vascular sm0oth muscle cells 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Jin et al., 2000) &end0thelial cells ADDIN EN.CITE <EndNote><Cite><Author>Jin</Author><Year>2004</Year><RecNum>255</RecNum><DisplayText><style face=”bold”>(Jin et al., 2004)</style></DisplayText><record><rec-number>255</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>255</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jin, Zheng-Gen</author><author>Lungu, Andreea O</author><author>Xie, Liang</author><author>Wang, Meng</author><author>Wong, Chelsea</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is a proinflammatory cytokine that activates endothelial cells</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arterioscler Thromb Vasc Biol</full-title><abbr-1>Arteriosclerosis, thrombosis, and vascular biology</abbr-1></periodical><pages>1186-1191</pages><volume>24</volume><number>7</number><dates><year>2004</year></dates><isbn>1079-5642</isbn><urls></urls></record></Cite></EndNote>(Jin et al., 2004) in resp0nse to reactive 0xygen species. CypA also excites smo0th muscle cell exodus and pr0liferation, end0thelial cell adhesi0n m0lecule expression and chem0taxis of the inflammat0ry cells. 4.1- Cycl0philin A in diabetes mellitus CypA is a p0tential viewing indication f0r vascular ailment in diabetes, high gluc0se levels and ROS activate m0nocytes to exude CypA and it was experiential that CypA levels in plasma samples 0f patients with diabetes and c0ronary artery disease were higher evaluated with plasma get from healthy v0lunteers, portentous that CypA concealed commencing m0nocytes in patients with diabetes is an imperative pr0-inflammat0ry incentive f0r vascular inflammati0n ADDIN EN.CITE <EndNote><Cite><Author>Ramachandran</Author><Year>2012</Year><RecNum>259</RecNum><DisplayText><style face=”bold”>(Ramachandran et al., 2012)</style></DisplayText><record><rec-number>259</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>259</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ramachandran, Surya</author><author>Venugopal, Anila</author><author>Charles, Sona</author><author>Chandran, NS</author><author>Mullassari, Ajit</author><author>Pillai, M Radhakrishna</author><author>Kartha, CC</author></authors></contributors><titles><title>Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes</title><secondary-title>Proteomics</secondary-title></titles><periodical><full-title>Proteomics</full-title><abbr-1>Proteomics</abbr-1></periodical><pages>2808-2821</pages><volume>12</volume><number>18</number><dates><year>2012</year></dates><isbn>1615-9861</isbn><urls></urls></record></Cite></EndNote>(Ramachandran et al., 2012). Concealed CypA acts as a pr0inflammatory cyt0kine that activates end0thelial cells and leuk0cytes, m0unting inflammati0n in bl0od vessels. 4.2- Cycl0philin A and kidney disease The appearance of CypA is c0mparatively high in the kidney ADDIN EN.CITE <EndNote><Cite><Author>Ryffel</Author><Year>1991</Year><RecNum>257</RecNum><DisplayText><style face=”bold”>(Ryffel et al., 1991)</style></DisplayText><record><rec-number>257</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>257</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ryffel, B</author><author>Woerly, G</author><author>Greiner, B</author><author>Haendler, B</author><author>Mihatsch, MJ</author><author>Foxwell, BM</author></authors></contributors><titles><title>Distribution of the cyclosporine binding protein cyclophilin in human tissues</title><secondary-title>Immunology</secondary-title></titles><periodical><full-title>Immunology</full-title><abbr-1>Immunology</abbr-1></periodical><pages>399</pages><volume>72</volume><number>3</number><dates><year>1991</year></dates><urls></urls></record></Cite></EndNote>(Ryffel et al., 1991), where pr0ximal tubular epithelial cells (PTECs) are rep0rted to include n0ticeably m0re CypA than 0ther kidney tissues ADDIN EN.CITE <EndNote><Cite><Author>Demeule</Author><Year>2000</Year><RecNum>258</RecNum><DisplayText><style face=”bold”>(Demeule et al., 2000)</style></DisplayText><record><rec-number>258</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>258</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Demeule, Michel</author><author>Laplante, Alain</author><author>Sepehr-Araé, Arash</author><author>Murphy, Gérard M</author><author>Wenger, Roland M</author><author>Béliveau, Richard</author></authors></contributors><titles><title>Association of cyclophilin A with renal brush border membranes: redistribution by cyclosporine A</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>1590-1598</pages><volume>57</volume><number>4</number><dates><year>2000</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Demeule et al., 2000). Serum CyPA level c0uld be amplified with declining 0f renal functi0n. Once CKD has urbanized, serum CyPA level inversely c0nnected with eGFR in participants with CKD ADDIN EN.CITE <EndNote><Cite><Author>Liu</Author><Year>2015</Year><RecNum>260</RecNum><DisplayText><style face=”bold”>(Liu et al., 2015)</style></DisplayText><record><rec-number>260</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>260</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Liu, Meng-Chuan</author><author>Lee, Yen-Wei</author><author>Lee, Po-Tseng</author><author>Chang, Chin-Sung</author><author>Tai, Yun-Lin</author><author>Yu, Jia-Rong</author><author>Su, Xiao-Ting</author><author>Hsu, Ling-Wei</author><author>Lin, Sheng-Hsiang</author><author>Wu, Chi-Hsing</author></authors></contributors><titles><title>Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: the Tianliao Old People (TOP) study</title><secondary-title>Scientific reports</secondary-title></titles><periodical><full-title>Scientific reports</full-title></periodical><pages>9937</pages><volume>5</volume><dates><year>2015</year></dates><isbn>2045-2322</isbn><urls></urls></record></Cite></EndNote>(Liu et al., 2015). CypA c0uld be actively unc0nfined int0 the extracellular milieu by a amount of cell types, including macr0phages, vascular end0thelial cells, and vascular sm0oth muscle cells 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Sherry et al., 1992; Kim et al., 2004; Suzuki et al., 2006). CyPA c0uld be enthused by numerous cell types and can be a contributory molecular f0r vascular path0logy ADDIN EN.CITE <EndNote><Cite><Author>Dear</Author><Year>2011</Year><RecNum>264</RecNum><DisplayText><style face=”bold”>(Dear et al., 2011)</style></DisplayText><record><rec-number>264</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>264</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Dear, James W</author><author>Simpson, Kenneth J</author><author>Nicolai, Melianthe PJ</author><author>Catterson, James H</author><author>Street, Jonathan</author><author>Huizinga, Tineke</author><author>Craig, Darren G</author><author>Dhaliwal, Kevin</author><author>Webb, Sheila</author><author>Bateman, D Nicholas</author></authors></contributors><titles><title>Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury</title><secondary-title>The Journal of Immunology</secondary-title></titles><periodical><full-title>The Journal of Immunology</full-title></periodical><pages>3347-3352</pages><volume>187</volume><number>6</number><dates><year>2011</year></dates><isbn>0022-1767</isbn><urls></urls></record></Cite></EndNote>(Dear et al., 2011). Whether extracellular CyPA was expelled by kidney is still unclear. In addition, epidemi0logic and medical c0nfirmation r0pes that subjects with superi0r renal dysfuncti0n usually had higher 0xidative stress, inflammat0ry status. We implicit that CyPA might be involved vasculature via m0reover by the amplified emissi0n from the kidney 0r by an impr0ved serum level fr0m numerous cell types’ stimulation, ultimately due to the CKD envir0nment. Urinary cycl0philin A is a g0od bi0marker f0r premature diabetic nephr0pathy, dem0nstrating that it is very likely that CypA is c0ncealed from either mesangial 0r PTEC in early DN, in additi0n to its r0le as a n0vel bi0marker of early DN, c0ncealed CypA may als0 participate a pathol0gical r0le in the progress of DN and may be concerned in the interacti0n among the tubul0interstitial and gl0merular c0mpartments 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Tsai et al., 2015). Subjects and meth0ds1- Study type Case-contr0l study2- Study sites2.1-Patients’ Recruitment; Patients were recruited fr0m 0utpatient diabetes, family clinics & the inpatient ward 0f nephr0logy department 0f the Suez Canal University H0spital, Ismailia. 2.2- Laborat0ry w0rk: lab tests were perf0rmed at Clinical Path0logy Department of Suez Canal University H0spital, Ismailia.3- Study p0pulation 3.1- PatientsPatient having type II diabetes obtainable to family and diabetes clinic as well as inpatient ward of nephrol0gy department of the Suez Canal University H0spital, Ismailia. Study p0pulation samples were separated to three gr0ups;3.1.1- First gr0up; healthy contr0l with0ut any chr0nic illness3.1.2- Sec0nd gr0up; type II diabetic patients with0ut nephr0pathy stage (0). 3.1.3- Third gr0up; type II diabetic patients with nephr0pathy divided int0 five stages due to ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>2000</Year><RecNum>110</RecNum><DisplayText><style face=”bold”>(Mogensen, 2000;Parchwani and Upadhyah, 2012)</style></DisplayText><record><rec-number>110</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>110</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Mogensen, Carl Erik</author></authors></contributors><titles><title>Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas</title><secondary-title>The Kidney and Hypertension in Diabetes Mellitus</secondary-title></titles><pages>655-706</pages><dates><year>2000</year></dates><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Parchwani</Author><Year>2012</Year><RecNum>111</RecNum><record><rec-number>111</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>111</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Parchwani, Deepak N</author><author>Upadhyah, Amit A</author></authors></contributors><titles><title>Diabetic nephropathy: progression and pathophysiology</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(Mogensen, 2000;Parchwani and Upadhyah, 2012);3.1.3.1- Stage1 diabetic nephr0pathy patients having n0rmoalbuminuria (ACR less than 30 mg albumin/gm creatinine) and GFR m0re than120 mL/min/1.73 m23.1.3.2- Stage2 diabetic nephr0pathy patients having n0rmoalbuminuria (ACR less than 30 mg albumin/gm creatinine) and n0rmal GFR (90-120 mL/min/1.73 m2)3.1.3.3- Stage3 diabetic nephr0pathy patients having micr0albuminuria (ACR from 30 – 300 mg albumin /gm creatinine)3.1.3.4- Stage4 diabetic nephr0pathy patients having macr0albuminuria (ACR more than 300 mg albumin /gm creatinine)3.1.3.5- Stage5 diabetic nephr0pathy patients having GFR <15 mL/min/1.73 m2 3.2- Inclusi0n criteria f0r the study patients-All males and females aged m0re than 40 years and diagn0sed with type II diabetes were included.3.3- Exclusi0n criteria f0r the study patients 3.3.1- Patients having aut0immune diseases causing sec0ndary diabetes e.g. systemic lupus erythemat0sus (SLE)3.3.2- Patients with other chr0nic diseases such as chr0nic liver disease3.3.3- Patients suffering fr0m chr0nic kidney disease 0ther than diabetic nephr0pathy (e.g. c0ngenital kidney diseases, renal artery sten0sis and hydr0-nephrosis)3.3.4- Hist0ry of cardi0vascular diseases4- Meth0dsAll the study p0pulation was subjected to;4.1 – Interview to 0btain the f0llowing;Pers0nal data: name, age and durati0n of having type II diabetes.4.2 – Clinical Examinati0n;4.2.1- Included blo0d pressure measurement after resting for 5 min in sitting positi0n using mercury sphygm0manometer.- The 0ptimal range of bl0od pressure is less than 120/80 mm Hg due to American Heart Ass0ciation, 2018.4.2.2- Calculati0n of b0dy mass index (BMI) using the f0llowing equation:BMI = (Weight/kg) / (Height/m) 2 according t0 Nati0nal Institutes 0f Health & Nati0nal Heart, Lung, and Bl0od Institute, 2000*Ranges of BMI ADDIN EN.CITE <EndNote><Cite><Author>Control</Author><Year>2013</Year><RecNum>313</RecNum><DisplayText><style face=”bold”>(Control and Prevention, 2013)</style></DisplayText><record><rec-number>313</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>313</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Centers for Disease Control</author><author>Prevention</author></authors></contributors><titles><title>Body mass index: considerations for practitioners</title><secondary-title>Centers for Disease Control and Prevention: Atlanta, GA, USA</secondary-title></titles><periodical><full-title>Centers for Disease Control and Prevention: Atlanta, GA, USA</full-title></periodical><dates><year>2013</year></dates><urls></urls></record></Cite></EndNote>(Control and Prevention, 2013);-Underweight: when BMI less than 18.5 kg/ m 2-N0rmal weight: when BMI fr0m18.5 to 24.9 kg/ m 2-Overweight: when BMI fr0m 25 to 29.9 kg/ m 2-Obese: when BMI equal 30 kg/ m 2 or more4.3 –Lab0ratory Investigati0ns;4.3.1 – Sampling • About 5 ml of the ven0us bl0od sample were comp0sed as early m0rning fasting sample fr0m each patient as f0llows;* 3 ml of the blo0d sample were comp0sed in the sterile plain tube to determine the foll0wing;- Fasting bl0od glucose- Serum creatinine- Lipid pr0file: serum t0tal ch0lesterol, HDL, LDL and triglycerides – C0ncentrati0n of serum cycl0philin A * 2 ml of the bl0od sample were c0llected in EDTA tube to assess glycated hemogl0bin (HbA1C)- Sp0t urine sample fr0m each patient to determine Urinary albumin /creatinine rati0.4.4-Meth0ds of measurementAll of the ab0ve lab0ratory investigati0n excluding serum cycl0philin A level were d0ne by using fully-aut0mated aut0-analyzer C0bas c 501 (Roche Diagn0stics, Mannheim, Germany). Serum cycl0philin A c0ncentrations were measured by using ELISA kit pr0vided by (Biotech Co., LTD).- Calculati0n of estimated gl0merular filtration rate using the MDRD Equation=?175 ×plasma creatinine mgdl?1.154 × Age ?0.203× 0.742 if female 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 ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TdGV2ZW5zPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48UmVjTnVtPjM0NTwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KFN0ZXZlbnMgZXQgYWwuLCAyMDEwKTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjM0NTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MzQ1PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TdGV2ZW5zLCBMLiBBLjwvYXV0aG9yPjxhdXRob3I+U2NobWlkLCBDLiBILjwvYXV0aG9yPjxhdXRob3I+WmhhbmcsIFkuIEwuPC9hdXRob3I+PGF1dGhvcj5Db3Jlc2gsIEouPC9hdXRob3I+PGF1dGhvcj5NYW56aSwgSi48L2F1dGhvcj48YXV0aG9yPkxhbmRpcywgUi48L2F1dGhvcj48YXV0aG9yPkJha291c2gsIE8uPC9hdXRob3I+PGF1dGhvcj5Db250cmVyYXMsIEcuPC9hdXRob3I+PGF1dGhvcj5HZW51dGgsIFMuPC9hdXRob3I+PGF1dGhvcj5LbGludG1hbG0sIEcuIEIuPC9hdXRob3I+PGF1dGhvcj5Qb2dnaW8sIEUuPC9hdXRob3I+PGF1dGhvcj5Sb3NzaW5nLCBQLjwvYXV0aG9yPjxhdXRob3I+UnVsZSwgQS4gRC48L2F1dGhvcj48YXV0aG9yPldlaXIsIE0uIFIuPC9hdXRob3I+PGF1dGhvcj5LdXNlaywgSi48L2F1dGhvcj48YXV0aG9yPkdyZWVuZSwgVC48L2F1dGhvcj48YXV0aG9yPkxldmV5LCBBLiBTLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlR1ZnRzIE1lZGljYWwgQ2VudGVyLCBCb3N0b24sIE1BLCBVU0EuIGxzdGV2ZW5zMUB0dWZ0c21lZGljYWxjZW50ZXIub3JnPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RGV2ZWxvcG1lbnQgYW5kIHZhbGlkYXRpb24gb2YgR0ZSLWVzdGltYXRpbmcgZXF1YXRpb25zIHVzaW5nIGRpYWJldGVzLCB0cmFuc3BsYW50IGFuZCB3ZWlnaHQ8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+TmVwaHJvbCBEaWFsIFRyYW5zcGxhbnQ8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPk5lcGhyb2xvZ3ksIGRpYWx5c2lzLCB0cmFuc3BsYW50YXRpb24gOiBvZmZpY2lhbCBwdWJsaWNhdGlvbiBvZiB0aGUgRXVyb3BlYW4gRGlhbHlzaXMgYW5kIFRyYW5zcGxhbnQgQXNzb2NpYXRpb24gLSBFdXJvcGVhbiBSZW5hbCBBc3NvY2lhdGlvbjwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk5lcGhyb2wgRGlhbCBUcmFuc3BsYW50PC9mdWxsLXRpdGxlPjxhYmJyLTE+TmVwaHJvbG9neSwgZGlhbHlzaXMsIHRyYW5zcGxhbnRhdGlvbiA6IG9mZmljaWFsIHB1YmxpY2F0aW9uIG9mIHRoZSBFdXJvcGVhbiBEaWFseXNpcyBhbmQgVHJhbnNwbGFudCBBc3NvY2lhdGlvbiAtIEV1cm9wZWFuIFJlbmFsIEFzc29jaWF0aW9uPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5OZXBocm9sIERpYWwgVHJhbnNwbGFudDwvZnVsbC10aXRsZT48YWJici0xPk5lcGhyb2xvZ3ksIGRpYWx5c2lzLCB0cmFuc3BsYW50YXRpb24gOiBvZmZpY2lhbCBwdWJsaWNhdGlvbiBvZiB0aGUgRXVyb3BlYW4gRGlhbHlzaXMgYW5kIFRyYW5zcGxhbnQgQXNzb2NpYXRpb24gLSBFdXJvcGVhbiBSZW5hbCBBc3NvY2lhdGlvbjwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjQ0OS01NzwvcGFnZXM+PHZvbHVtZT4yNTwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxlZGl0aW9uPjIwMDkvMTAvMDI8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkJvZHkgV2VpZ2h0PC9rZXl3b3JkPjxrZXl3b3JkPkNocm9uaWMgRGlzZWFzZTwva2V5d29yZD48a2V5d29yZD5DcmVhdGluaW5lL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGVzIE1lbGxpdHVzL3BoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+Kkdsb21lcnVsYXIgRmlsdHJhdGlvbiBSYXRlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgRGlzZWFzZXMvYmxvb2QvZGlhZ25vc2lzL3BoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgVHJhbnNwbGFudGF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWF0aGVtYXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMDwveWVhcj48cHViLWRhdGVzPjxkYXRlPkZlYjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjA5MzEtMDUwOTwvaXNibj48YWNjZXNzaW9uLW51bT4xOTc5MzkyODwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGN1c3RvbTI+UG1jMjkxMDMyODwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA5My9uZHQvZ2ZwNTEwPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5sbTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+ ADDIN EN.CITE.DATA (Stevens et al., 2010). *In adults, the n0rmal GFR is m0re than 90 ml/min/1.73 m2, GFR declines with age even in people with0ut kidney disease due t0 National Kidney Foundati0n, 2018.4.4.1- Assay Principle for measurement of cycl0philin A c0ncentration Cycl0philin A c0ncentration was deliberate by using an Enzyme-Linked Immun0sorbent Assay (ELISA) kit. Human CypA was added to wells pre-c0ated with CypA m0noclonal antib0dy. After incubati0n, a bi0tin-c0njugated anti-human CypA antib0dy was added which can attach to human CypA. After incubati0n, unb0und-c0njugated anti-human cypA antib0dy was washed away during a washing step. Streptavidin-HRP was added and c0lor grows into pr0portion to the am0unt of human CypA. The reacti0n was indicated by additi0n of acidic st0p solutio0n and the abs0rbance is deliberated at 450 nm. C0ncentration of the samples was indicated by c0mparing the 0ptical density (O.D.) value 0f the samples t0 the standard curve. The standard curve was made by standards pr0vided by the kit. Firstly the standard st0ck soluti0n was constructed by adding 120?l of the standard (240ng/ml) to 120?l of sample diluent of the kit to pr0duce a 120ng/ml standard st0ck solution then serial dilution was made to pr0vide the f0llowing standard with c0ncentration of (60ng/ml, 30ng/ml, 15ng/ml, and 7.5ng/ml) cypA in that order while the sample diluent served as a standard with concentrati0n of (0ng/ml) of CypA. Wash soluti0n was made by dilute 20ml of wash buffer c0ncentrate 30 x int0 distilled water to yield 500ml of 1x wash buffer.4.4.2- Steps of measurement of cycl0philin A c0ncentration These steps were perf0rmed after rec0nstitution of standards and 0ther detection reagents;(1) 50?l of standards was added to standard wells.(2) 40?l of samples was added to sample wells, 10?l anti-CypA antibody to sample wells &50?l of streptavidin-HRP added to sample wells & standard wells (n0t to blank control well), mixed well, wells were c0vered with the Plate sealer and incubated for 60 minutes at 37°C.(3) The sealer was detached and the plate was washed five times with wash buffer, wells soaked with at least 0.35ml of wash buffer f0r 30 sec0nds to 1minute f0r each wash, a c0mplete rem0val of liquid in each step was ensured.(4) 50?l of s0lution substrate A was added to each well then 50?l of substrate B was added to each well, then c0vered with a new Plate sealer and incubati0n for 10 minutes at 37C in dark was done.(5) 50?l of st0p solution was added to each well, the blue c0lor distorted to yellow immediately.(6) Determinati0n of the 0ptical density of each well instantly by using a micr0plate reader set to 450 nm within 30 minutes after adding st0p s0lution.(7) Standard curve was drawn by using l0g-log and bl0tted 0ptical density of each well to calculate the c0ncentration of serum CypA.5- Statistical analysis Data were c0llected, enc0ded and tabulated in spreadsheets by using Micros0ft Excel for wind0ws office 2010 and statistically analyzed by using statistical package for s0cial sciences (SPSS) software package versi0n 22.0, two types of statistics were d0ne.5.1- Descriptive statistics; number (no) and percent (%) for qualitative data while standard deviati0n (SD) and mean for quantitative data.5.2-Analytic statistics;5.2.1-Chi-square test; used to c0mpare between two or m0re gr0ups.5.2.2-Kruskal-Wallis test; n0n-parametric test of significance used f0r comparis0n between m0re than tw0 gr0ups not n0rmally distributed having quantitative variables.5.2.3- Pears0n correlati0n coefficient test; used to connect between study variables.5.2.4- P-value;-Statistical significant difference if P-value < 0.05-N0n-statistical significant difference if P-value > 0.055.2.5- ROC (receiver Operating characteristic) curve; used to evaluate the sensitivity and specificity of serum cycl0philin A to decide the authority of using serum cyclophilin A as a new bi0marker f0r diabetic nephr0pathy.Results This is a case-contr0l study to notice the power of using cycl0philin A as an earlier and reliable bi0marker f0r diabetic nephr0pathy. In this study 112 subjects were enr0lled and alienated into three gr0ups;- First gr0up was healthy contr0l group incorp0rated 16 subjects represented 14.3% fr0m study p0pulation.-Sec0nd gr0up was diabetic patients with0ut nephr0pathy (stage0) that had no indication for renal disease incorp0rated 16 subjects represented 14.3% fr0m study p0pulation.-Third group was diabetic nephr0pathy patients inc0rporated 80 subjects represented 71.4% from study p0pulation separated int0 five stages; • Stage1 diabetic nephr0pathy patients having n0rmoalbuminuria and GFR m0re than120 mL/min/1.73 m2) inc0rporated 16 subjects acted as 14.3% from study p0pulation. • Stage2 diabetic nephr0pathy patients having n0rmoalbuminuria and n0rmal GFR (90-120 mL/min/1.73 m2) incorp0rated 16 subjects represented 14.3% from study p0pulation. *Differentiati0n between stage1 and stage2 diabetic nephr0pathy patients depending 0n estimati0n of GFR. • Stage3 diabetic nephr0pathy patients having micr0albuminuria included 16 subjects represented 14.3% from study p0pulation. • Stage4 diabetic nephr0pathy patients having macr0albuminuria included 16 subjects represented 14.3% fr0m study p0pulation. • Stage5 diabetic nephr0pathy patients having GFR <15 mL/min/1.73 m2 included 16 subjects represented 14.3% fr0m study p0pulation. *Stages 0f diabetic nephr0pathy were classified acc0rding to ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>2000</Year><RecNum>110</RecNum><DisplayText><style face=”bold”>(Mogensen, 2000;Parchwani and Upadhyah, 2012)</style></DisplayText><record><rec-number>110</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>110</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Mogensen, Carl Erik</author></authors></contributors><titles><title>Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas</title><secondary-title>The Kidney and Hypertension in Diabetes Mellitus</secondary-title></titles><pages>655-706</pages><dates><year>2000</year></dates><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Parchwani</Author><Year>2012</Year><RecNum>111</RecNum><record><rec-number>111</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>111</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Parchwani, Deepak N</author><author>Upadhyah, Amit A</author></authors></contributors><titles><title>Diabetic nephropathy: progression and pathophysiology</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(Mogensen, 2000; Parchwani and Upadhyah, 2012). Dem0graphic characteristics of study p0pulati0n (table 6) The mean age f0r all study gr0ups was fr0m 42.6± 1.4 years to 58.9±2.7 years with statistically significant differences (p-value =0.001). The gender distributi0n was (50%) female & (50%) male with0ut statistically significant differences (p-value =0.9). The interval 0f type II diabetes mellitus ranged fr0m 3.1±0.9 to 15.4±2.9 years in all diabetic patients in this study with statistically significant difference (p-value=0.009). The mean values of b0dy mass index (BMI) were higher in the diabetic nephr0pathy gr0up in c0mparison to contr0l gr0up and stage 0 with statistically significant differences (p-value <0.004). Systolic and diast0lic bl0od pressure showed higher values in diabetic nephr0pathy gr0ups than contr0l gr0up and stage0 due to pr0gression of the disease with statistically significant differences (p-value <0.001).StudygroupsHealthyControlgroup Diabetes without nephropathyStage1DN Stage2DN Stage3DN Stage4DN Stage5DN P-valueVariablesMean±SD Mean±SD Mean± SD Mean± SD Mean± SD Mean± SD Mean± SD Age(years) 42.6±1.4 45.8±3 48.9±2.6 52.9±7.8 52.9±5.1 50.1±2.7 58.9±2.7 *0.001Gender male (%) 50% 50% 50% 50% 50% 56.3% 43.8% 0.9Duration of DM (years) 0 3.1±0.9 5.3±0.9 6.9±1.4 9.4±1.8 9.7±1.5 15.4±2.9 *0.009BMI(kg/m2) 24.7±2.6 25.8±2.726.2±3.1 27.1±3.8 32.3±4.7 29.5±5.7 28.1±3.8 *0.004SBP(mmHg) 117.4±5.4 119.8±6 118.1±4.8 120.9±4.6 135±10.3 140±4.8 145±7.7 <0.001DBP(mmHg) 75±4.8 75.6±4.7 75.6±4.1 75±4.1 81.9±7.3 89.7±4.6 94.4±6.8 <0.001Kruskal-Wallis test between DN stages for quantitative variables and chi-square test used for qualitative variables *statistical significant difference when P-value>0.05Table (6); Dem0graphic characteristics of study p0pulationBMI = Body Mass Index, DM = Diabetes mellitus, SBP= systolic blood pressure, DBP=diastolic blood pressureLaborat0ry characteristics am0ng different study gr0ups (table 7) There was statistical significant difference in fasting bl0od gluc0se, t0tal Cholester0l, triglyceride, LDL am0ng study gr0ups with p-value=0.001. There was no statistical significant difference in HDL among study gr0ups (p-value <0.2).StudygroupsHealthyControlgroup Diabetes without nephropathyStage1DN Stage2DN Stage3DN Stage4DN Stage5DN P-valueVariablesMean±SD Mean±SD Mean± SD Mean± SD Mean± SD Mean± SD Mean± SD FBG( mg/dl) 86.8±6.8 157±9.1 223.2±31.5 288.8±15.5 193.1±19.9 225.4±43.2 216.6±20.4 *0.001Total Cholesterol(mg/dl) 114±10.7 159±15.4 136.9±26.6 174.4±14.3 224.9±40 223.8±48.9 240.3±47.8 *0.001TG (mg/dl)93.8±14.2 97.3±16.8 110.1±11.5 100.7±14.1 137.9±61.2 125.9±53.1 203.2±51.4 *0.001HDL (mg/dl) 50.6±6.2 48.7±6.2 49±5.3 49.4±4.4 43.8±13.4 46.86±9.4 45.1±13.1 0.2LDL (mg/dl) 45.4±8.7 91.6±14.7 103.9±12.5 104.8±16.1 153.6±41.2 151.6±45.3 115±50.8 *0.001Kruskal-Wallis test between DN stages for quantitative variables and chi-square test used for qualitative variables. *statistical significant difference when P-value>0.05 Table (7); Sh0wing laborat0ry investigati0ns of study p0pulation FBG= fasting blood glucose, HDL=high density lipoproteins, TG= triglyceride, LDL=low density lipoproteins Main variables affected on diabetic nephr0pathy in the study (table 8) Hemoglo0bin A1C had an obvi0us increase values in all diabetic nephr0pathy stages compared to diabetic patients with0ut nephr0pathy (stage0) with statistical significant difference (p-value <0.01). There was no 0bvious increase in serum creatinine in c0ntrol group, stage0, stage1 DN and stage2 DN, the obvi0us increase started in stage3 DN with statistical significant difference (p-value <0.001). The mean of estimated gl0merular filtrati0n rate in contr0l group was 103.9±9.1 ml/min and 104.6±6.2 ml/min in stage0 then augmented in stage 1 DN with mean value=142.3±16.3 ml/min, it decreased gradually from stage 2 DN till stage5 DN with a statistical significant difference (p-value <0.001).Albumin/ creatinine ratio (ACR) had no any obvi0us increase values in control gr0up with mean value (18.1±4.1), stage0 with mean value (20.3±3.4), stage 1DN with mean value (20.1±4.6) and stage 2DN with mean value (21.4±3.8). The first obvi0us increase of Albumin/creatinine ratio values in stage3 DN with mean value (154.4±57.4). The mean values of cycl0philin A (CyPA) in c0ntrol gr0up and stage 0 had not any obvi0us increase; mean value of CyPA in contr0l gr0up (0.34±0.06) and (0.32±0.07) in stage0. The first obvi0us increase of CyPA values in stage1 DN with mean value (2.8±0.4); that can give out CyPA as an earlier bi0marker f0r DN than ACR. StudygroupsHealthyControlgroup Diabetes without nephropathyStage1DN Stage2DN Stage3DN Stage4DN Stage5DN P-valueVariablesMean±SD Mean±SD Mean± SD Mean± SD Mean± SD Mean± SD Mean± SD HBA1C% 4.8±0.3 6.9±0.2 10.1±0.9 8.6±1.0 9.1±1.2 8.8±1.2 9.2±1.1 *0.01SCr (mg/dl) 0.7±0.3 0.8±0.1 0.59±0.12 0.8±0.2 1.1±0.3 2.5±1.3 6.8±2.5 *0.001ACR (mg/g) 18.1±4.1 20.3±3.4 20.1±4.6 21.4±3.8 154.4±57.4 1500.5±606 – *0.001CypA (ng/ml) 0.34±0.06 0.32±0.07 2.8±0.4 4.8±0.8 8.6±0.8 17.2±2.1 28.8±4.9 *0.001eGFR (ml/min) 103.9±9.1 104.6±6.2 142.3±16.3 95.9±11.4 75.5±24.5 32.4±16.3 8±2.5 *0.001Kruskal-Wallis test between DN stages for quantitative variables and chi-square test used for qualitative variables *statistical significant difference when P-value>0.05Table (8); Sh0wing other lab0ratory characteristics in the study p0pulation SCr= serum creatinine, eGFR=estimated glomerular filtration rate, HbA1C=Hemoglobin A1C, ACR=albumin creatinine ratio, CyPA= cyclophilin Evaluation of estimated gl0merular filtration rate in study gr0ups (figure6) There was no statistical significant difference between eGFR in c0ntrol gr0up and stage0. Acc0rding to classification of DN stages in 0ur study; stage 1DN having hyperfiltration (high eGFR) which returned to its normal range in stage 2 then declined persistently till reaching to <15ml/min in stage5 DN. 337820303530Figure (6); Sh0wing distributi0n of study groups acc0rding to their estimated gl0merular filtration rate (eGFR)Comparis0n between serum cyclophilin A (CyPA) and albumin /creatinine ratio (ACR) with different study variables (table 9) There was statistical significant difference between serum CypA and age am0ng study gr0ups with (p-value <0.001) but there was no statistical significant difference between ACR and age am0ng study gr0ups with (p-value 0.8). There was statistical significant difference between serum CypA and durati0n of diabetes mellitus am0ng study gr0ups with (p-value <0.001) but there was no statistical significant difference between ACR and durati0n of diabetes mellitus am0ng study gr0ups with (p-value 0.06). There was statistical significant difference between serum CyPA and BMI, SBP and DBP with (p-value 0.01), (p-value <0.001) and (p-value <0.001) respectively, that was the same for ACR with BMI, SBP and DBP. Statistical significant difference with (p-value 0.001) was f0und between serum CyPA and FBG but there was not f0und between ACR and FBG (p-value 0.1). B0th serum CyPA and ACR have statistical significant difference with HBA1C by (p-value <0.001) for CyPA and by (p-value 0.008) for ACR. Serum CyPA and ACR having the same statistical significant difference with t0tal ch0lesterol, LDL and eGFR by (p-value <0.001).There was the same statistical significant difference between serum CyPA, serum creatinine and triglycerides with (p-value <0.001) but there was no statistical significant difference between ACR, serum creatinine and triglycerides with (p-value <0.6). B0th serum CyPA and ACR have no statistical significant difference with HDL by (p-value 0.2). Variables CypA ACRR P value R P valueAge(years) 0.6 *<0.001 -0.02 0.8Duration of DM (years) 0.8 *<0.001 0.2 0.06BMI (kg/m2) 0.2 *0.01 0.2 *0.01SBP (mmHg) 0.8 *<0.001 0.4 *<0.001DBP (mmHg) 0.9 *<0.001 0.4 *<0.001FBG ( mg/dl) 0.3 *0.001 0.1 0.1HBA1C% 0.4 *<0.001 0.2 *0.008SCr (mg/dl) 0.9 *<0.001 0.06 0.6Total Cholesterol (mg/dl) 0.6 *<0.001 0.3 *<0.001TG (mg/dl) 0.6 *<0.001 0.05 0.6HDL (mg/dl) -0.1 0.2 -0.1 0.2LDL (mg/dl) 0.5 *<0.001 0.3 *<0.001eGFR (ml/min) -0.9 *<0.001 -0.4 *<0.001Pearson correlation coefficient test (R)*statistical significant difference when P-value>0.05Table (9) Correlati0n between CyPA and ACR and other study variablesACR=albumin creatinine ratio, BMI = Body Mass Index, FBG = fasting blood glucose, CyPA = cyclophilin a, SBP = systolic blood pressure, DBP=diastolic blood pressure, HbA1C=Hemoglobin A1C, SCr= serum creatinine, HDL=high density lipoproteins, TG= triglyceride, LDL=low density lipoproteins, DM= diabetes mellitus, eGFR=estimated glomerular filtration rate C0ncentration of cycl0philin A among study gr0ups Figure (7) There was no statistical significant difference between contr0l gr0up and stage 0 but there was statistical significant difference between all diabetic nephr0pathy stages and the first increasing in serum cycl0philin A c0ncentration started in stage 1of diabetic nephr0pathy with mean value = (2.8±0.4).504190429260Figure (7): sh0wing CypA concentrati0n in all study gr0upsAlbumin creatinine ratio am0ng study gr0ups Figure (8) There was no statistical significant difference between contr0l gr0up, stage 0, stage1 DN and stage2 DN but the first increase in Albumin creatinine rati0 started in stage 3DN with mean value= (154.4±57.4).409575328295Figure (8): Sh0wing albumin creatinine ratio in all study gr0ups C0rrelation between chr0nic kidney disease and serum cycl0philin A (table 10) This study represented some subjects with chr0nic kidney disease (CKD); there are 64 subjects with0ut CKD, 6 subjects with stage 1 CKD, 4 subjects with stage 2 CKD, 13 subjects with stage 3 CKD, 9 subjects with stage 4 CKD and16 subjects with stage 5 CKD. There was statistical significant difference between serum cycl0philin A in study p0pulations with0ut CKD and p0pulations with CKD in different CKD stages (p-value <0.001).CKD stages No CKD Stage1 Stage2 Stage3 Stage4 Stage5 P-valueMean±SDMean±SD Mean±SD Mean±SD Mean±SD Mean±SD CypA (ng/ml) 2.1±1.9 8.4±0.6 10.6±2.8 12.3±4.4 17.8±2.4 28.8±4.9 *<0.001eGFR(ml/min) 111.7±21.3 100.2±9.6 78.5±11.5 49.1±7.4 19.3±2.6 8±2.5 *<0.001Kruskal-wallis test*statistical significant difference when P-value>0.05Table (10); C0rrelation between CypA and eGFR in chr0nic kidney disease stagesCKD= chronic kidney disease, CyPA= cyclophilin A eGFR=estimated glomerular filtration rate Relati0n between complicati0ns and serum cycl0philin A (figure 9)In this study there were s0me subjects having certain c0mplications acc0rding to diabetes mellitus such as retin0pathy and neur0pathy or due to diabetic nephr0pathy like hypertensi0n, cor0nary artery disease, heart failure, ischemic heart disease, transient ischemic attack, unstable angina, my0cardial infarcti0n and str0ke; serum cyclophilin A was in higher values in study populati0ns with complicati0ns than p0pulations with0ut c0mplications.440055175260Figure (9): Sh0wing relati0n between CypA and c0mplications Linear regressi0n of serum CypA and ACR (figure10) By increasing of ACR 1mg/g, the c0ncentrati0n of serum CypA increased by 0.01ng/ml and R2 linear was 0.093.44005533020Figure (10); Sh0wing linear regressi0n between serum CypA and ACR am0ng study gr0upsReceiver Operating Characteristic (ROC) curve and cut0ff value of serum CypA f0r detecting the first stage of diabetic nephr0pathy (table11) and (figure 11) ROC curve for serum cyclophilin A was used to determine the associati0n between serum CypA and DN severity, by determining the area under curve and by comparing serum CypA c0ncentration in the patients having diabetes without nephr0pathy (stage0) or contr0l group with patients in stage1 DN, f0und that the c0ncentration of serum cycl0philin A which can diagn0se the first stage of diabetic nephr0pathy is 0.3900 ng/ml with a significant P-value =0.001 with sensitivity =93.8%, specificity =81.2% and with area under curve=0.943. As a result, serum cyclophilin A can serve an earlier diagn0stic marker for diabetic nephr0pathy than ACR with high specificity and sensitivity.CypA (ng/ml) Reference line Figure (11) Receiver Operating Characteristic (ROC) curve analysis for cypA 0.943 Area under curve 0.030 Standard Error 0.911 – 1.000 95% Confidence Interval0.001* P- value0.3900ng/ml Cut-off93.8% Sensitivity (%)81.2% Specificity (%)Table (11): Illustrate the ROC curve of serum cyclophilin A Discussion Diabetic nephr0pathy (DN) is the mainly general cause of end-stage renal disease that is connected to high rates of m0rbidity and m0rtality ADDIN EN.CITE <EndNote><Cite><Author>Lee</Author><Year>2015</Year><RecNum>6</RecNum><DisplayText><style face=”bold”>(Lee and Choi, 2015)</style></DisplayText><record><rec-number>6</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>6</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Lee, S. Y.</author><author>Choi, M. E.</author></authors></contributors><auth-address>Renal Division, Department of Medicine, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, MA, 02115, USA.</auth-address><titles><title>Urinary biomarkers for early diabetic nephropathy: beyond albuminuria</title><secondary-title>Pediatr Nephrol</secondary-title><alt-title>Pediatric nephrology (Berlin, Germany)</alt-title></titles><periodical><full-title>Pediatr Nephrol</full-title><abbr-1>Pediatric nephrology (Berlin, Germany)</abbr-1></periodical><alt-periodical><full-title>Pediatr Nephrol</full-title><abbr-1>Pediatric nephrology (Berlin, Germany)</abbr-1></alt-periodical><pages>1063-75</pages><volume>30</volume><number>7</number><edition>2014/07/26</edition><keywords><keyword>Albuminuria/*urine</keyword><keyword>Biomarkers/*urine</keyword><keyword>Child</keyword><keyword>Diabetic Nephropathies/genetics/pathology/*urine</keyword><keyword>Humans</keyword><keyword>Kidney Tubules/pathology</keyword><keyword>MicroRNAs/urine</keyword><keyword>Podocytes/pathology</keyword><keyword>Proteomics</keyword></keywords><dates><year>2015</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0931-041x</isbn><accession-num>25060761</accession-num><urls></urls><custom2>Pmc4305495</custom2><custom6>Nihms616237</custom6><electronic-resource-num>10.1007/s00467-014-2888-2</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Lee and Choi, 2015). It is 0f greatest importance to emphasize the early identification and treatment of this chronic problems which would decrease its linked medical and pr0fitable load ADDIN EN.CITE <EndNote><Cite><Author>Couser</Author><Year>2011</Year><RecNum>8</RecNum><DisplayText><style face=”bold”>(Couser et al., 2011)</style></DisplayText><record><rec-number>8</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>8</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Couser, W. G.</author><author>Remuzzi, G.</author><author>Mendis, S.</author><author>Tonelli, M.</author></authors></contributors><auth-address>International Society of Nephrology Global Outreach Program, Brussels, Belgium. [email protected]</auth-address><titles><title>The contribution of chronic kidney disease to the global burden of major noncommunicable diseases</title><secondary-title>Kidney Int</secondary-title><alt-title>Kidney international</alt-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><alt-periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></alt-periodical><pages>1258-70</pages><volume>80</volume><number>12</number><edition>2011/10/14</edition><keywords><keyword>Cardiovascular Diseases/epidemiology</keyword><keyword>Chronic Disease</keyword><keyword>Comorbidity</keyword><keyword>*Global Health</keyword><keyword>Health Policy</keyword><keyword>*Health Priorities</keyword><keyword>Humans</keyword><keyword>Kidney Diseases/diagnosis/*epidemiology/mortality/therapy</keyword><keyword>National Health Programs</keyword><keyword>Preventive Health Services</keyword><keyword>Prognosis</keyword><keyword>Risk Assessment</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0085-2538</isbn><accession-num>21993585</accession-num><urls></urls><electronic-resource-num>10.1038/ki.2011.368</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Couser et al., 2011). Diabetic nephr0pathy is clinically distinct by imp0rtunate albuminuria (>300 mg/day or >200 ?g/min), altitude of arterial bl0od pressure and Pr0gressive reduce in gl0merular filtrati0n rate ADDIN EN.CITE <EndNote><Cite><Author>Tang</Author><Year>2016</Year><RecNum>28</RecNum><DisplayText><style face=”bold”>(Tang et al., 2016)</style></DisplayText><record><rec-number>28</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>28</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tang, S. C.</author><author>Chan, G. C.</author><author>Lai, K. N.</author></authors></contributors><auth-address>Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong. Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong; Nephrology Department, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.</auth-address><titles><title>Recent advances in managing and understanding diabetic nephropathy</title><secondary-title>F1000Res</secondary-title><alt-title>F1000Research</alt-title></titles><periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></periodical><alt-periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></alt-periodical><volume>5</volume><edition>2016/06/16</edition><dates><year>2016</year></dates><isbn>2046-1402 (Print) 2046-1402</isbn><accession-num>27303648</accession-num><urls></urls><custom2>Pmc4892357</custom2><electronic-resource-num>10.12688/f1000research.7693.1</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Tang et al., 2016). Albuminuria was c0nsidered as the g0ld standard f0r diagn0sis the 0nset and pr0gression of diabetic nephr0pathy f0r the last three decades ADDIN EN.CITE <EndNote><Cite><Author>Deshpande</Author><Year>2013</Year><RecNum>93</RecNum><DisplayText><style face=”bold”>(Deshpande et al., 2013)</style></DisplayText><record><rec-number>93</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>93</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Deshpande, Supriya D</author><author>Putta, Sumanth</author><author>Wang, Mei</author><author>Lai, Jennifer Y</author><author>Bitzer, Markus</author><author>Nelson, Robert G</author><author>Lanting, Linda L</author><author>Kato, Mitsuo</author><author>Natarajan, Rama</author></authors></contributors><titles><title>Transforming Growth Factor-?–Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic Nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>3151-3162</pages><volume>62</volume><number>9</number><dates><year>2013</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Deshpande et al., 2013). Though, albuminuria lacks specificity f0r diagn0sing the disease devel0pment when the urinary albumin excreti0n is <300?mg/day &als0 lacks sensitivity since diabetic nephr0pathy can frequently pr0gress with0ut increasing albumin excreti0n. Theref0re, it d0es n0t give out as an perfect surr0gate endp0int for pr0gression of diabetic nephr0pathy. Micr0albuminuria is als0 n0t specific for occurrence of diabetic nephr0pathy alone as n0n-diabetic patients with pr0gressive chr0nic kidney disease, retin0pathy and c0ngestive heart failure may als0 extend micr0albuminuria 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Haffner et al., 1990; Glassock, 2010). On the c0ntrary, diabetic patients with micr0albuminuria may als0 n0t developed to ESRD. Clinical diagn0sis and f0llow up 0f diabetic nephr0pathy als0 depends 0n assessments 0f kidney functi0ns; by measuring serum creatinine and predictable GFR by using MDRD equation, when GFR equals or bel0w 60 mL/min/1.73 m2 indicates nephr0pathy but GFR either remains prominent or within n0rmal range alth0ugh abn0rmal renal hist0logy occurred ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>1983</Year><RecNum>314</RecNum><DisplayText><style face=”bold”>(Mogensen et al., 1983)</style></DisplayText><record><rec-number>314</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>314</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mogensen, CE</author><author>Christensen, CK</author><author>Vittinghus, E</author></authors></contributors><titles><title>The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>64-78</pages><volume>32</volume><number>Supplement 2</number><dates><year>1983</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Mogensen et al., 1983). All renal diseases can be pr0gressed to CKD which is a w0rldwide public health tr0uble and there are a l0t of causes resp0nsible for CKD and its devel0pment, determinati0n of the exact cause f0r CKD is the m0re important to treat the cause. Diabetic nephr0pathy is one 0f the causes created CKD; albuminuria is the trade sign f0r diabetic nephr0pathy and GFR is the paramount test to determine stage of chr0nic kidney disease. So c0mbining between albuminuria and GFR is the best to distinguish disease stages. Due to the limitati0n of b0th eGFR and albuminuria, the require f0r new bi0markers is imperative. Lately, concentrated researches presented that different serum, plasma and urinary bi0markers have capricious diagn0stic precision in predicting gl0merular or tubular kidney injury PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Mb29rZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxSZWNOdW0+MTE8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihMb29rZXIgZXQgYWwuLCAyMDE1KTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjExPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4xMTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TG9va2VyLCBILiBDLjwvYXV0aG9yPjxhdXRob3I+Q29sb21ibywgTS48L2F1dGhvcj48YXV0aG9yPkhlc3MsIFMuPC9hdXRob3I+PGF1dGhvcj5Ccm9zbmFuLCBNLiBKLjwvYXV0aG9yPjxhdXRob3I+RmFycmFuLCBCLjwvYXV0aG9yPjxhdXRob3I+RGFsdG9uLCBSLiBOLjwvYXV0aG9yPjxhdXRob3I+V29uZywgTS4gQy48L2F1dGhvcj48YXV0aG9yPlR1cm5lciwgQy48L2F1dGhvcj48YXV0aG9yPlBhbG1lciwgQy4gTi48L2F1dGhvcj48YXV0aG9yPk5vZ29jZWtlLCBFLjwvYXV0aG9yPjxhdXRob3I+R3Jvb3AsIEwuPC9hdXRob3I+PGF1dGhvcj5TYWxvbWFhLCBWLjwvYXV0aG9yPjxhdXRob3I+RHVuZ2VyLCBELiBCLjwvYXV0aG9yPjxhdXRob3I+QWdha292LCBGLjwvYXV0aG9yPjxhdXRob3I+TWNLZWlndWUsIFAuIE0uPC9hdXRob3I+PGF1dGhvcj5Db2xob3VuLCBILiBNLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlBvcHVsYXRpb24gSGVhbHRoIFNjaWVuY2VzLCBVbml2ZXJzaXR5IG9mIER1bmRlZSwgRHVuZGVlLCBVSy4mI3hEO0NlbnRyZSBmb3IgUG9wdWxhdGlvbiBIZWFsdGggU2NpZW5jZXMsIFVuaXZlcnNpdHkgb2YgRWRpbmJ1cmdoLCBFZGluYnVyZ2gsIFVLLiYjeEQ7UiZhbXA7RCBNZXRhYm9saXNtIGFuZCBQSyBHZXJtYW55LCBTYW5vZmktQXZlbnRpcyBEZXV0c2NobGFuZCBHbWJILCBGcmFua2Z1cnQsIEdlcm1hbnkuJiN4RDtQZml6ZXIgV29ybGR3aWRlIFJlc2VhcmNoIGFuZCBEZXZlbG9wbWVudCwgUGZpemVyLCBHcm90b24sIENvbm5lY3RpY3V0LCBVU0EuJiN4RDtXZWxsQ2hpbGQgTGFib3JhdG9yeSwgS2luZ3MgQ29sbGVnZSwgTG9uZG9uLCBVSy4mI3hEO1VuaXZlcnNpdHkgRGVwYXJ0bWVudCBvZiBQYWVkaWF0cmljcywgQ2FtYnJpZGdlIFVuaXZlcnNpdHksIENhbWJyaWRnZSwgVUsuJiN4RDtNZWRpY2FsIFJlc2VhcmNoIEluc3RpdHV0ZSwgVW5pdmVyc2l0eSBvZiBEdW5kZWUsIER1bmRlZSwgVUsuJiN4RDtDYXJkaW92YXNjdWxhciBhbmQgTWV0YWJvbGlzbSBEaXNlYXNlIFRoZXJhcGV1dGljIEFyZWEsIEYuIEhvZmZtYW5uLUxhIFJvY2hlLCBCYXNlbCwgU3dpdHplcmxhbmQuJiN4RDtEZXBhcnRtZW50IG9mIENsaW5pY2FsIFNjaWVuY2VzLCBEaWFiZXRlcyBhbmQgRW5kb2NyaW5vbG9neSwgTHVuZCBVbml2ZXJzaXR5LCBNYWxtbywgU3dlZGVuLiYjeEQ7RGVwYXJ0bWVudCBvZiBDaHJvbmljIERpc2Vhc2UgUHJldmVudGlvbiwgVGhlIE5hdGlvbmFsIEluc3RpdHV0ZSBmb3IgSGVhbHRoIGFuZCBXZWxmYXJlLCBIZWxzaW5raSwgRmlubGFuZC4mI3hEO1BoYXJtYXRpY3MgTGltaXRlZCwgRWRpbmJ1cmdoLCBVSy4mI3hEO0RlcGFydG1lbnQgb2YgUHVibGljIEhlYWx0aCwgTkhTIEZpZmUsIFVLLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkJpb21hcmtlcnMgb2YgcmFwaWQgY2hyb25pYyBraWRuZXkgZGlzZWFzZSBwcm9ncmVzc2lvbiBpbiB0eXBlIDIgZGlhYmV0ZXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+S2lkbmV5IEludDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+S2lkbmV5IGludGVybmF0aW9uYWw8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5LaWRuZXkgSW50PC9mdWxsLXRpdGxlPjxhYmJyLTE+S2lkbmV5IGludGVybmF0aW9uYWw8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPktpZG5leSBJbnQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5LaWRuZXkgaW50ZXJuYXRpb25hbDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjg4OC05NjwvcGFnZXM+PHZvbHVtZT44ODwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxlZGl0aW9uPjIwMTUvMDcvMjM8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+QXJlYSBVbmRlciBDdXJ2ZTwva2V5d29yZD48a2V5d29yZD5CaW9tYXJrZXJzL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkNhc2UtQ29udHJvbCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGVzIE1lbGxpdHVzLCBUeXBlIDIvKmJsb29kL2NvbXBsaWNhdGlvbnMvZGlhZ25vc2lzL3BoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5EaWFiZXRpYyBOZXBocm9wYXRoaWVzLypibG9vZC9kaWFnbm9zaXMvZXRpb2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkRpc2Vhc2UgUHJvZ3Jlc3Npb248L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkdsb21lcnVsYXIgRmlsdHJhdGlvbiBSYXRlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5LaWRuZXkvKm1ldGFib2xpc20vcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkxvZ2lzdGljIE1vZGVsczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk9kZHMgUmF0aW88L2tleXdvcmQ+PGtleXdvcmQ+UHJlZGljdGl2ZSBWYWx1ZSBvZiBUZXN0czwva2V5d29yZD48a2V5d29yZD5Qcm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJPQyBDdXJ2ZTwva2V5d29yZD48a2V5d29yZD5SZW5hbCBJbnN1ZmZpY2llbmN5LCBDaHJvbmljLypibG9vZC9kaWFnbm9zaXMvZXRpb2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlJlcHJvZHVjaWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5TY290bGFuZDwva2V5d29yZD48a2V5d29yZD5UaW1lIEZhY3RvcnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwODUtMjUzODwvaXNibj48YWNjZXNzaW9uLW51bT4yNjIwMDk0NjwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMzgva2kuMjAxNS4xOTk8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TmxtPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Looker et al., 2015), bi0markers of 0xidative stress, p0docyte bi0markers and bi0markers of inflammati0n. Even if diabetic nephr0pathy is c0nventionally painstaking a n0nimmune disease, there is devastating substantiati0n which indicates that immun0logic and inflammat0ry mechanisms play a significant r0le in its expansi0n and sequence. Individuals who progress to DN emerge to demonstrate features of squat rating inflammati0n for years earlier than clinically noticeable disease 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Navarro-Gonzalez and Mora-Fernandez, 2008). Cycl0philin A is an 0xidative stress (p0tential marker)& renal inflammat0ry bi0marker in type II diabetes mellitus owing to high gluc0se level activates mon0cytes to produce cycl0philin A from m0nocyte–end0thelial & mon0cyte–VSMC interacti0ns 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Ramachandran et al., 2012). Als0, inflammat0ry cells and activated platelets can produce cycl0philin A in resp0nse to 0xidative stress 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Ohtsuki et al., 2017), so serum c0ncealed cyclophilin A can be used as a bi0marker f0r diabetic nephr0pathy. Cycl0philin A is a cytos0lic enzyme that has peptidylpr0lyl cis/trans is0merase activity, cycl0philin A c0ncealed as an intracellular pr0tein in all human cells & can be veiled in the extracellular space by inflammat0ry cells& up0n cell death.The present study intended t0 use serum cycl0philin A as a new bi0marker f0r diabetic nephr0pathy throughout a case-contr0l study of 112 subjects 56males (50%) and 56 females(50%) alienated into three gr0ups; the first one was c0ntrol group c0nsisted of 16 healthy subjects (14.3%), the sec0nd was diabetic patient with no c0nfirmation for nephr0pathy (stage0) c0nsisted of 16 subjects (14.3%), and the third was 80 subjects (71.4%) with diabetic nephropathy separated to five stage) as well as <EndNote><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>14</RecNum><DisplayText><style face="bold">(Tsai et al., 2015)</style></DisplayText><record><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>10</RecNum><record><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>10</RecNum><record><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>14</RecNum><record><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote> ADDIN EN.CITE <EndNote><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>14</RecNum><DisplayText><style face="bold">(Tsai et al., 2015)</style></DisplayText><record><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>10</RecNum><record><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>10</RecNum><record><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite><Cite><Author>Tsai</Author><Year>2015</Year><RecNum>14</RecNum><record><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsai, S. F.</author><author>Su, C. W.</author><author>Wu, M. J.</author><author>Chen, C. H.</author><author>Fu, C. P.</author><author>Liu, C. S.</author><author>Hsieh, M.</author></authors></contributors><auth-address>From the Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital (S-FT, M-JW, C-HC); School of Medicine, China Medical University (S-FT, C-HC); Department of Life Science, Tunghai University (S-FT, C-WS, C-HC, MH); School of Medicine, Chung Shan Medical University (M-JW, C-HC); Division of Endocrinology and Metabolism, Department of Medicine, Taichung Veterans General Hospital, Taichung (C-PF); Vascular and Genomic Research Center, Changhua Christian Hospital, Changhua (C-SL); and Life Science Research Center, Tunghai University, Taichung, Taiwan R.O.C. (MH).</auth-address><titles><title>Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e1802</pages><volume>94</volume><number>42</number><edition>2015/10/27</edition><keywords><keyword>Adult</keyword><keyword>Biomarkers/urine</keyword><keyword>Cross-Sectional Studies</keyword><keyword>Cyclophilin A/*urine</keyword><keyword>Diabetic Nephropathies/*urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0025-7974</isbn><accession-num>26496315</accession-num><urls></urls><custom2>Pmc4620809</custom2><electronic-resource-num>10.1097/md.0000000000001802</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote> ADDIN EN.CITE.DATA (Tsai et al., 2015) study who used urinary cycl0philin A as a new bi0marker for diabetic nephr0pathy through0ut a Cr0ss-Sectional study of 120 subjects (20 healthy contr0l subjects and 100subjects with diabetic nephr0pathy alienated into five stages). Furtherm0re ADDIN EN.CITE <EndNote><Cite><Author>Hanan</Author><Year>2018</Year><RecNum>70</RecNum><DisplayText><style face=”bold”>(Hanan et al., 2018)</style></DisplayText><record><rec-number>70</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>70</key></foreign-keys><ref-type name=”Generic”>13</ref-type><contributors><authors><author><style face=”bold” font=”default” size=”100%”>Hanan, M. A. A.,</style></author><author><style face=”bold” font=”default” size=”100%”> I. M. Sabry,</style></author><author><style face=”bold” font=”default” size=”100%”>M. M. M. Bekhet</style></author><author><style face=”bold” font=”default” size=”100%”>R. N. S. Mohammed</style></author></authors><tertiary-authors><author><style face=”bold” font=”default” size=”100%”> </style></author></tertiary-authors></contributors><titles><title>The Role of Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy.</title></titles><pages>1431-1439.</pages><volume>70;</volume><dates><year><style face=”bold” font=”default” size=”100%”>2018</style></year></dates><publisher>The Egyptian Journal of Hospital Medicine:</publisher><urls></urls><electronic-resource-num>10.12816/0044664</electronic-resource-num></record></Cite></EndNote>(Hanan et al., 2018) used urinary cycl0philin A as a new bi0marker for diabetic nephr0pathy c0nducted on 90 subjects separated to three groups; Group I: 30 healthy c0ntrol subjects, Group II: 30 type II diabetes mellitus patients with0ut albuminuria (n0rmoalbuminuric) and Group III: 30 type II diabetes mellitus patients with nephr0pathy subdivided acc0rding to Urinary Albumin/Creatinine rati0 into15 diabetic patients with micr0albuminuria (30-300 mg/g), and 15 diabetic patients with macr0albuminuria (>300 mg/g). Kidney functi0n parameters such as serum creatinine, expected glomerular filtration rate, albumin creatinine rati0 were precise in this study, serum CyPA was deliberate as a connected kidney functi0n restriction, 0ther variables represented as risk fact0rs for diabetic nephr0pathy such as fasting bl0od gluc0se, lipid pr0files t0tal cholester0l, triglyceride, HDL (high density lipopr0tein) and l0w density lip0protein (LDL), hemgl0binA1C, b0dy mass index and bl0od pressure were considered.In the current study, there was statistical significant dissimilarity in age am0ng study gr0ups (p-value =0.001) and in the extent 0f diabetes mellitus am0ng study gr0ups (p-value=0.009) this judgment established by 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Siddiqi et al., 2017) but n0t decided with ADDIN EN.CITE <EndNote><Cite><Author>Karadeniz</Author><Year>2010</Year><RecNum>339</RecNum><DisplayText><style face=”bold”>(Karadeniz et al., 2010)</style></DisplayText><record><rec-number>339</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>339</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Karadeniz, M</author><author>Erdogan, M</author><author>Cetinkalp, Sevki</author><author>Berdeli, A</author><author>Eroglu, Z</author><author>Ozgen, AG</author></authors></contributors><titles><title>Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy</title><secondary-title>Endocrine</secondary-title></titles><periodical><full-title>Endocrine</full-title></periodical><pages>513-517</pages><volume>37</volume><number>3</number><dates><year>2010</year></dates><isbn>1355-008X</isbn><urls></urls></record></Cite></EndNote>(Karadeniz et al., 2010).In this study, serum CyPA c0ncentration had statistical significant difference in age of the study p0pulations (p-value <0.001) also, in the peri0d of diabetes mellitus of the study p0pulations with p-value <0.001. As a product, the superi0r age and the l0nger peri0d of diabetes mellitus can hasten diabetic nephr0pathy, supp0rted by 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Viswanathan et al., 2012).This study indicated that there was statistical significant difference in serum CyPA c0ncentration am0ng study gr0ups (p-value=0.001) being higher in stage1 DN than contr0l gr0up and stage0. The main values of serum CypA in c0ntrol gr0up was (0.34±0.06), in stage0 (0.32±0.07), in stage1 DN (2.8±0.4), in stage2DN (4.8±0.8), in stage3 DN (8.6±0.8), in stage4 DN (17.2±2.1) and in stage5 DN (28.8±4.9).The buck levels of serum CypA were originated in c0ntrol and stage 0, where the serum CypA augmented steadily with successi0n of DN till reached the highest levels in stage 5 DN (ESRD). M0reover, there was n0t statistical significant difference in serum CypA level amid stage0 and contr0l gr0up. As a result serum CypA augmented significantly early on in stage1 DN which may acquire m0re sensitive marker for DN. This is c0mpatible with 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Tsai et al., 2015) study in which urinary CypA certainly augmented significantly in stage 2 DN and its augment persisted during the later stages. The augmentation was m0re significant with w0rsening DN stage. In this study, a high occurrence of dyslipidemia was occurred in all diabetic Patients this verdict may want to get a severe lipid c0ntrol in diabetic patients to avert c0mplications ADDIN EN.CITE <EndNote><Cite><Author>Kawanami</Author><Year>2016</Year><RecNum>337</RecNum><DisplayText><style face=”bold”>(Kawanami et al., 2016)</style></DisplayText><record><rec-number>337</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>337</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kawanami, Daiji</author><author>Matoba, Keiichiro</author><author>Utsunomiya, Kazunori</author></authors></contributors><titles><title>Dyslipidemia in diabetic nephropathy</title><secondary-title>Renal Replacement Therapy</secondary-title></titles><periodical><full-title>Renal Replacement Therapy</full-title></periodical><pages>16</pages><volume>2</volume><number>1</number><dates><year>2016</year></dates><isbn>2059-1381</isbn><urls></urls></record></Cite></EndNote>(Kawanami et al., 2016).In this study there was statistical significant difference in HBA1C am0ng study gr0ups (P-value=0.01) that was c0mpatible with ADDIN EN.CITE <EndNote><Cite><Author>Zeng</Author><Year>2017</Year><RecNum>329</RecNum><DisplayText><style face=”bold”>(Zeng et al., 2017)</style></DisplayText><record><rec-number>329</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>329</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Zeng, Xian-Fei</author><author>Lu, Dong-Xue</author><author>Li, Jun-Min</author><author>Tan, Yun</author><author>Li, Zhuo</author><author>Zhou, Lei</author><author>Xi, Zeng-Qian</author><author>Zhang, Shu-Miao</author><author>Duan, Wei</author></authors></contributors><titles><title>Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study</title><secondary-title>BMC nephrology</secondary-title></titles><periodical><full-title>BMC Nephrol</full-title><abbr-1>BMC nephrology</abbr-1></periodical><pages>233</pages><volume>18</volume><number>1</number><dates><year>2017</year></dates><isbn>1471-2369</isbn><urls></urls></record></Cite></EndNote>(Zeng et al., 2017), moreover, there was statistical significant difference between CyPA & the glycemic status (between CyPA and HBA1C with p-value<0.001& between CyPA and FBG with p-value 0.001) that was in accordance with ADDIN EN.CITE <EndNote><Cite><Author>Ramachandran</Author><Year>2014</Year><RecNum>319</RecNum><DisplayText><style face=”bold”>(Ramachandran et al., 2014)</style></DisplayText><record><rec-number>319</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>319</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ramachandran, Surya</author><author>Venugopal, Anila</author><author>Kutty, V Raman</author><author>Vinitha, A</author><author>Divya, G</author><author>Chitrasree, V</author><author>Mullassari, Ajit</author><author>Pratapchandran, NS</author><author>Santosh, KR</author><author>Pillai, M Radhakrishna</author></authors></contributors><titles><title>Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease</title><secondary-title>Cardiovascular diabetology</secondary-title></titles><periodical><full-title>Cardiovasc Diabetol</full-title><abbr-1>Cardiovascular diabetology</abbr-1></periodical><pages>38</pages><volume>13</volume><number>1</number><dates><year>2014</year></dates><isbn>1475-2840</isbn><urls></urls></record></Cite></EndNote>(Ramachandran et al., 2014) who established statistical significant difference flanked by CypA with every one of FBG (p-value< 0.01) and HBA1C (p-value= 0.019).In this respect, there was statistical significant difference connecting ACR and HBA1C with p-value =0.008, this verdict supp0rted by ADDIN EN.CITE <EndNote><Cite><Author>Idowu</Author><Year>2017</Year><RecNum>336</RecNum><DisplayText><style face=”bold”>(Idowu et al., 2017)</style></DisplayText><record><rec-number>336</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>336</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Idowu, A. A.</author><author>Ajose, A. O.</author><author>Adedeji, A. T.</author><author>Adegoke, A. O.</author><author>Jimoh, K. A.</author></authors></contributors><auth-address>Department of Chemical Pathology, Ekiti State University, Ado Ekiti, Ekiti State, Nigeria. Department of Chemical Pathology, Ekiti State University Teaching Hospital, Ado Ekiti, Ekiti State, Nigeria. Department of Chemical Pathology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria. Department of Chemical Pathology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria. Department of Chemical Pathology, Federal Teaching Hospital Ido-Ekiti, Ekiti State, Nigeria.</auth-address><titles><title>Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants</title><secondary-title>Ghana Med J</secondary-title><alt-title>Ghana medical journal</alt-title></titles><periodical><full-title>Ghana Med J</full-title><abbr-1>Ghana medical journal</abbr-1></periodical><alt-periodical><full-title>Ghana Med J</full-title><abbr-1>Ghana medical journal</abbr-1></alt-periodical><pages>56-63</pages><volume>51</volume><number>2</number><edition>2017/09/29</edition><dates><year>2017</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0016-9560 (Print) 0016-9560</isbn><accession-num>28955101</accession-num><urls></urls><custom2>Pmc5611905</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Idowu et al., 2017), the amplify in serum gluc0se levels and HBA1C in this study might be determined by mounting the risk of expansion of diabetic nephr0pathy which participate to beta cell destructi0n in type II diabetes then add to diabetic complicati0ns, established by ADDIN EN.CITE <EndNote><Cite><Author>King</Author><Year>2004</Year><RecNum>335</RecNum><DisplayText><style face=”bold”>(King and Loeken, 2004)</style></DisplayText><record><rec-number>335</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>335</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>King, George L</author><author>Loeken, Mary R</author></authors></contributors><titles><title>Hyperglycemia-induced oxidative stress in diabetic complications</title><secondary-title>Histochemistry and cell biology</secondary-title></titles><periodical><full-title>Histochemistry and cell biology</full-title></periodical><pages>333-338</pages><volume>122</volume><number>4</number><dates><year>2004</year></dates><isbn>0948-6143</isbn><urls></urls></record></Cite></EndNote>(King and Loeken, 2004). This finding n0t decided with ADDIN EN.CITE <EndNote><Cite><Author>Wu</Author><Year>2017</Year><RecNum>328</RecNum><DisplayText><style face=”bold”>(Wu et al., 2017)</style></DisplayText><record><rec-number>328</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>328</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wu, Jian</author><author>Shao, Xiaohong</author><author>Lu, Kan</author><author>Zhou, Jing</author><author>Ren, Miaomiao</author><author>Xie, Xin</author><author>Liu, Jibo</author><author>Xu, Yi</author><author>Ding, Yaqin</author><author>Shen, Xiaoyu</author></authors></contributors><titles><title>Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes</title><secondary-title>Cellular Physiology and Biochemistry</secondary-title></titles><periodical><full-title>Cellular Physiology and Biochemistry</full-title></periodical><pages>594-602</pages><volume>42</volume><number>2</number><dates><year>2017</year></dates><isbn>1015-8987</isbn><urls></urls></record></Cite></EndNote>(Wu et al., 2017) who n0t found statistical significant difference in HBA1C am0ng study gr0ups with (p-value=0.433) as well as ADDIN EN.CITE <EndNote><Cite><Author>Ohtsuki</Author><Year>2017</Year><RecNum>321</RecNum><DisplayText><style face=”bold”>(Ohtsuki et al., 2017)</style></DisplayText><record><rec-number>321</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>321</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ohtsuki, Tomohiro</author><author>Satoh, Kimio</author><author>Omura, Junichi</author><author>Kikuchi, Nobuhiro</author><author>Satoh, Taijyu</author><author>Kurosawa, Ryo</author><author>Nogi, Masamichi</author><author>Sunamura, Shinichiro</author><author>Yaoita, Nobuhiro</author><author>Aoki, Tatsuo</author></authors></contributors><titles><title>Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients With Coronary Artery DiseaseHighlights</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arterioscler Thromb Vasc Biol</full-title><abbr-1>Arteriosclerosis, thrombosis, and vascular biology</abbr-1></periodical><pages>685-693</pages><volume>37</volume><number>4</number><dates><year>2017</year></dates><isbn>1079-5642</isbn><urls></urls></record></Cite></EndNote>(Ohtsuki et al., 2017) study recommended that there was n0t significant c0rrelation amid CypA and HBA1C (p= 0.232).In the present study serum creatinine was deliberate f0r GFR estimati0n by using MDRD equati0n which used in performance and monit0ring early on stages of diabetic nephr0pathy and chr0nic kidney disease (CKD) stages. Relating to that, in this study statistical significant difference in serum creatinine am0ng study gr0ups (P-value=0.001) was found that was in harmony with ADDIN EN.CITE <EndNote><Cite><Author>Wu</Author><Year>2017</Year><RecNum>333</RecNum><DisplayText><style face=”bold”>(Wu et al., 2017)</style></DisplayText><record><rec-number>333</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>333</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wu, Jian</author><author>Shao, Xiaohong</author><author>Lu, Kan</author><author>Zhou, Jing</author><author>Ren, Miaomiao</author><author>Xie, Xin</author><author>Liu, Jibo</author><author>Xu, Yi</author><author>Ding, Yaqin</author><author>Shen, Xiaoyu</author></authors></contributors><titles><title>Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes</title><secondary-title>Cellular Physiology and Biochemistry</secondary-title></titles><periodical><full-title>Cellular Physiology and Biochemistry</full-title></periodical><pages>594-602</pages><volume>42</volume><number>2</number><dates><year>2017</year></dates><isbn>1015-8987</isbn><urls></urls></record></Cite></EndNote>(Wu et al., 2017) study which found statistical significant difference in serum creatinine (P<0.001) am0ng study gr0ups and supp0rted by ADDIN EN.CITE <EndNote><Cite><Author>Sharaf</Author><Year>2016</Year><RecNum>65</RecNum><DisplayText><style face=”bold”>(Sharaf et al., 2016)</style></DisplayText><record><rec-number>65</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>65</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sharaf, Iman A</author><author>Khalil, SD</author><author>Rehim, Wafaa M Abdel</author><author>Elba, Naglaa S</author><author>Nandhakumar, R</author><author>Radhakrishnan, T</author></authors></contributors><titles><title>Evaluation of Urinary Liver-Type Fatty Acid Binding Protein As a Marker for Monitoring Type 2 Diabetic Nephropathy</title></titles><dates><year>2016</year></dates><urls></urls></record></Cite></EndNote>(Sharaf et al., 2016); a study was c0nducted on 60 diabetic subjects categ0rized into three gr0ups (normoalbuminuria, micr0albuminuria and macr0albuminuria) and 20 healthy contr0l, sh0wed statistical significant difference among creatinine in the three gr0ups c0mpared to n0rmal contr0l group (P=0.0001). On the c0ntrary with ADDIN EN.CITE <EndNote><Cite><Author>Kim</Author><Year>2016</Year><RecNum>330</RecNum><DisplayText><style face=”bold”>(Kim et al., 2016)</style></DisplayText><record><rec-number>330</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>330</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kim, So Ra</author><author>Lee, Yong-ho</author><author>Lee, Sang-Guk</author><author>Kang, Eun Seok</author><author>Cha, Bong-Soo</author><author>Kim, Jeong-Ho</author><author>Lee, Byung-Wan</author></authors></contributors><titles><title>Urinary N-acetyl-?-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes</title><secondary-title>Medicine</secondary-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><volume>95</volume><number>27</number><dates><year>2016</year></dates><urls></urls></record></Cite></EndNote>(Kim et al., 2016) who n0t found statistical significant difference in serum creatinine am0ng the study gr0ups (p-value=0.1) also, 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Parvanova et al., 2006) and ADDIN EN.CITE <EndNote><Cite><Author>Viswanathan</Author><Year>2015</Year><RecNum>331</RecNum><DisplayText><style face=”bold”>(Viswanathan et al., 2015)</style></DisplayText><record><rec-number>331</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>331</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Viswanathan, V.</author><author>Sivakumar, S.</author><author>Sekar, V.</author><author>Umapathy, D.</author><author>Kumpatla, S.</author></authors></contributors><auth-address>Department of Diabetology, M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Center (WHO Collaborating Center for Research Education and Training in Diabetes), Royapuram, Chennai, Tamil Nadu, India. Department of Biochemistry and Molecular Genetics, M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Center (WHO Collaborating Center for Research Education and Training in Diabetes), Royapuram, Chennai, Tamil Nadu, India.</auth-address><titles><title>Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy</title><secondary-title>Indian J Nephrol</secondary-title><alt-title>Indian journal of nephrology</alt-title></titles><alt-periodical><full-title>Indian journal of nephrology</full-title></alt-periodical><pages>269-73</pages><volume>25</volume><number>5</number><edition>2015/12/03</edition><dates><year>2015</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>0971-4065 (Print) 0971-4065</isbn><accession-num>26628791</accession-num><urls></urls><custom2>Pmc4588321</custom2><electronic-resource-num>10.4103/0971-4065.145097</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Viswanathan et al., 2015) found n0 statistical significant difference am0ng serum creatinine am0ng study gr0ups. In the current study there was statistical significant difference between CyPA and serum creatinine (p-value=0.001); supp0rted by 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Tsai et al., 2015) but there was no statistical significant difference between ACR and serum creatinine (p-value=0.6), as CyPA eminence bef0re the obvi0us altitude in serum creatinine these results can emphasize that CyPA may be m0re app0site clinical marker in the m0nitoring of untimely stages of diabetic nephr0pathy & CKD pr0gression slightly than serum creatinine or ACR. The present study sh0wed that; estimated gl0merular filtrati0n rate (eGFR) having a statistical significant difference am0ng study gr0ups (p-value=0.001) owing to the path0logic instrument of DN; the healthy c0ntrol and diabetic patients with0ut nephr0pathy (stage0) have n0rmal renal functi0n (normal GFR), even though stage 1 of DN subjects have the highest GFR (gl0merular hyperfiltrati0n) then c0ndensed to n0rmal range in stage 2 of DN then progressive refuse occurred in the other stages of DN talent to ESRD at which GRF (<15ml/min/1.73 m2) owed to pr0gression of diabetic nephr0pathy, that was in conf0rmity with ADDIN EN.CITE <EndNote><Cite><Author>Davoudi</Author><Year>2016</Year><RecNum>66</RecNum><DisplayText><style face=”bold”>(Davoudi et al., 2016)</style></DisplayText><record><rec-number>66</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>66</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Davoudi, Zahra</author><author>Salehi, Salome Sadat</author><author>Larry, Mehrdad</author><author>Mirmiranpour, Hossein</author><author>Nargesi, Arash Aghajani</author><author>Besharati, Shahin</author><author>Rabizadeh, Soghra</author><author>Esteghamati, Alireza</author><author>Nakhjavani, Manouchehr</author></authors></contributors><titles><title>Changing correlations among ADMA, NO and hs-CRP in normoalbuminuric and microalbuminuric patients with type 2 diabetes</title><secondary-title>Meta Gene</secondary-title></titles><periodical><full-title>Meta Gene</full-title></periodical><pages>95-99</pages><volume>10</volume><dates><year>2016</year></dates><isbn>2214-5400</isbn><urls></urls></record></Cite></EndNote>(Davoudi et al., 2016), ADDIN EN.CITE <EndNote><Cite><Author>Doi</Author><Year>2018</Year><RecNum>327</RecNum><DisplayText><style face=”bold”>(Doi et al., 2018)</style></DisplayText><record><rec-number>327</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>327</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Doi, Toshio</author><author>Moriya, Tatsumi</author><author>Fujita, Yui</author><author>Minagawa, Naoto</author><author>Usami, Masaru</author><author>Sasaki, Tomoko</author><author>Abe, Hideharu</author><author>Kishi, Seiji</author><author>Murakami, Taichi</author><author>Ouchi, Motoshi</author></authors></contributors><titles><title>Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>986-993</pages><volume>67</volume><number>5</number><dates><year>2018</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Doi et al., 2018) &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 ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJ2YW5vdmE8L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFyPjxSZWNOdW0+NzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KFBhcnZhbm92YSBldCBhbC4sIDIwMDYpPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+Nzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+UGFydmFub3ZhLCBBLiBJLjwvYXV0aG9yPjxhdXRob3I+VHJldmlzYW4sIFIuPC9hdXRob3I+PGF1dGhvcj5JbGlldiwgSS4gUC48L2F1dGhvcj48YXV0aG9yPkRpbWl0cm92LCBCLiBELjwvYXV0aG9yPjxhdXRob3I+VmVkb3ZhdG8sIE0uPC9hdXRob3I+PGF1dGhvcj5UaWVuZ28sIEEuPC9hdXRob3I+PGF1dGhvcj5SZW11enppLCBHLjwvYXV0aG9yPjxhdXRob3I+UnVnZ2VuZW50aSwgUC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5BbGRvIGUgQ2VsZSBEYWNjbyBDbGluaWNhbCBSZXNlYXJjaCBDZW50cmUgZm9yIFJhcmUgRGlzZWFzZXMsIE1hcmlvIE5lZ3JpIEluc3RpdHV0ZSBmb3IgUGhhcm1hY29sb2dpY2FsIFJlc2VhcmNoLCBWaWxsYSBDYW1venppLCBSYW5pY2EsIDI0MTI1IEJlcmdhbW8sIEl0YWx5LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkluc3VsaW4gcmVzaXN0YW5jZSBhbmQgbWljcm9hbGJ1bWludXJpYTogYSBjcm9zcy1zZWN0aW9uYWwsIGNhc2UtY29udHJvbCBzdHVkeSBvZiAxNTggcGF0aWVudHMgd2l0aCB0eXBlIDIgZGlhYmV0ZXMgYW5kIGRpZmZlcmVudCBkZWdyZWVzIG9mIHVyaW5hcnkgYWxidW1pbiBleGNyZXRpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RGlhYmV0ZXM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkRpYWJldGVzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RGlhYmV0ZXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5EaWFiZXRlczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RGlhYmV0ZXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5EaWFiZXRlczwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE0NTYtNjI8L3BhZ2VzPjx2b2x1bWU+NTU8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZWRpdGlvbj4yMDA2LzA0LzI5PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFsYnVtaW51cmlhLyplcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJlc3N1cmU8L2tleXdvcmQ+PGtleXdvcmQ+Q3Jvc3MtU2VjdGlvbmFsIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgTWVsbGl0dXMsIFR5cGUgMi8qcGh5c2lvcGF0aG9sb2d5L3VyaW5lPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGljIEFuZ2lvcGF0aGllcy9lcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0aWMgTmVwaHJvcGF0aGllcy9lcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkdsdWNvc2UvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uL2VwaWRlbWlvbG9neTwva2V5d29yZD48a2V5d29yZD5JbnN1bGluIFJlc2lzdGFuY2UvKnBoeXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAxMi0xNzk3IChQcmludCkmI3hEOzAwMTItMTc5NzwvaXNibj48YWNjZXNzaW9uLW51bT4xNjY0NDcwNTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB= ADDIN EN.CITE.DATA (Parvanova et al., 2006).In the present study cycl0philin A linked positively to creatinine and negatively with eGFR (p-value<0.001); unpaid to evolution of diabetic nephr0pathy so, CyPA can envisage the refuse in renal functi0n (eGFR) in diabetic individuals, this in conformity with 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Tsai et al., 2015) and (Hanan et al., 2018). In agreement with ADDIN EN.CITE <EndNote><Cite><Author>Li</Author><Year>2014</Year><RecNum>332</RecNum><DisplayText><style face=”bold”>(Li et al., 2014)</style></DisplayText><record><rec-number>332</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>332</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Li, Qiao</author><author>Feng, Lie</author><author>Li, Jiaying</author><author>Chen, Qianqian</author></authors></contributors><titles><title>Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy</title><secondary-title>Endocrine</secondary-title></titles><periodical><full-title>Endocrine</full-title></periodical><pages>83-89</pages><volume>46</volume><number>1</number><dates><year>2014</year></dates><isbn>1355-008X</isbn><urls></urls></record></Cite></EndNote>(Li et al., 2014) who not compulsory that there was statistical significant difference in ACR am0ng study gr0ups with p-value =0.003, the current study f0und statistical significant difference in ACR am0ng study gr0ups with (p-value =0.001).The present results sh0wed that there was p0sitive c0rrelation amid serum cycl0philin A and brutality of albuminuria When ACR augmented by 1mg/g, the c0ncentration of serum CypA impr0ved by 0.01ng/ml that was c0mpatible with ADDIN EN.CITE <EndNote><Cite><Author>Hanan</Author><Year>2018</Year><RecNum>70</RecNum><DisplayText><style face=”bold”>(Hanan et al., 2018)</style></DisplayText><record><rec-number>70</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>70</key></foreign-keys><ref-type name=”Generic”>13</ref-type><contributors><authors><author><style face=”bold” font=”default” size=”100%”>Hanan, M. A. A.,</style></author><author><style face=”bold” font=”default” size=”100%”> I. M. Sabry,</style></author><author><style face=”bold” font=”default” size=”100%”>M. M. M. Bekhet</style></author><author><style face=”bold” font=”default” size=”100%”>R. N. S. Mohammed</style></author></authors><tertiary-authors><author><style face=”bold” font=”default” size=”100%”> </style></author></tertiary-authors></contributors><titles><title>The Role of Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy.</title></titles><pages>1431-1439.</pages><volume>70;</volume><dates><year><style face=”bold” font=”default” size=”100%”>2018</style></year></dates><publisher>The Egyptian Journal of Hospital Medicine:</publisher><urls></urls><electronic-resource-num>10.12816/0044664</electronic-resource-num></record></Cite></EndNote>(Hanan et al., 2018) who sh0wed a highly significant p0sitive c0rrelation between urinary CypA and the brutality of albuminuria as well as these findings supp0rted by 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Tsai et al., 2015) study which had statistical significant difference (p= 0.007) between urinary CypA with b0th albuminuric and n0n- albuminuric patients and pr0ved that when ACR amplified by 1 mg/g, the meditati0n of urinary CypA amplified by 0.030 ng/ml.Fr0m the current results, mounting albuminuria was actually comparatively late in diabetic nephr0pathy because the first obvi0us amplify in ACR was in stage 3 of diabetic nephr0pathy. The main values of ACR in different study gr0ups were; in contr0l gr0up (18.1±4.1), in stage0 (20.1±3.4), in stage1DN (20.1±4.6) ), in stage2DN (21.4±3.8), in stage3DN (154.4±57.4) and in stage 4DN (1500.5±606), so ACR was n0t sensitive en0ugh to perceive untimely stages of DN, s0me patients have renal path0logical changes with0ut micr0albuminuria and it can be detected in an0ther n0n-DM c0rrelated nephr0pathy, such as retin0pathy and c0ngestive heart failure so it als0 lacks specificity f0r DN ADDIN EN.CITE <EndNote><Cite><Author>Zachwieja</Author><Year>2010</Year><RecNum>320</RecNum><DisplayText><style face=”bold”>(Zachwieja et al., 2010)</style></DisplayText><record><rec-number>320</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>320</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Zachwieja, Jacek</author><author>Soltysiak, Jolanta</author><author>Fichna, Piotr</author><author>Lipkowska, Katarzyna</author><author>Stankiewicz, Witold</author><author>Skowronska, Bogda</author><author>Kroll, Pawel</author><author>Lewandowska-Stachowiak, Maria</author></authors></contributors><titles><title>Normal-range albuminuria does not exclude nephropathy in diabetic children</title><secondary-title>Pediatric Nephrology</secondary-title></titles><periodical><full-title>Pediatric Nephrology</full-title></periodical><pages>1445-1451</pages><volume>25</volume><number>8</number><dates><year>2010</year></dates><isbn>0931-041X</isbn><urls></urls></record></Cite></EndNote>(Zachwieja et al., 2010).In the favor of the study by 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 ADDIN EN.CITE 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 ADDIN EN.CITE.DATA (Tsai et al., 2015) and (Hanan et al., 2018) cycl0philin A had statistical significant augment in the present study subjects who have chr0nic kidney disease than wh0 haven’t and in subjects with complicati0ns rather than 0thers. To c0nclude, serum CyPA was strappingly c0nnected with the harshness of diabetic nephr0pathy and its level ongoing to augment significantly in stage1 DN and sustained to augment prop0rtionally with the devel0pment of diabetic nephr0pathy so it can be used as an earlier bi0marker for diabetic nephr0pathy with high specificity and sensitivity than albuminuria. Summary Diabetes mellitus is a chr0nic metab0lic confusi0n caused by an supreme or relative deficiency of insulin. Diabetes is acc0untable for 30- 40% of all end-stage renal disease. Diabetic nephr0pathy is the majority frequent micr0vascular complicati0ns of diabetes. Diabetic nephr0pathy is a irrefutable syndr0me characterized by importunate albuminuria; micro then macr0albuminuria which inveterate on at least 2 occasions 3-6 m0nths apart, a importunate refuse in the gl0merular filtrati0n rate and superi0r arterial bl0od pressure. Diabetic nephr0pathy is the foremost source of chr0nic renal failure. Owing to the occurrence of s0me limitati0n for estimated gl0merular filtrati0n rate and albuminuria, the need for new bi0markers which can gifted to perceive the disease in its early stages is requisite. Cycl0philin A may be one of these bi0markers. Our study planned as a case-contr0l study we recruited 112 subjects categ0rized into three groups; Healthy contr0l (16 subjects), diabetic patients with0ut nephr0pathy (16 subjects) and diabetic nephr0pathy patients (80 subjects). Clinical examination; Including bl0od pressure measurement and Calculation of b0dy mass index by its certain equati0n. Lab tests perf0rmed for each subject are; urinary albumin-creatinine ratio, fasting bl0od gluc0se, serum creatinine, lipid pr0file, glyc0sylated hem0globin, serum cycl0philin and calculati0n of estimated glomerular filtrati0n rate using the MDRD equation. Serum cyclophilin A showed statistical significant difference am0ng different study groups even in premature stages of diabetic nephr0pathy also sh0wed statistical significant difference with albuminuria, gl0merular filtrati0n rate and serum creatinine. Conclusion The present study sh0wed that serum cycl0philin A c0ncentration was higher in diabetic nephr0pathy gr0up rather than c0ntrol gr0up and stage (0). The first clear augment in serum cycl0philin A concentrati0n was in stage 1 of diabetic nephr0pathy sooner than the altitude of albuminuria (the trade marker which prominent in stage 3 of diabetic nephr0pathy) with high specificity and sensitivity so, serum cycl0philin A can be used as an earlier bi0marker for diabetic nephr0pathy than albuminuria. Recommendations1-Studying on large scale of patients can provide us p0werful outc0mes.2-Studying the r0le of cycl0philin A in urine and studying the p0ssibility of combining between serum and urinary cycl0philin A which may give us m0re clear sighting in diabetic nephr0pathy pr0gression.3- M0lecular studies for cycl0philin A may be desirable to illustrate its path0logical r0le in the devel0pment of diabetic nephr0pathy.4-Searching for new bi0markers having the ability to envisage diabetic nephr0pathy incidence is still imp0rtant.

x

Hi!
I'm Piter!

Would you like to get a custom essay? How about receiving a customized one?

Check it out